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A number of poxviruses, including members of the genera Capripoxvirus and Avipoxvirus, 
are being developed as recombinant vaccine vectors for use in veterinary medicine as they 
have restricted host ranges and have already been used as effective and safe vaccines in 
animals for many years. But, before recombinant vaccines can be used in the field, a 
thorough knowledge of the genetic diversity and stability of field isolates is necessary. The 
first part o~ this study was therefore initiated to compare the genomes of southern African 
vaccine strain .and field isolates of the capripoxvirus, lumpy skin disease virus (LSDV). 
However, before this goal could be achieved, conditions for the growth and purification of 
LSDV virions and extraction of high quality viral DNA had to be optimised. It was found 
that propagation of LSDV at in Iamb testes (L T) or foetal bovine testes (FBT) cells, using a 
combination of Dulbecco's modified Minimal Essential Medium (DMEM) and Ham's F-12 
culture medium, resulted in a 2-3 fold increase in the yield of infectious virions when 
compared to "standard" culture conditions. Triton X-100 and ~-mercaptoethanol, used to 
release virus particles from infected cells, and a Sarkosyl (sodium lauroyl sarcosinate) lysis 
buffer (including ~-mercaptoethanol), used to lyse the virus, were found to yield the desired 
high quantity and quality of viral DNA. 
Once optimal growth and purification conditions had been determined, DNA from the four 
LSDV field isolates and the vaccine strain was restricted with the endonucleases Pst I, Eco 
RI, Hin dill and Bam HI. The resulting fragments were separated on agarose gels using field 
inversion gel electrophoresis (FIGE). Comparisons of the resulting electrophoretic patterns 
revealed a number of minor differences in the Pst I, Hin dill, Bam HI and Eco RI restriction 
profiles. The terminal Bam HI and Eco RI fragments were identified by "snap-back" analysis. 
There were a number of distinct differences in the terminal regions of the isolates. On the 
basis of the lengths of the terminal fragments, the genomes of the virulent Neethling and 
Maputo isolates appeared to be similar, as were those of the vaccine strain and Haden, but 
Gaborone was found to be unique. The terminal regions of poxvirus genomes are known to 
be the least conserved genomic regions and it is thus of interest that these regions are not 
identical for different isolates of LSDV. This genomic polymorphism may be useful in the 
future for distinguishing between field isolates and recombinant vaccines. 
Homologous recombination has been a standard technique used to introduce foreign genes 
into poxvirus genomes for the development of recombinant vector vaccines. An alternative 
v 
technique makes use of in vitro ligation to clone genes into unique or rare restriction s~tes. 
The restriction sites of a number of rare restriction-site endonucleases were mapped within 
the genome of the LSDV vaccine strain. The restriction endonucleases Sma I, Not I, Apa I, 
Nae I, Nar I, Ksp I and Bss HII were tested. The genome lacked Not I, Nar I and . Ksp I 
·· restrictior:.. :;ites, contained more th~ one Nae I and Bss IDI sit.- md ;:;iu~e SP!a ·I and Apa I 
sites. The unique Sma I and Apa I sites might prove useful for the development of a 
recombinant LSDV vaccine. 
The second part of this study was the isolation of southern African field isolates of 
avipoxviruses from wild birds and the characterisation of these isolates using restriction 
digest analysis of their DNA. Avipoxviruses have been isolated from a large number of bird 
species. A number of vaccines have been available since the 1920s with commercial vaccines 
against fowlpox virus, pigeonpox virus and turkeypox virus being readily available. Poxvirus 
outbreaks in quails and psittacines have led to renewed interest in vaccine production, as well 
as in the development of avipoxvirus-based recombinant vector vaccines. For similar reasons 
as described for LSDV, a knowledge of the genetic diversity of field isolates ofavipoxviruses 
is crucial before recombinant strains can be field tested. The DNA of an avipoxvirus isolated 
from a Rock pigeon," Columba guinea, was compared with the DNA from isolates from 
i;;:!.~c dcvc, J::.c!;..ass penguin and parrot, as well as from a local vaccine strain (Jordaan) of 
pigeonpox virus. These restriction digest patterns were compared with strains of the well-
characterised avipoxviruses, canarypox virus and fowlpox virus. The restriction patterns 
were found to be unique for avipoxviruses from each avian species and the Rock pigeon 
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A GENERAL INTRODUCTION TO POXVIRUSES: 
1.1 Introduction: 
Poxviruses are large DNA-containing animal v1ruses which infect both vertebrate and 
invertebrate hosts and were the first viruses to be visualised by light microscopy (as reviewed 
by Moss, 1990). An important characteristic of poxviruses is their ability to replicate in the 
cytoplasm of infected cells. The family Poxviridae is divided into two subfamilies, namely 
the Chcn'dopoxvirinae (vertebrate poxviruses) and the Entemopoxvirinae (insect poxviruses). 
These in turn consist of a number of genera (Table 1) (Matthews, 1982; Esposito, 1991). 
The Orthopoxvirus genus contains the two most well-known poxviruses; variola, which was 
the causative agent of smallpox and its benign relative vaccinia, which was used successfully 
as a vaccine against variola and played an important role in the global eradication of 
smallpox. Avipoxviruses have been isolated from many avian species and the type member, 
fowl pox virus, has caused considerable economic losses to the poultry industry (as cited by 
Ghildyal et a!., 1989). Capripoxviruses, which infect cattle, sheep and goats, are also 
economically important (as cited by Gershon and Black, 1988). 
A number of members of the Poxviridae occur in southern Africa. Vaccinia virus was still 
being administered here as a vaccine against smallpox until a number of years ago, when it 
was confirmed that global eradication of the disease had been successful (Moss, 1990). 
Parapoxviruses and suipoxvirus occur worldwide (Fenner eta!., 1987). Lumpy skin disease 
virus (LSDV) is the only capripoxvirus found in South Africa, although it occurs throughout 
the rest of Africa along with the other members of the capripoxvirus genus, sheeppox virus 
and goatpox virus. A vipoxviruses have been isolated from a number of species of southern 
African birds (Kow, 1992). 
The genome organisation and cell entry and exit mechanisms of vaccinia virus have been well 
studied, whereas this work is relatively new for the capripoxviruses and avipoxviruses. In 
view of this, the following sections on poxvirus structure and composition will mainly be 
discussed with relation to vaccinia virus. 
3 
TABLE 1.1 Family Poxviridae: Genera and Members 
CHORDOPGXVIRINAE CAPRIPOXVIRUS lumpy skin disease virus, goatpox 
virus, sheeppox virus 
(Vertebrate poxviruses) 
A VIPOXVIRUS fowlpox virus, pigeonpox virus 
ORTHOPOXVIRUS vaccinia virus, variola virus 
PARAPOXVIRUS Orf virus 
LEPORIPOXVIRUS Shope fibroma virus 
SUIPOXVIRUS swinepox virus 
YATAPOXVIRUS tanapox virus 
MOLLUSCIPOXVIRUS Molluscum contagiosum 
ENTEMOPOXV!RINAE A Melantha melontha 
(Insect poxviruses) B Amsacta maori 
c Chironimus b1ridus 
· (Adapted from Moss, .1990} 
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1.2 Virion structure: 
Vaccinia virions appear by electron microscopy to be brick-shaped bodies approximately 
300-400 x 170-260 nanometers (nm) (Westwood et al., 1964). Early studies of electron 
micrographs of vaccinia virus revealed the presence of two types of particles; the one form, 
thought to be the complete form, consisted of a nucleoid with surrounding envelope material 
and the other, incomplete form, consisted of envelope material with or without nucleoid 
components (Nagington and Home, 1962). Thin-sections of virions reveal a lipoprotein 
bilayer, called .the outer membrane, surrounding a central core that encases the viral DNA. 
The core is surrounded by a palisade layer of rod-shaped molecules (Dales and Pogo, 1981) 
(Figure 1.1 ). In vertebrate poxviruses, the core appears biconcave with two structures, called 
lateral bodies, nestled in the concavities. The lateral bodies are attached to the outer 
membrane and are ellipsoidal in shape (Medzon and Bauer, 1970). The outer surface of the 
outer membrane is studded with randomly arranged surface tubule elements (MW 58,000) 
which give the virion its textured surface (Stem and Dales, 1976; Dales, 1963). An 
additional lipid-bilayer, called the envelope, is most often found surrounding mature 
particles. Its presence or absence seems to depend on the specificity of the virus isolate and 
of the host cell (Payne, 1979). The outer membrane and envelope contain a number of virus-
encoded proteins, some of which are important in eliciting an immune response in infected 
hosts (Payne and Kristensson, 1985). 
1.3 Genomic structure and organisation: 
Poxvirus genomes consist of a linear, double-stranded DNA molecule which is covalently 
cross-linked at the terminals (Berns and Silverman, 1970; Gershelin and Berns, 1974; Black 
et al., 1986). These terminal sequences have been shown to contain repeat sequences which 
are inverted with respect to one another (Wittek et al., 1978). The inverted terminal repeats 
of the vaccinia virus genome are each 10 kilobases (kb) in length (Baroudy et al., 1982). 
The termini are incompletely based-paired giving rise to 1 04 base pairs (bp) inverted loops 
which are adenine and thymine (A-T) rich. They also consist of two sets of 70 bp tandem 
direct repeats. The first set, consisting of 13 direct repeats, is disrupted by a 325 bp region 








Schematic representation of a poxvirus virion. (Adapted from Dales and Pogo, 1981) 
The genomes are large [the genome length of vaccinia virus (Copenhagen) is 191.6 kb], 
potentially coding for 263 proteins greater than 65 amino acids in length (review by Johnson 
eta/., 1993 ). At least 30 of these are structural proteins, and the majority are viral enzymes 
concerned with nucleic acid synthesis and processing, e.g. a multisubunit DNA-dependant 
RNA polymerase and a DNA polymerase (Broyles and Moss, 1986; Challberg and Englund, 
1979). 
Vaccinia virus genomes were found to be considerably more divergent towards their termini 
than in their central regions. "Host-range" genes have been mapped towards the left-hand 
termini of orthopoxvirus genomes (Gillard eta/., 1985), whereas genes coding for structural 
proteins and enzymes are placed more centrally. 
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1.4 Replication of poxviruses: 
1.4.1 Virus cell entry: 
Electron micrographs revealed attachment of enveloped and non-enveloped vaccinia virus to 
the plasma membrane at the surface of the cell (Dales and Kajioka, 1964). A number of 
, mechanisms have been proposed for virus cell entry. The results of morphological studies 
suggest that vaccinia may obtain entry by endocytic mechanisms and by fusion of the viral 
envelope with the host plasma membrane. Experiments using methylamine and chloroquine 
[Iysomotropic agents (weak bases which have the ability to raise the pH of endosomes, thus 
blocking proteolysis)] showed that these agents increased the infectivity of vaccinia virus 
(Janeczko et al., 1987). Subcellular fractionation studies also revealed the absence of viral 
polypeptides from endosomes, whereas an abundance of these proteins co-migrated with the 
plasma membrane fraction. Since plaque formation is not inhibited by lysomotropic agents, 
pH-independent fusion with the plasma membrane may be the most important entry 
mechanism. 
Once inside the cell, the virus undergoes at least two discrete stages of disassembly (Pedley 
and Cooper, 1987): The first stage is associated with the loss of virion coat proteins and 
lipids, although the genome is still ·protected within the core (Holowczak, 1972; Sarov and 
Joklik, 1972). During the second stage the genome becomes accessible to DNase. · A 
putative, viral-encoded uncoating protein of 23 kilodaltons (kD) with trypsin-like activity is 
thought to be involved in uncoating (Pedley and Cooper, 1987). 
1.4.2 Gene expression: 
Almost immediately after entering the cell, and after uncoating, transcription takes place 
within the core particles producing functional and capped polyadenylated messenger RNA 
(mRNA) (Brake! and Kates, 1974). Adenosine triphosphate (ATP) .is required for the 
extrusion of transcripts into the cytoplasm where they bind ribosomes for translation. RNA-
DNA hybridisation studies revealed that about one-half of the genome is transcribed prior to 
DNA replication (review by Moss, 1990). Transcription factors have been identified which 
bind to, and initiate transcription from viral promoters (Li and Broyles, 1993). Although the 
large genomes are able to code for most of the enzymes required for gene expression, the 
host cell nucleus is required for the production of infectious virions (Yuwen et al., 1993). 
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Vaccinia virus-encoded proteins have been located in the nucleus and one of these (E3L 
gene product) is able to bind double-stranded RNA (Yuwen eta/., 1993). Viral induction of 
the synthesis of host factors has been reported (Moss and Filler, 1970). These factors are 
thought to be required for the translation of viral mRNA. During the infection cycle, 
however, the virus eventually causes the complete inhibition of host protein synthesis. 
Vaccinia virus gene expression is temporal, with classes of early, intermediate and late genes 
being identifiable (Moss, 1990). Early genes are expressed from 20-100 minutes post-
infection, intermediate genes from 100-120 minutes post-infection and after the onset of 
DNA replication, whereas late genes are expressed only after replication (140 minutes post-
infection) (Baldick and Moss, 1993). A number of regulatory mechanisms, controlling the 
switch from early to late gene expression, have been proposed (Moss, 1990). One of these 
suggests the involvement of regulatory factors which might suppress early gene transcription 
by binding to transcription factors or early gene promoters (McAuslan, 1963). In addition, 
early and intermediate gene transcripts have short half lives (30 minutes) providing the basis 
for rapid changes in gene expression (Baldick and Moss, 1993). Early protein synthesis is 
terminated once late gene products are being synthesised, unless the early genes contain late 
promoter sequences in addition to their early promoters (Cochran eta/., 1985). Late gene 
products consist mainly of structural proteins and enzymes to be packaged within the 
progeny vmons. 
The functional elements of promoter sequences are conserved between poxvirus genera; 
evidence of this is provided by recent studies demonstrating the ability of the thymidine 
kinase (TK) promoter of fowlpox virus to function in a recombinant vaccinia virus and of 
vaccinia virus promoters to function in a recombinant fowlpox virus (Coupar et al., 1990; 
Prideaux eta/., 1990). 
1.4.2.1 Early transcription: 
A class of early promoters has been identified (Davison and Moss, 1989). They are A-T rich 
and contain a critical region for activity which corresponds to the downstream site of 
transcription initiation (AAAAATGAAAAAAAA). Probably the most important enzyme 
required for transcription is the vaccinia virus RNA polymerase and subunits (Broyles and 
Pennington, 1990). Another important gene is the DNA topoisomerase (Fogelsong and 
Bauer, 1984). Inhibition of the activity of this enzyme results in inhibition of transcription 
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of viral genes from intact core particles. Vaccinia virus also codes for an early transcription 
factor (VETF) which consists of two subunits (70 and 83 kDa) and has ATPase activity 
required for early gene transcription (Broyles et a/., 1988; Broyles and Moss, 1988; Li and 
Broyles, 1993). An 85 kDa protein (called RAP94) has been identified which is tightly 
associated with the RNA polymerase, and along with the VETF is important for transcription 
of early genes. 
The 5' ends of early mRNA transcripts are capped by a viral-encoded capping enzyme (Moss 
et al., 1976) and the 3' ends are polyadenylated by a poly(A) polymerase (Nevins and Joklik, 
1977). A transcription termination factor (VTF) was found associated with the capping 
enzyme (Shuman et al., 1987). Termination signals (TTTTTNT) were discovered 20 to 50 
bp upstream of the transcription termination sites (Yuen and Moss, 1987). 
1.4.2.2 Intermediate gene transcription: 
Expression of these genes is dependant upon DNA replication and requires transcription 
factors coded for by early genes (Wright and Moss, 1989). There appear to be two classes of 
intermediate genes, viz. early intermediate (consisting of at least two genes) (Vos and 
Stunnenberg, 1988) and true intermediate (consisting of three genes coding for late gene 
transcription factors; AlL, A2L and G8R) (Baldick and Moss, 1993). The promoter 
sequences of the true intermediate genes have been found to contain two critical regions for 
gene expression (AAAT AA and T AAA) (Baldick et al., 1992). 
1.4.2.3 Late gene transcription: 
Late gene expression is dependant on replication of the viral genome (Belle Isle et al., 1981) 
and translation of the three late gene transcription factors. Most late genes occur in the 
central region of the genome and code for structural proteins and many of the enzymes 
destined for packaging within progeny virions. There are two classes of late genes; one 
which is expressed immediately after DNA replication and the other which is delayed. The 
promoter sequences of late genes consist of a critical region with the consensus sequence: 
T AAATG (Weir and Moss, 1984). 
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A major difference between early and late mRNA transcripts is thai late transcripts do not 
have defined 3' ends and continue downstream through early genes, not recognising early 
gene termination sequences (Mahr and Roberts, 1984). The 5' capped ends of the late 
mRNAs also differ from those of early transcripts (Boone and Moss, 1977) and include 
poly(A) tracts which ~·~ thcu!;;iu to be important for ribf'svmal binding (Ahn and ~!foss, 
1989). Vaccinia late transcription factor (VLTF-1), VETF and RNA polymerase have been 
identified in cell extracts purified late in the infection cycle (review by Moss, 1990a). 
Proteolytic maturation of some vaccinia virus proteins (e.g. late gene core proteins 4a, 4b 
and 25K) occurs via cleavage of precursor polypeptides (Van Slyke et a/., 1991). A 
conserved "cleavage signal" sequence (Alanine-Glycine-Alanine) has been identified. 
1.4.3 DNA replication: 
The cytoplasm, as the site for replication, is unique to the poxviruses and African Swine 
Fever virus (Dales and Pogo, 1981; Harford eta/., 1966). Most, or all, of the genes required 
for DNA replication are encoded by the virus as it is still able to replicate in enucleated cells, 
although the nucleus is required for the product;c11 ·2£' i!"'.t~ctim!s t-articies (Pennington and 
Follet, 1974; Yuwen et al., 1993). Replication begins within the first three hours after 
infection (Harford et a/., 1966). Discrete "virus factories" have been identified which are 
electron dense regions in the cytoplasm where the virus replicates (Moss, 1990). No specific 
origins of replication have been found in the genome and it is speculated that replication 
occurs via nicking of the DNA at random points, followed by self-priming and replication 
giving rise to large concatemeric-branched structures. These might be resolved into unit 
genomes at a later stage. Concatemeric forms have been isolated when inhibitors of late 
protein synthesis are added to infected cells. Resolution occurs upon reversal, however, 
indicating that the concatemers are replicative intermediates. 
A number of viral enzymes are required to facilitate the high levels of DNA synthesis. Two 
of these include the vaccinia virus single unit DNA polymerase (MW 110,000) (Charllberg 
and Englund, 1979; Traktman et al., 1984) and a DNA ligase (Moss, 1990). Another 
enzyme involved in replication is a TK enzyme. The TK is important for nucleotide 
metabolism and is thus needed early in ir.fccticn, especialiy in ncn-replicating infected cells 
with a low level of thymidylic acid. Although important, vaccinia virus can survive ~thout 
it, making the TK gene a useful insertion site for recombinant vaccine development (refer to 
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section 1.5). Other viral enzymes important for replication include a ribonucleotide 
reductase, which converts ribonucleotides into DNA precursors and a serine/threonine kinase 
(Hanham and Smith, 1992). 
Recombination of poxvims DNA has been linked w ri..piicatior·· and '·could '·explain· the 
considerable amount of variation in the terminal regions of poxvirus genomes (as reviewed by 
Buller and Palumbo, 1991 ). Genetic recombination between orthopoxvirus genomes has . 
been well documented (Ball, 1987; Sam and Dumbell, 1981) and it is thought that a member 
of the Capripoxvirus genus arose by genetic recombination between two other members 
(Gershon et a/., 1989 b). The ability of poxvirus genomes to recombine, and to replicate 
after regions of their genomes have been deleted and replaced with foreign DNA, has 
resulted in the development of recombinant vector vaccines (Taylor eta/., 1988; Cadoz et 
a/., 1992; Taylor eta/., 1992) (refer to section 1.5). 
1.4.4 Virus assembly and release: 
Many of the assembly proteins undergo proteolytic processing prior to assembly. Assembly 
is initiated in the cytoplasm and the first step is the appearance of crescent-shap~ri sb:.lls ·~1~h 
a border of "spicules" on the convex surface and granular material adjacent to the concave 
surface (Dales and Pogo, 1981 ). Evidence exists to suggest that these crescent-shaped shells 
consist of a bilayer membrane derived from the intermediate compartment between the 
cellular endoplasmic reticulum and the Golgi stacks of the Golgi apparatus (Sordeik eta/., 
1993). The spicules (MW 65,000) are thought to provide a scaffolding for the viral 
assembly (Essani eta/., 1982; Sodeik eta/., 1994). The immature envelope circularises and 
the nucleoproteins and DNA genome enter just before it is completely sealed (as reviewed by 
Buller and Palumbo, 1991). The immature virion then undergoes internal differentiation 
producing the core and lateral bodies. The surface spicules are replaced by surface tubular 
elements and the virion attains its brick-like morphological appearance. Mature virions are 
transported to the cell periphery either in vacuoles or bound in a double membrane (or 
envelope). There is much controversy over the origin of this second envelope as evidence 
exists to support an early endosomal origin (Tooze et al., 1993) and an equal degree of 
evidence exists to support a trans Golgi network origin (Schmelz, 1994). A viral-encoded 42 
kDa glycoprotein has been shown to be necessary for this second enveloping event (woiffe et 
al., 1993). Virions may also become associated with a proteinaceous A-type inclusion body 
which is thought to protect the virus from the external environment (lchihashi eta/., 1971). 
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The virions are released from the cell either by fusion of the surrounding membrane with the 
plasma membrane or via budding from the cell surface, especially at sites on the microvilli. 
1.5 Poxvirus recombinant vector vaccines: 
The introduction of recombinant vaccinia virus in 1981 provided a new strategy for vaccine 
development (Sam and Dumbell, 1981 ). A recombinant vaccinia virus expressing the 
haemagglutinin of the swine influenza virus induced immune responses when inoculated into 
cattle, sheep and poultry (Boyle and Coupar, 1986). None of these animals displayed 
disease symptoms when inoculated with wild-type swine influenza virus and there was no 
detectable spread of either recombinant or wild-type virus from the inoculation sites or to 
uninoculated animals in close proximity. 
The basic technologies used to construct vaccinia virus recombinants have been modified 
and extended to other members of the Poxviridae family, particularly members of the 
Avipoxvirus genus. Fowlpox and canarypox viruses have natural host ranges limited to avian 
species. As such, these viruses have been developed as species-specific recombinant viral 
vectors (Taylor et al., 1988; Cadoz et al., 1992; Taylor et al., 1992). In April 1983, an 
avirulent avian influenza virus appeared in the chicken population in Pensylvania and in 
November that same year a highly virulent strain appeared in turkeys in Ireland. Conversion 
to virulence was obtained by inducing a single mutation in the hemagglutinin gene. This gene 
was cloned into a non-essential region of the fowl pox virus genome and recombinant virus 
was obtained expressing the virulent form of the hemagglutinin protein. When inoculated 
into chickens, birds survived challenge with homologous or heterologous influenza viruses. 
A recombinant pigeonpox virus has also been constructed expressing the fusion glycoprotein 
of Newcastle disease virus (Letellier et al., 1991 ). The glycoprotein gene was inserted into 
the non-essential TK gene of the pigeonpox virus genome (Letellier, 1993). Chickens 
vaccinated with this construct via the follicular method induced high anti-fusion glycoprotein 
antibody titres, and good protection against challenge with virulent Newcastle disease virus 
was shown. 
As avipoxviruses do not produce infectious particles in mammalian cells, it is surprising that 
fowlpox virus has been successfully used to vaccinate non-avian species. A recombinant 
fowlpox virus expressing the rabies glycoprotein, afforded protective immunity to live rabies 
challenge in mice, cats and dogs (Taylor et al., 1988). Human trials of a recombinant 
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canarypox virus also expressing the rabies glycoprotein resulted in induction of levels of 
neutralising antibody comparable with protection in animals (Cadoz eta/., 1992). 
A number of pros and cons exist as to the use of vaccinia virus recombinant vaccines: Their 
molecular biology has been well studied and a number of selection techniques are available 
for the construction of recombinants (Moss, 1990; Merchlinsky and Moss, 1992): They 
stimulate all facets of the host's immune response (cellular and humoral) as the recombinant 
is able to replicate and present antigen to the cell surface as in a normal infection {Taylor et 
a/., 1992). The vaccines are safer than live, attenuated vaccines as convertance to virulence 
of the "protecting virus" is impossible as only a single immunogenic subunit of this virus is 
expressed. A recombinant vaccine has the potential to protect against a number of diseases 
at the same time if immunogens from more than one pathogen are cloned into its genome. 
Due to the large sizes of poxvirus genomes and their ability to package excess DNA, 
insertions of large fragments of foreign DNA is possible (Merchlinsky and Moss, 1992). 
Field trials of recombinant vaccines have already demonstrated their safety and effectiveness 
in controlling pathogens (Brochier eta/., 1991). 
On the negative side, there are concerns as to the safety of vaccinia virus recombinants in 
immunosuppressed people, as vaccinia virus has been shown to cause complications in these 
patients, although the virus rarely causes problems in healthy subjects (as cited by Cadoz et 
a/., 1992). Another problem is the possibility that a recombinant vector might recombine 
with a more virulent strain in the field giving rise to a potentially pathogenic vector virus. 
Combined with this concern is the broad host-range of vaccinia virus, making it difficult to 
control virus spread, although avipoxvirus vector vaccines have an advantage over vaccinia 
virus in this respect, as they are host-specific and are unable to replicate in non-avian cells 
(Cadoz eta/., 1992). 
The possibility of using members of the genus Capripoxvirus as host-restricted vaccme 
vectors for the expression of immunogens has been investigated (Gershon et a/., 1989a). 
Since then, a recombinant capripoxvirus, Kenya Sheep-1 (KS-1 ), expressing the 
hemagglutinin gene of the Rift Valley Fever virus, has been constructed (Romero, 1993). 
This recombinant is reported to protect cattle against challenge with virulent Rift Valley 
Fever virus. 
The alternative development of avipoxvirus and capripoxvirus recombinant vaccines has 
necessitated the further molecular characterisation of these viruses in order to ascertain their 
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potential safety and efficacy for use in the field. A thorough knowledge of the genetic 
diversity and stability of poxvirus field isolates might provide valuable information pertaining 
to the performance and stability of genetically engineered poxviruses once released into the 
field. This study was therefore initiated to compare the genomes of southern African vaccine 
and field isolates of the capripoxvirus, LSDV, and various avipoxviruses. 
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CHAPTER2 
LUMPY SKIN DISEASE VIRUS: 
2.1 Introduction 
Lumpy skin disease (LSD) was first described as a skin disease of cattle called "pseudo-
urticaria" in Zambia in 1929 (as cited by Weiss, 1968). In subsequent years the infectious 
nature of the disease was recorded after its rapid spread throughout large parts of sub-
Saharan Africa, including Madagascar. In 1957 a virus was isolated on numerous occasions 
from skin lesions of diseased cattle and, after passage in cell culture, was shown to be the 
cause of LSD. Morphological characterisation of LSDV (prototype Neethling) provided 
evidence of its membership in the Poxviridae family. LSDV is grouped with goatpox virus 
and sheeppox virus to constitute the Capripoxvirus genus (Matthews, 1982). The 
ultrastructural details seen on virions isolated in this department were very similar to those of 
vaccm1a virus, but LSDV particles were somewhat less symmetrical in shape (Fig 2.1) 
(Weiss, 1968). 
The name Capripox is derived from capri, Latin for goat, and pox, Old English for pustule or 
ulcer, and describes the symptoms exhibited by infected animals (Matthews, 1982; Weiss, 
1968). For example, cattle infected with LSDV-exhibit fever, swelling of the lymph nodes 
and raised nodules 5-50 mm in diameter on the skin covering the entire body (Erasmus et al., 
1986). The diseases induced by the capripoxviruses are a major cause of morbidity and 
mortality in sheep, goats and cattle in Africa and Asia (as cited by Gershon and Black, 
1988). Lumpy skin disease (Neethling) was first diagnosed in South Africa in 1944 and 
affected eight million cattle with up to 75% mortality on some infected premises (Thomas 
and Mare, 1945; as cited by Weiss, 1968). 
The capripoxviruses are economically the most important group of poxviruses (Kitching et 
al., 1989). Their natural host range is restricted to sheep, goats and cattle and the central 
African and Asian isolates have been designated by Gershon and Black (1987) by their 
country and animal species of origin, e.g. Kenya cattle-1 was isolated from infected cattle 
~during an outbreak of LSD in Londiani, Kenya. 
Figure 2.1 
Electron micrograph of a cluster of LSDV particles purified from infected bovine 
kidney cells. The envelope around most of the virions has collapsed to reveal the 
surface tubular structure of the outer membrane. One particle (arrow) has been 
penetrated by stain and exposes the core outline and palisade layer (X 75 000). 
(Photograph kindly supplied by Dr L.M. Stannard, Medical School, UCT) 
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Although the majority of capripoxvirus strains examined show a preference for growth in 
only one of the three host species, some strains appear to be able to naturally infect both 
sheep and goats (Davies, 1981 ). However, in South _Africa, capripoxvirus has only been 
isolated from cattle during outbreaks of LSD and has never been reported in sheep or goats 
(Thomas and Mare, 1945; as cited by Kitching et al., 1989). Strains also vary in their 
pathogenicity in different host species and in different breeds of the same animal. 
A number of successful live, attenuated vaccines have been developed to protect livestock 
from virulent capripoxvirus infections (Davies, 1976; Kitching and Taylor, 1985). A vaccine 
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was developed from the Neethling strain of LSDV in South Africa and is used to protect 
cattle from LSD. 
2.2 Genomic structure and organisation: 
The original work on the elucidation of poxvirus genomic structures and gene organisation 
was performed on the vaccinia virus genome (for a summary refer to Chapter 1). More 
recently, however, similar studies have been performed on other poxvirus genomes, including 
those of capripoxviruses (Gershon and Black, 1987). Summation of the DNA restriction 
fragments generated by Hin dill digestion of a cattle isolate from Kenya, Kenya cattle- I 
(KC-1), yielded a genome length of 145.6 kbp (Gershon and Black, 1987). A later re-
estimation of the size of this genome, including isolates from sheep (India sheep-1) and goats' 
(Iraq goat-1), using pulse field gel electrophoresis yielded a genome length of 148 kbp for 
each isolate. These are much shorter than the genome lengths of orthopoxviruses and 
avipoxviruses, but are similar in lengths to the genomes of a number of parapoxviruses 
(Robinson et al., 1987). 
As observed for orthopoxvirus genomes, the termini of the KC-1 genome were shown to be 
covalently cross-linked (Gershon and Black, 1987). These terminal sequences have been 
shown to contain repeat sequences which are possibly inverted with respect to one another. 
The lengths of the terminal repeats of India sheep- I DNA were determined to be between 
2.25 and 3.40 kbp (Gershon and Black, 1988) and were shown to be inverted with respect to 
one another. Four tandemly repeated 81 - 82 bp elements were identified within these 
inverted terminal repeats (Gershon and Black, 1989). 
A comparison of the whole genome organisation of a capripoxvirus [Kenya sheep-1 (KS-1)] 
with an orthopoxvirus (vaccinia WR) using cross-hybridisation revealed a similar pattern of 
gene arrangement as observed within the Orthopoxvirus genus (Esposito and Knight, 1985; 
Gershon et al., 1989). In general, poxvirus genomes are considerably more divergent toward 
their termini than in their central regions. "Host-range" genes have been mapped towards the 
left-hand termini of orthopoxvirus genomes (Gillard eta/., 1985) and it is thus possible that a 
similar set of genes are contained within the termini of capripoxvirus genomes. Thus, the 
central regions of KS-1 and vaccinia virus genomes are conserved, however, the terminal 
regions of vaccinia virus contains approximately 45 kb of DNA which is absent from the 
genome of KS-1. A number of open reading frames (ORFs), including one coding for a TK 
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gene, are shared between KS-1 and vaccinia virus genomes, although the KS-1 genome 
contains one complete ORF in a centrally placed, conserved region, which is absent from the 
DNA of vaccinia virus and fowlpox virus, but is present downstream of the TK gene of 
Shope Fibroma virus DNA (Gershon and Black, 1989). 
2.3. Characterisation of capripoxviruses 
The agar gel immunodiffusion test {AGID) has been used to demonstrate the serological 
relationship between members of the orthopoxvirus group, the avipoxvirus group and the 
capripoxvirus group (as cited by Kitching et a/., 1986). Kitching et a/. (1986) used 
[35S]methionine-labelled viral antigen to improve the sensitivity of this test during their 
attempt to distinguish individual members of the Capripoxvirus genus. However, it was 
found that the AGID test could not be used to distinguish between the different members as 
isolates of sheeppox virus, goatpox virus, sheep-and-goatpox virus and LSD virus all share a 
common major precipitating antigen as revealed by polyacrylamide gel electrophoresis. It 
was also found that this antigen cross-reacted with sera taken from a lamb recovering from 
contagious pustular dermatitis virus (a parapoxvirus). These results indicated that the AGID 
test was not suitable as a diagnostic tool for capripoxvirus infection. 
Restriction endonucleases have been successfully used to distinguish members of closely 
related orthopoxviruses and parapoxviruses (as cited by Black et al., 1986). This technique 
has also been used on capripoxviruses (Black et a/., 1986; Gershon and Black, 1987; 
Gershon and Black, 1988). Hin dill restriction digest patterns of a number of strains of 
capripoxvirus from sheeps, goats and cattle have confirmed the close degree of relatedness of 
this poxvirus group as evidenced from the AGID test (Kitching eta/., 1986; Gershon and 
Black, 1988). 
Gershon and Black (1988) found that the capripoxvirus genomes differ from one another in 
length by not more than 2 kb with an average genome length of 148 kb (Black et a/., 1986; 
Gershon and Black, 1988; Gershon and Black, 1987). The South African vaccine strain of 
LSDV has, however, been accurately sized at 152.6 kb and differs from the Kenyan isolate in 
three Hin dill fragments (Black eta/., 1986; Gershon and Black, 1988; Perlman, 1993). Pst 
I, Sal I and Ava I restriction site maps of a number of isolates of capripoxvirus have also 
been constructed (Fig. 2.2) (Gershon and Black, 1988; Perlman, 1993). These maps indicate 
that the South African LSDV vaccine strain shares a number of Ava I and Pst I restriction 
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sites with KC-1, although the Sal I maps are quite different. It thus appears that at least 
these two isolates are genetically distinct and raises questions as to the evolution of LSD 
virus (or viruses) as it has only been reported in cattle over the last 65 years (as compared to 
sheep and goat pox which has been known for centuries) and appears to be maintained in 
wild buffalo populations (Davies, 1982; as cited by Kitching eta/., 1989). 
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FIGURE 2.2 
Genomic maps of capripoxvirus isolates. Pst I, Ava I and Sal I maps of India 
Sheep-1 (InS-1), Kenya Cattle- I (KC-1), Iraqi Goat-1 (IrG-1) (A) and the South 
African vaccine strain of LSDV (B). (From Gershon and Black, 1988; Perlman, 
1993). Note that the maps in A are reversed in respect to the maps in B. 
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Analysis of the Hin dill restriction digest patterns of capripoxviruses have indicated that 
isolates from sheep and cattle are more closely related to one another than either are to goat 
isolates (Gershon and Black, 1988). These results in tum suggest that, if the capripoxviruses 
diverged from a common ancestor, the sheep and cattle isolates diverged from the goat 
isolates prior to diverging from one another. 
Hin dill restriction digest patterns of Kenya sheep isolates were found to be very similar, 
whereas when these patterns were compared with typical sheep isolates from other countries, 
e.g. Nigeria, India and Iraq, larger differences were observed (Gershon and Black, 1988). In 
fact, the Kenyan isolates were found to be more closely related to capripoxvirus isolates 
taken from Oman (sheep) and Yemen (goats) (Kitching eta/., 1989). 
On the basis of these criteria, capripoxviruses can be divided into 5 groups: group 1 isolates 
are only isolated from sheep (e.g. India sheep-1 ), group 2 isolates are only isolated from 
goats (e.g. Iraq goat-1 ), group 3 isolates are isolated from sheep, goats and cattle, but are 
restricted to Africa (e.g. Kenya cattle-1 ), group 4 isolates are isolated from either sheep or 
goats in Africa or the Middle East (Gershon eta/., 1989 b) and group 5 isolates are isolated 
only from cattle in southern Africa [e.g. LSDV (Neethling)]. 
2.4 Epidemiology and Transmission: 
LSD first appeared in Zambia in 1929 (as reviewed by Woods, 1988). Fourteen years later it 
appeared in Bechuanaland (Botswana) and soon spread throughout the country. LSD 
appeared in the Marico District of the Transvaal, South Africa in 1944 (Thomas and Mare, 
1945; as cited by Weiss, 1968). Due to the extensive transport and communications network 
within South Africa, the disease had developed into an explosive epidemic within three years 
(as reviewed by Woods, 1988). It remained enzootic (potentially infectious, but stable in 
animal hosts). The disease then spread slowly north, probably through Mozambique and 
Tanganika (Tanzania), with an outbreak occurring in Kenya in 1957 with only 10 LSD 
associated deaths. By 1970 the disease had spread north into Sudan and then west into 
Nigeria in 1974, and Mauritania in 1977 ( as cited by Kitching eta/., 1989). In 1981 a new 
epizootic ofLSD was reported, which between 1981 and 1986 had affected Tanzania, Kenya, 
Zimbabwe, Somalia and the Cameroons. LSD was reported in Egypt in 1988 and was first 
reported outside of Africa in Kuwait in 1986, and in 1989 LSD was reported in Israel (Ali et 
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a/ , 1990: as reviewed by Cam. 1993 ) Figure 2 . 3 shows the distribution of LSDV in Africa 
and Israel 
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A vaccine was prepared from the South African Neethling isolate of LSDV and has been in 
use for many years (as cited by Weiss. 1968). Although sporadic outbreaks of LSD have 
occurred within the last fifty years in South Africa, a major outbreak was reponed in 1990 
(Dumbell. personal communication ), suggesting that even though there is an effective 
vaccine. improper or inadequate use is made of the vaccine . 
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A characteristic of the epidemiology of LSD is the appearance of the disease in epizootics 
(major outbreaks of viral infection in animal hosts) which appear to spread north from 
southern Afiica. Epidemic behaviour of LSD has been shown to be associated with certain 
climatic conditions, such as prolonged, or heavy rains which are considered to favour an 
increase -in the insect populi1.tion. Davies ( 1982) stuc! i -~d the distribution of LS.C m K~nya 
and discovered that the highest incidence of the disease occurred in forests or at forest 
edges in a fairly high rainfall zone at 1000 - 2500 m above sea level. The virus is thought to 
be transmitted during the epidemics by biting insects, but their exact identity remains 
unknown. Weiss (1968) reported the isolation of LSDV from Stomoxys ca/citrans and 
Biomyia fascia/a and yet experimental transmission from these insects to cattle . failed. 
Kitching and Mellor (1986) successfully transmitted Yemen-goat capripoxvirus between 
sheep using Stomoxys ca/citrans as a vector. They were unable to achieve transmission using 
other Arthropod species, although they were able to isolate virus from sheep head flies 
(Hydrotaea irritans). Although cattle produce local reactions when inoculated with 
sheep pox or goat pox virus isolates, no natural transmission of these viruses to cattle has been 
reported, even when cattle were maintained in close contact with infected flocks in Kenya 
(Davies, 1981). 
Antibodies to LSDV have been found in Afiican buffalo, Syncersus caffer, and it is probable 
that they are the long-term maintenance hosts for the virus. Davies (1982) suggested that 
epizootics occur when the virus spreads from buffalo into a sufficiently large susceptible 
cattle population. Experimental transmission of LSDV (Neethling) to game animals, 
including giraffe, impala, buffalo and wildebeest, resulted in the deaths of the impala and 
giraffe (Young eta/., 1970). They exhibited typical symptoms and lesions associated with 
the disease and virus was successfully isolated from them. Neither the wildebeests or the 
buffaloes reacted clinically and they also failed to develop antibodies to LSDV. 
2.5 Disease symptoms induced by LSDV: 
Two viruses have been shown to cause lumpy skin disease-like symptoms in cattle (Weiss, 
196R)_ !\.!.i. l1ough the poxvirus, L~DV (Neethling), is generally associated with true lumpy 
skin disease, another virus, the Allerton herpesvirus, produces similar symptoms under field 
conditions (Prozesky and Barnard, 1982). Cattle infected experimentally with Allerton or 
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LSD (Neethling) viruses produced symptoms which, although similar, were distinguishable 
on the basis of lesion appearance and spread (Capstick, 1959). LSD is characterised by 
fever, swelling of the lymph nodes and large nodules in the skin over the whole body 
(Erasmus et a/., 1988). Soft yellow-grey nodules and ulcers also occur in the mucous 
membranes of the •llOU •• , nuse, n,sr iratory tract an:i the reproductive orga.:r:ts and 
subcutaneous swellings of the legs are often seen (Figure 2.4 A). Seven to ten days after 
their first appearance, the nodules start to break away and form scabs which ultimately fall 
off Early rejection of the skin lesions due to secondary bacterial infection often leaves 
purulent, raw ulcers and abscesses (Figure 2.4 B). The disease causes appreciable 
economic losses due to emaciation (excessive loss in weight), temporary and even permanent 
loss of milk production, sterility in bulls and damage to the hide (Green, 1959). 
FIGURE 2.4 . A 
A cow infected with LSDV and displaying raised nodules covering the entire body. 
(Photo kindly supplied by Onderstepoort Veterinary Institute, Pretoria) 
FIGURE 2.4 B. 
A close-up view of a disrupted ulcer on the hide of a cow infected with LSDV. 
(Photo kindly supplied by the Onderstepoort Veterinary Institute, Pretoria) 
2.6 Control of LSDV: 
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As previously mentioned, certain strains of capripoxvirus infect more than one of the three 
natural hosts (Kitching and Taylor, 1985). Sheep, goats and cattle that have recovered from 
infection with capripoxvirus isolates from a heterologous host (i .e. one of the three hosts 
which is not a natural host for that isolate) are immune to challenge with virulent, 
homologous virus (Kitching, 1986a; Kitching, et a/. , 1987). This characteristic of some 
capripoxvirus isolates has been successfully used in producing vaccines to control LSD, 
goatpox and sheeppox. Davies (1976) isolated capripoxvirus from a sheep (strain 0180) and 
from a goat (strain F53) in a group in which both sheep and goats were clinically infected 
with capripoxvirus (Kitching et al. , 1987). A second sheep isolate (0240) was collected later 
in the same outbreak. Davies attenuated the 0180 strain by 18 passages in bovine foetal 
muscle cells to produce a vaccine which is used in Kenya to protect sheep and goats against 
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Kenya sheeppox and goatpox, and cattle against LSD. The 0204 strain was passaged five 
times in lamb testes cells and inoculated intradermally into British sheep and goats. Only a 
mild local reaction resulted, without pyrexia, and the vaccine was shown to protect sheep and 
goats against challenge with virulent capripoxvirus isolates collected in Nigeria and India 
(Kitching and Taylor, 1985). 
In South Africa, a LSD vaccine was developed at the Veterinary Research Institute, 
Onderstepoort. The vaccine was prepared in cell culture from a capripoxvirus strain 
(Neethling) that was attenuated through passage in embryonated eggs (as reviewed by 
Erasmus et al., 1988). The live virus is freeze-dried and thoroughly tested to ensure it 
conforms to standards of safety and efficacy. The freeze-dried vaccine is stable and the 
efficacy is maintained for at least one year if stored at 4 °C. Calves acquire an immunity to 
LSD for up to six months of age from maternal colostrum of cows which have been 
previously immunised or which have recovered from the disease (Erasmus et al., 1988). After 
six months, the calves are susceptible and must be vaccinated. The vaccine is administered as 
an injection and a single dose provides full protective immunity. 
Under specific circumstances there could be considerable advantages to a dead vaccine, such 
as safety, stability in high ambient temperatures and its use in animals intended for export 
from capripoxvirus-free to capripoxvirus-enzootic areas (as cited by Kitching, 1983). 
However, numerous attempts to replace live capripoxvirus vaccines with dead preparations 





Avian poxvirus diseases have caused appreciable economic losses in poultry and in game 
birds such as quails (as cited by Winterfield and Reed, 1985). More recently, poxviruses 
have been identified in other bird species such as psittacines. As early as 1873, when 
Bollinger described the pathology of fowl pox, he mentioned the susceptibility of pheasants 
to the causative agent (as cited by Kirmse, 1969). Experimental transmission of avian 
poxviruses, especially fowlpox, to non-host wild bird species revealed differences in the 
degree of susceptibility of the non-host species to infection (Kirmse, 1969). This 
phenomenon has been used in the production of commercial vaccines such as a fowlpox virus 
vaccine being derived from a pigeonpox virus isolate (as cited by Ogawa et a/., 1993). 
Mc;.mmals inoculated with fowlpox virus showed no evidence of clinical dist;;as~ ili.i.G to dz.te 
no mammalian cells have been able to support a productive infection of avian poxviruses 
(Taylor et a/., 1988). Thus certain avipoxviruses have been studied in great detail in recent 
years, both for their ability to cross-protect other avian species and for their development as 
potential recombinant vector vaccines (Winterfield and Reed, 1985; Taylor eta/., 1988). 
3.2 Genomic structure and organisation: 
As was the case with capripoxviruses, the genome structure and organisation of 
avtpoxviruses have only recently been studied. The genome of fowlpox virus (the 
a vi poxvirus type species) has been the most extensively studied and will therefore be 
reviewed as a representative of avipoxvirus genomes. 
It has been shown that the fowlpox virus genome is composed of a single, double-stranded 
D!'LA, molecule with covalently linked terminal hairpins. The g~norr.c is approximateiy 300 
kb in length and consists of a 35 % guanine and cytocine (G+C) content (Szybalski eta/., 
1963; Coupar et al., 1990). 
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A number of genomic regiOns of fowlpox virus have been sequenced and have been 
compared with vaccinia virus. Regions have been identified containing ORFs similar to 
those found in vaccinia virus, as well as ORFs which appear to be unique to fowlpox virus 
(Tartaglia eta!., 1990; Coupar eta!., 1990). Analysis of the fowl pox virus 3.1 kbp and 6.1 
kbp Bam ID fragments revealed extensive conservation between these fragments and the Hin 
dill J fragment of vaccinia virus (Binns et al., 1988). A TK gene, located on the Hin dill J 
fragment of vaccinia virus, was however lacking. The fowlpox virus TK gene was mapped 
within the centrally placed Pst I D region of the fowlpox virus genome (Boyle et al., 1987; 
Coupar et al., .1990). 
A 11.2 kbp Bam ID fragment of fowlpox virus was mapped towards one of the termini. 
This fragment was found to contain a number of ORFs which share homology with three 
predicted gene products of vaccinia virus, viz. the 42K early gene product, the 32.5K host 
range gene product and the 38K haemorrhagic gene product (Tomley et al., 1988). 
Tartaglia et al. (1990) sequenced and analysed the ORFs contained within a 10.5 kbp Hin 
dill fragment of fowlpox virus and compared these ORFs with those found in the central 
portion of the vaccinia virus Hin dill D region. Ten ORFs were identified, with eight of 
these being completely contained within the fragment. Five were found to share a high 
degree of sequence conservation at the amino acid level with vaccinia virus ORFs D4, D5, 
D6, D7 and D9 and the other five were found to be unique for fowlpox virus. Experiments 
have suggested that the shared vaccinia virus ORFs are essential for DNA replication. 
Putative promoter elements and early transcription termination sequences were identified 
within the 10.5 kbp fragment, suggesting that fowlpox virus genes are also temporally 
regulated. 
As avipoxvirus genomes are much larger than those of other poxviruses, it is possible that 
they code for more proteins, or that a larger genome is required for other, as yet unknown, 
functions for expression in avian cells (Tartaglia et al., 1990). 
3.3 Characterisation of avipoxviruses: 
Early attempts to differentiate avian poxviruses were made on the basis of host susceptibility, 
lesion characteristics on the dermal epithelium, growth on chorioallantoic membranes, cross-
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protection, cross-neutralisation, complement fixation, agar-gel precipitation and passive 
hemagglutination tests (as cited by Tripathy et al., 1973). Antibody responses from the latter 
I 
tests indicated that fowlpox virus was more closely. related to turkeypox virus than to either 
pigeonpox or canarypox viruses (Tripathy et al., 1973). Canarypox virus isolated from wild 
passerines (e.g. canaries and sparrows) proved to be highly virulent when inoculated into 
higher passerines and relatively inocuous in chickens, turkeys and pigeons (Giddens et al., 
1971). These results suggest that canarypox virus is quite distinct from fowlpox, turkeypox : 
and pigeonpox viruses. 
More recently, however, restriction enzyme analysis of viral DNA has been successfully used 
to distinguish avipoxvirus isolates. The genomes of fowlpox virus, pigeonpox virus, 
quailpox virus and other avipoxviruses, including canarypox virus have been characterised 
using Bam HI, Eco Rl and Hind III endonucleases (Ghildyal et al., 1989; Schnitzlein et al., 
1988): Their results indicated that fowlpox virus, juncopox virus and pigeonpox virus are 
very closely related to each other with a probable sequence homology of greater than 80% 
(Ghildyal et al., 1989). Quailpox virus, however, produced patterns distinct from the other 
species. When the immunogenic proteins were examined by immunoblotting, common as 
well as unique antigens were detected (Ghildyal et al., 1989). As expected, the greatest 
disparity was between quailpox virus and the other three avipoxvirus species. These results 
are in agreement with cross-protection studies whereby pigeonpox virus has the ability to 
cross-immunise chickens against fowlpox virus,- but not against quailpox or turkeypox viruses 
. ' 
(Winterfield and Reed, 1985; as cited by Schriitzlein et al., 1988). 
3.4 Epidemiology and transmission 
The avipoxviruses have been a successful genus in terms of their global distribution. They 
have been isolated from a vast number of avian species including most wild and domesticated 
birds (as cited by Kirmse, 1969; Giddens et al., 1971; Winterfield and Reed, 1985). 
Although limited to replication in avian species, a number of avipoxviruses are able to 
naturally infect more than one avian host (Giddens et al., 1971). 
Mechanical, aerosol and insect transmission of poxviruses has been reported and insect 
transmission of avipoxviruses has been documented (Kitching and Mellor, 1986; as .cited by 
Warner, 1968; Taylor et al., 1988). The natural modes of transmission of avipoxviruses 
are, however, still unclear. Birds often preen themselves and each other and many sleep with 
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their heads folded under their wings (personal observation). They also clean their beaks 
against branches and often share a favourite perching and roosting branch with other birds. 
These behavioural traits could result in mechanical and/or aerosol transmission of . . 
avipoxviruses and could explain the occurrence of pox lesions frequently associated with 
specific regions on birds (Figure 3.1 ). It is thus probable that all three modes of 
transmission are responsible for the spread of avipoxviruses. 
3.5 Disease characteristics induced by avian poxviruses: 
Fowlpox virus, pigeonpox virus and turkeypox virus usually cause a cutaneous disease of 
high morbidity, but ofvariable mortality (as cited by Giddens eta!., 1971). Large pocks with 
umbilicated centres form on the skin of fowlpox virus infected birds and are normally 
accompanied by lesions in the upper respiratory and digestive tract (as cited by Mockett et 
a/., 1987). The cutaneous lesions change from the initial papules to vesicles, then to 
pustules before finally forming a scab. The scab sloughs off releasing virus particles in 
intracellular inclusions which are available for transmission to other birds (as cited by 
Mockett et a/., 1987). Within the cutaneous lesions, which are generally confined to the 
epidermis, occur epithelial cells with pronounced hypertrophy and hyperplasia (Giddens et 
a!., 1971). The cytoplasm of these cells often contains Bollinger bodies, which are large 
eosinophilic inclusions composed of clusters of viral particles. Canarypox, however, 
produces a different intracellular disease scenario (Giddens eta/., 1971): The cytoplasmic 
inclusion bodies found in epithelial cells associated with canarypox are not as common or as 
distinct as the Bollinger bodies associated with fowlpox (Giddens eta/., 1971). This made 
early diagnosis· of canarypox difficult. 
During a study of wild birds naturally infected with canarypox virus, lesions were most 
commonly observed as a proliferative dermatitis around the eyes and/or base of the beak 
(Giddens eta/., 1971). The second most frequent location of lesions was in the skin of the 
axillary and upper pectoral regions beneath the folded wings. Often lesions of the breast 
were accompanied by multifocal papules on the legs. Post-mortem investigations of infected 
birds revealed lesion development in the respiratory tract. Complications associated with 
secondary bacterial or mycotic infection have been described when comparing the 
progression of natural poxvirus infection (Giddens eta/., 1971). Wild passerines, which were 
infected experimentally with canarypox virus, developed lesions five days afer inoculation 
(Giddens eta/., 1971). All infected birds were dead within 16 days post-inoculation. 
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FIGURE3 .1 A 
Lesions around the beak of a racing pigeon recovering from poxvirus infection. 
FIGURE3 .1 B 
Large pock covering the entire left eye of a juvenile Rock pigeon. 
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3.6 Control of aviooxviruses: 
Fowl pox is one of the oldest known viral diseases affecting avian species and has been 
responsible for major economic losses to the poultry industry (as cited by Ghildyal et al., 
1989). Since the 1920's vaccination with a live attenuated fowlpox virus vaccine was found 
to be an effective method for control of this disease. Although fowlpox occurs wotld-wide, 
judicious farming practice, including vaccination and the use of insect-proof housing, has 
brought the disease under control. The vaccine is administered to day-old chicks as a web 
wing puncture.( as cited by Taylor and Paoletti, 1988). Older birds are re-vaccinated before 
laying commences. The vaccine usually consists of a mild naturally occurring strain or a 
strain attenuated by serial passage. In some countries attenuated strains of pigeonpox virus 
are used to vaccinate fowl against fowlpox (as cited by Taylor and Paoletti, 1988). 
Commercial vaccines have also been available for the control of pigeonpox (as cited by 
Ghildyal et al., 1989). In host-specificity studies, Kirmse ( 1969) found that pigeon pox virus 
failed to produce disease symptoms when inoculated into other wild and domestic birds, 
indicating a high degree of host specificity, although no attempts were made to infect other 
wild species of the Columbidae, which are known to be susceptible to avian poxviruses. 
Kirmse also noted partial immunity in pigeons infected and re-exposed to a highly virulent, 
monopathogenic pigeonpox strain (Kirmse, 1969). Some ofthe pigeons developed localised 
primary lesions when re-challenged three months after the initial lesions had disappeared. It 
was recorded in 1906 that pigeons recovered from pigeonpox were fully protected against re-
infection, but that protection was of short duration (as reviewed by Kirmse, 1969). In some 
cases re-infection was possible after two me chs, but other pigeons were still immune after 
four to five months. A pigeonpox vaccine for use in racing pigeons in South Mrica has been 
produced from a local pigeonpox virus strain (Jordaan) at the Onderstepoort Veterinary 
Research Institute (Erasmus et al., 1988). As a result of the short term immunity afforded 
by pigeonpox, immunisation with the vaccine is recommended annually. 
Winterfield and Reed ( 1985) tested a number of avipoxviruses in host and non-host species as 
potential vaccines. They found that quails, chickens and turkeys vaccinated with pigeonpox 
and fowlpox viruses were not protected against challenge with quailpox virus. When quails 
and chickens were vaccinated with quailpox virus and given ptgeonpox and fowlpox 
challenge viruses, no protection was provided. 
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Clinical epomitics ~f pox have recently been diagnosed in psittacines (as cited by Winterfield 
and Reed, 1985).- Psittacinepox virus applied as a vaccine in quail and chickens also failed to 
protect against quailpox virus challenge. However, quails, chickens and turkeys vaccinated 
with quailpox virus were protected against quailpox virus challenge. An isolate of 
psittacinepox virus, applied as a vaccine, protected chickens against challenge with the same 
virus isolate and also against challenge with two other psittacinepox virus isolates. When 
combined in a multivalent vaccine, quailpox, psittacinepox and fowlpox viruses induced 
excellent protection in chickens against challenge with the three respective viruses. From 
these studies it was concluded that quailpox virus had little, or no immunologic relationship 
to fowlpox, pigeonpox or psittacinepox viruses. Nor does it appear that psittacinepox virus 
has any antigenic relationship to fowlpox or pigeonpox viruses (as cited by Winterfield and 
Reed, 1985). 
SECTION2 
CHARACTERISATION OF SOUTHERN AFRICAN 
ISOLATES OF LSDV 
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CHAPTER4 
DEVELOPMENT OF AN ACCURATE INFECTIVITY ASSAY FOR LSDV: 
4.1 INTRODUCTION: 
It was an important aim of this study to compare vaccine and field isolates of LSDV using 
restriction endonuclease digestion of viral DNA. LSDV does not reach the high titres 
experienced with other poxviruses, such as vaccinia virus when grown in cell culture 
(Esposito, 1981; Black, personal communication). Thus, before viral DNA could be isolated 
and subjected to molecular analysis, it was necessary to establish optimal conditions for the 
propagation and purification of LSDV. An accurate technique for determining the exact 
concentration of infectious virions had to be developed before optimal growth and 
purification conditions could be assessed. Infectivity assays were conducted in three different 
types of cells. 
4.2 MATERIALS AND METHODS: 
4.2.1 Cells us·ed for infectivity assays: 
A continuous cell line of bovine kidney cells [MDBK: American type culture collection 
(ATCC) catalogue, reference certified cell line (CCL) 22] were obtained from stocks 
maintained in liquid nitrogen (passage no. 186) in the Department of Medical Microbiology, 
UCT. DNA-fluorescence staining of these cells revealed the presence of mycoplasma. 
These were eliminated by six passages of the cells in the presence of a combination of 
. antibiotics (tradename BM-Cyclin, Boehringer Mannheim, Germany). 
Primary calf foetal kidney (CFK) and lamb testes (LT) cells were prepared as described 
below (4.2.3). 
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4.2.2. Sterile technique used for cell culture <Freshney. 1987): 
A laminar flow hood (Laminaire, Model-4BH, Bino Instrumentation, Bellville, South Africa) 
was used at all times when dealing with culture cells or related chemicals (e.g. antibiotics). 
The following sterile. technique was adopted: 
The hood was kept free of extraneous items and the circulator fan was switched ·on at all 
times. The interior was irradiated with ultra-violet (UV) light for at least 10 minutes before 
the hood was to be used. The working surface inside the hood was cleaned thoroughly with 
70% EtOH. All items to be used inside the hood were also cleaned with 70% ethanol 
(EtOH) before being returned to the hood. To ensure sterility, the operator's hands and arms 
were washed with soap and water and then with 70% EtOH. After work had been completed 
in the hood, all movable items were removed, the working surface was again washed with 
70% EtOH and irradiated with UV light for at least 1 0 minutes. 
4.2.3. Primary cell culture preparation: 
Various techniques are available for producing primary cell cultures from animal tissue (Paul, 
1972; Freshney, 1987) with the main variables being the source and type of animal tissue, the 
percentage of trypsin used and the temperature at which the tissue is trypsinised. A number 
of these techniques were tested and the following method was found to yield the most 
consistant and best cell growth: 
Fresh foetal Iamb or calf tissue was obtained from the State Abbotoir (Maitland, Cape 
Town) and placed in ice-cold phosphate buffered saline (PBS) (Appendix I) with Penicillin-
Streptomycin (PS) (2X) (Appendix 1). The kidneys or testes were washed in PBS (with 2X 
PS) in the laboratory and the outer connective tissue was removed using. scissors and sterile 
technique. The tissue was then washed in PBS (with 2X PS) and cut up finely using two 
scapel blades. This tissue was placed in PBS (with 2X PS) and left on ice for 10 minutes (or 
longer if it contained a large quantity of blood). It was transferred to a small conical flask 
containing a magnetic bar and 1 %trypsin (Appendix 1) was added to just cover the tissue. 
This flask was heated to 30 °C and placed on a magnetic stirrer (Fried Electric, Haifa, Israel) 
to stir at 200 revolutions per minute (rpm) at room temperature for 30 minutes. This trypsin 
was discarded, replaced with fresh trypsin and the stirring was repeated as before. After 30 
minutes the trypsin (containing digested tissue and single cells) was removed and fresh 
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trypsin was added to the remaining tissue. The stirring was repeated and in the meantime the 
trypsinised tissue was diluted 1: 1 in diluent, consisting of 10 mM N-2-
Hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES) and Dulbecco's modified 
Minimum Essential Medium (DMEM) (pH 7.4) (Appendix 1). The cells were pelleted in a 
Si~rna 301K benchtop cer~trifuge (Sigma, Germany)~~-: 1000 rpm (120g) for 10 hnn.Jtes. 1he 
cell pellets were resuspended in DMEM supplemented with 10 % foetal calf serum (FCS) 
(Appendix 1) and were stored at 4 °C. 
After 30 minutes of stirring, the freshly trypsinised tissue was removed from the flask and the 
cells were treated in a similar manner (as described above). The tissue remaining in the flask 
was subjected to two more cycles of trypsinisation. Cells recovered from each round of 
digestion were pooled and were then counted using a Neubauer haemocytometer. They were 
seeded in plastic culture flasks at a density of 1xi05 cells per cm2. Fifty ml of culture 
medium (DMEM. 10% FCS), was added per 175 cm2 flask (Nunclon, Nunc, Delta, 
Denmark). These were placed in a 5% C02 incubator (Queue, USA) at 37 oc for 48 hours 
before being examined for cell growth. Once the cells had formed a monolayer they were 
passaged as described below. 
4.2.4. Passaging culture cells (Freshney, 1987): 
The medium was removed from a culture flask which contained a confluent cell monolayer. 
The cell sheet was then washed with cold sterile PBS. The PBS was removed after one 
minute and Activated trypsin Versene (ATV) (Appendix 1) was added. The ATV was 
swirled over the cells and was then removed. Fresh ATV was then added. The flask was 
gently shaken and placed at 3 7 oc. Once the cells started lifting off the floor of the flask, it 
was removed from the incubator and the contents made up to a predetermined final volume 
with DMEM. 10% FCS. This volume depended on the split ratio of the cells (The split ratio 
ofthe cells refers to the number of confluent cell monolayers that can be obtained within 3-4 
days after subculture of cells from one parental flask. The time taken for cells to become 
confluent depends on the specific cell line being used. For example, a cell line which grows 
quickly may be split 1:8, whereas a cell line which grows slowly may be split only 1:4. For a 
split ratio of 1:8, one flask of confluent cells are divided into eight flasks of the same size. If 
a differ~Hi flask size is to be ustd, then the ratio must be adjusted accordingly. For example, 
four 150 cm2 flasks are made from one 75 cm2 flask for a split ratio of 1:8.). The cells were 
pipetted up and down in a pipette until no cell clumps were visible. The cell suspension was 
36 
then divided evenly between the flasks and if necessary, extra medium was added to ensure 
that the cells were submerged to a depth of 4 mm. The cells were incubated at 3 7 oc in a 5% 
C02 incubator until confluent. 
4.2.5. Source of LSDV: 
The vaccine strain of LSDV {Neethling) was used for this study and all subsequent studies 
dealing with the culture and purification of LSDV. This isolate is derived from the original 
virulent LSDV (Neethling) isolate which was passaged in eggs and cell culture to produce an 
attenuated live vaccine at the Onderstepoort Veterinary Institute, Pretoria (as described by 
Weiss, 1968). The sample used in this study was kindly supplied by D. Kow (Department of 
Medical Microbiology, Medical School, UCT) after several passages in CFK cells. 
4.2.6. Infecting culture cells with LSDV: 
Virus stock was thawed at room temperature and diluted in diluent to the desired 
concentration. The medium was discarded ii'om culture flasks containing a 90% confluent 
monolayer of cells, and enough diluent (containing virus) was added to each flask so that the 
diluent just covered the cells. The flasks were then incubated at 3 7 °C for 1 hour in a 5 % 
C02 incubator (Queue, U.S.A.) (they were rocked gently every 20 minutes). After the 
adsorption period, the virus was discarded and the cell sheet was covered with fresh diluent 
(37 °C). This diluent was replaced with DMEM. 4% FCS (or DMEM. 2% FCS for rapidly 
dividing cells). The flasks were then returned to the C02 incubator (3 7 °C) .and the cells 
were monitored every day for cytopathic effects (CPE). 
4.2. 7 Infectivity assays: 
4.2. 7.1 Cell culture and virus titration: 
MDBK, CFK and LT cells were each seeded into a 24-well titration plate (Nunclon, Delta, 
Nunc, Denmark) at a concentrl!~bn 0f 1.1 x 1 o5 ceiis per wdl {area of one well = 2.27 cm2) 
in DMEM. 10 % FCS culture medium. The plates were then incubated in a 5 % COz 
incubator at 37 °C. When the cells reached 90% confluency, the culture medium was 
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removed. A I 0-fold dilution series of a stock of LSDV was prepared in diluent. The first 
column (four wells per column) of each plate was used as a control (virus-free) and the 
remaining columns were used for consecutive dilutions. A 0.1 m1 aliquot of each virus 
dilution was added per well. The plates were returned to the incubator. After a 60 minute 
adsorption period, the viral inoculum was removed, the cells were washed in PBS (37 °C) 
and the PBS was then replaced with 1 m1 of DMEM. 4 % FCS. Incubation was continued 
for 3 days in a 5 % C02 incubator at 3 7 °C. The cells were viewed each day post-infection 
using an Olympus CK 2 inverted microscope (Olympus, Japan) for the appearance of CPE. 
The nature of the CPE was determined for each cell line by comparing the gross morphology 
of infected cells with that of non-infected cells. The results were photographed as 
described in Appendix 2. 
4.2. 7.2 Calculation of viral infectivity: 
The number of foci of cells exhibiting CPE were counted in wells where between one and ten 
foci were present. The following techniques were then employed to obtain an accurate count 
of the number of CPE (foci) per well (each technique was performed on the same. row of 
wells, in the order described below): 
A. The foci were counted per well without removing the culture medium. 
B. The culture medium was then removed and the cells were viewed for CPE. 
C. The wells· were divided into sections using a grid overlay marked on the lid of the 
titration plate. The use of an inverted microscope to view the cells resulted in the casting of 
a shadow-image of the grid over the cell sheet. The number of foci were then counted in 
each grid section, and these subtotals were added together to give the total number of foci 
per well. 
D. The cells were stained with Ziehl Neelsen carbol fuchsin stain (Lennette and Schmidt, 
1969). 
Once the optimum conditions had been determined for counting the number of virus-infected 
cells per well, the concentration of the original virus stock could be accurately determined as 
follows:-
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Assuming that one focus of infected cells (or plaque) in a cell sheet represents one infectious 
viral particle, then the virus concentration, quoted as plaque forming units per millilitre 
(p.fu./ml), was calculated as follows:-
p.fu./ml = X x Y x Z 
where X = the reciprocal of the dilution at which the number of foci 
averaged between one and ten per well 
. Y = the average number of foci per well inoculated 
with the dilution in X 
Z =the reciprocal of the inoculum volume 
e.g. in this study 0,1 m1 of each virus dilution was plated per well, 
therefore Z = I 0 
4.2.8 Techniques used to confirm the presence of LSDV in infected cells: 
4.2.8.1 Indirect Immunoperoxidase staining technique: 
In order to confirm whether the CPE were due to the presence of virus or due to other 
factors, the cells were stained using an indirect immunoperoxidase staining technique (Payne 
et al., I986). 
MDBK cells were grown on glass coverslips in 6-well titration plates (Nunclon, Delta, Nunc, 
Denmark) (area per well= 5.3 cm2). They were infected with virus as described (4.2.6.) and 
left in a C02 incubator at 3 7 °C for I-3 days. The cells were then washed three times in 
PBS after the medium was removed. They were fixed in cold acetone for 5 minutes and 
were then air dried (after this stage they were always maintained in a moist environment). 
The fixed cells were washed in PBS and non-specific protein binding sites were blocked by 
immersion in 2% ovalbumin (Sigma, U.S.A.), in PBS, for 20 minutes. 
Thereafter cells were covered with hyperimmune bovine anti-LSDV serum [diluted I: I 00 in 
2% ovalbumin (in PBS)] for I-2 hours at room temperature. After washing three times in 
PBS with 0.5% Triton X-IOO (BDH, Poole, England), cells were covered with peroxidase-
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conjugated rabbit anti-bovine immunoglobulin-G (DAKO-immunoglobulins, Denmark) 
(diluted 1 :400 in PBS) for 1 hour at room temperature. The Triton X-1 00 wash was 
repeated and the cells were exposed to substrate solution [(10 mg DAB (3,3'- diamino 
benzidine tetrahydrochloride) (Sigma, U.S.A.), 20 ml PBS and 40 J.ll 30 % hydrogen 
peroxide (BDH, Poole, England)] for 5 minutes. 
After being washed gently in tap water, the cells were counter-stained with haemotoxylin 
(Gurr's, London) for 30 seconds and residual stain was removed by washing under running 
tap water. The cells were dehydrated by successive immersion in: 50 % ethanol - 70 % 
ethanol - 95 % ethanol - absolute ethanol - xylol (Merck, Germany) - xylol. Stained 
coverslips were finally mounted on glass slides using Entellan mounting fluid (Merck, 
Germany) and were viewed using a Leitz SM-LUX light microscope (Leitz and Wetzlar, 
Germany). 
4.2.8.2 DNA-detection fluorescent staining: 
Along with iridoviruses, poxviruses are unique amongst animal DNA viruses in their ability to 
replicate in the cytoplasm of infected cells (Moss, 1990). When poxvirus-infected cells are 
stained with a DNA-specific fluorescent stain and viewed using a fluorescence microscope, 
the cell nuclei fluoresce strongly, in addition to discrete areas in the cytoplasm. These 
cytoplasmic foci of fluorescence are due to sites of viral replication, called virus factories, 
containing large amounts of viral DNA. 
The technique of Chen (1977) was used to stain infected and uninfected MDBK cells: 
Chemical solutions: 
Stock solution of Bisbenzamide fluorochrome stain: 5 mg of Hoechst no. 33258 powder 
(Hannover, Germany) was dissolved in 100 ml PBS. The solution was mixed thoroughly at 
22-25 °C with a magnetic stirrer for 30 minutes and the bottle containing the stain was then 
wrapped in aluminium foil and stored in the dark at 2-8 °C. 
Working solution ofHoechst no. 33258 stain: 1 ml of stock solution was dissolved in 100 ml 
ofPBS (final concentration of0.5 J.tg/ml). It was then stored in the dark at 2-8 oc after first 
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being wrapped in aluminium foil. Before use, the solution was mixed thoroughly with a 
magnetic stirrer at 22-25 oc for 30 minutes. 
Mounting fluid: 22,2 ml citric acid {0, 1 M) (Merck, Germany), 27,8 ml disodium phosphate 
(0,2 M) and 50 ml glycerol were mixed. The pH was adjusted to 5,5 and the mounting fluid 
was stored at 2-8 °C. 
Fixative: Glacial acetic acid- methanol (I :3) 
Method: 
Cells were grown on glass coverslips in 6-well titration plates (Nunclon, Delta, Nunc, 
Denmark) (area per well= 5.3 cm2) and infected as described in 4.2.6. At 24 hour intervals 
the growth medium was removed from one well and the cells were fixed for 5 minutes with 
3-4 ml of fixative. The fixative was removed and fixation was repeated for 1 0 minutes. The 
cells were air dried for 30 minutes, then covered with Hoechst stain for 30 minutes. The 
stain was then removed by washing the cells three times in deionised water. The coverslip 
was mounted on a glass slide in a drop of mounting fluid and the cells were viewed using a 
fluorescence microscope [Leitz SM-LUX microscope (Leitz and Wetzlar, Germany)] with 
UV light at a wavelength of 360 nm. 
4.3 RESULTS: 
4.3.1 Optimal conditions for virus titration: 
4.3.1.1 Choice of cells: 
Three different kinds of cells were evaluated in respect of the ease and reproducibility with 
which LSDV infection could be detected by criteria ofCPE. 
Comparisons of uninfected LT, CFK and MDBK cells with cells infected with LSDV are 
shown in Fig 4.1, A to F. Early plaque formation, characterised by foci of rounded cells, 
were observed in infected CFK (Fig. 4.1 B) and LT (Fig. 4.1 D) cells from three days post-
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infection. These foci eventually developed into irregular plaques, with the rounded cells 
lifting from the cell sheet, leaving a hole, by four to five days post-infection. 
Foci, resembling raised ridges of cell growth, were observed from two days post-infection 
when MDBK cells wc::e infected at 80 - 90 % conf!uenc:y a.11d three days postMinfection when 
infected at 90 - 100 % confluency. Figure 4.1 F shows the presence of these foci as 
compared to the uninfected MBDK cells which lack them (Fig 4.1 E). These foci remained 
stable for a number of days~ although they were most clearly discernible from the cell sheet 
until approximately four days post-infection by which time the rest of the cell monolayer had 
started producing a ridged appearance. 
4.3.1.2 Calculating the concentration of infectious virions: 
The foci produced in MDBK cells were much more easily recognisable than those produced 
in CFK and LT cells and developed more rapidly. The MDBK cells were also easier to 
maintain and grew more reliably than primary cells. For these reasons it was decided to use 
MDBK cells for virus titration studies. 
A titration plate, consisting of a 90 % confluent monolayer of MDBK cells was infected 
with a 10-fold dilution series of a stock of LSDV as described (4.2.7.1), except that 6 wells 
were used for each dilution. The virus titre was calculated after 3 days. 
The number of foci, in each of the 6 wells, at the 1 o-4 dilution, averaged between 1 and 10 
per well. The optimal method for counting plaques was determined by comparing each of 
the four techniques described (the same row of six wells was used for each technique). The 
results are presented in Table 4.1: 
Counting the foci without removing the cell culture medium or using a grid overlay 
(Technique A) gave rise to a low average count (3.0 p.fu./well) with the greatest standard 
deviation (1.41). Removal of the cell culture medium and the use of a grid overlay 
(Technique C) produced the highest average count (6.3 p.fu./well) with the lowest standard 
deviation (1.21). Removal of the cell culture medium without the use of a grid overlay 
(Technique B) resulted 
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TABLE 4.1: Comparisons of techniques used to titrate infectious LSDV. 
TECHNIQUE a NO. OF FOCI PER WELL AT to-4 AVERAGE STANDARD 
DILUTION OF LSDV. NO. OF DEVIATION 
WELL NO. FOCI 
I 2 3 4 5 6 
A 3 5 4 1 3 2 3.0 1.41 
B 7 6 6 4 8 6 6.2 1.33 
c 7 7 7 4 7 6 6.3 1.21 
D NR NR NR NR NR NR - -
NR = not readable a A = foci counted in medium, B = foci counted with medium removed 
C = foci counted with grid overlay, D = foci counted using stain 
in a comparable average count (6.2 p.f.u./well), but with a greater standard deviation (1.33). 
The foci were uncountable when using the Ziehl Neelsen carbol fuchsin stain (Technique D) 
as the stain gave the entire cell monolayer a ridged appearance. 
The data obtained using technique C was therefore used to determine the concentration of 
infectious virions in the original stock: 
Infectious LSDV = X x Y x Z 
= 6,3 X IQ4 X 1 0 
= 6,3 X 105 p.f.u./ml 
4.3.2. Techniques used to confirm presence of LSDV in infected cells: 
Confirmation of the viral nature of the foci produced by infected MDBK cells was obtained 
using two staining techniques; one which specifically detects the presence of viral antigen and 
the other which indicates the presence of DNA (both viral and cellular). 
43 
4.3.2.1 Immunoperoxidase staining ofMDBK cells: 
Fig. 4.2 B-D indicates that the raised ridges or foci seen on MDBK cells infected with LSDV 
are due to the presence of virus, and not other factors, as these ridges have been specifically 
labelled with anti-LSDV hyperimmune serum. Non-infected cells, and areas on infected cells 
which show no ridging, were not tagged with LSDV-specific antibody (as no brown stain is 
observable in these regions). Infected cells labelled with control, non-immune serum also 
failed to produce a brown stain (Fig. 4.2 A) 
Viral antigen could be specifically labelled from as early as 24 hours post-infection in the 
cytoplasm of infected cells (Fig. 1.2 B). A progressive increase in the number of cells 
staining positive for viral antigen and a corresponding increase in the intensity of the 
peroxidase staining is shown in Fig. 4.2 C (48 hours post-infection) and Fig. 4.2 D (72 hours 
post-infection). 
4.3.2.2 DNA-fluorescence staining of MDBK cells: 
Staining of infected cells with a DNA-specific fluorescent stain (Hoechst no. 33258) 
revealed the presence of brightly fluorescing nuclei and discrete areas of fluorescence in the 
cytoplasm (Fig. 4.3 B) which were absent in non-infected control cells (Fig. 4.3 A). The 
possibility of mycoplasma contamination was ruled out as the cells and virus had been treated 
with BM-Cyclin (Boehringer Mannheim, Germany) for the eradication of mycoplasma. 
Electron microscopy also confirmed the absence of mycoplasma from virus stocks and 
infected cells.· The cytoplasmic fluorescent "spots" were thus probably the factory sites 
associated with virion replication . These viral "factories" were present within 24-hours post-
infection. 
Figure 4. 1 A. 
Monolayer of uninfected CFK cells. (X 150) 
Figure 4. 1 B. 
Monolayer of CFK cd!s infected with LSDV (10-3 dilution) . Three days post-
infection. Note the early stage of diffuse plaque formation (arrow) characterised by 
foci of cells with atypical morphology. (X 150) 
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Figure 4.1 C. 
Monolayer of uninfected LT cells. (X 150) 
Figure 4.1 D. 
Monolayer of LT cells !nfccied with LSDV (io-3 dilution) . Three days post-
infection. Note the early stage of plaque formation (arrow) characterised by foci of 
rounded cells (X 150). 
46 
Figure 4.1 E. 
Monolayer of uninfected MDBK cells. (X 150) 
Figure 4.1 F. 
Monolayer of MDBK cells infected with LSDV 3 days post-infection (10-2 dilution). 
Note the prominent foci (arrows). (X 150) 
FIGURE 4.2. A 
.MDBK cells infected with LSDV (3 days post-infection) after incubation with 
serum from an uninfected cow (diluted 1/20). Cells were stained using an indirect 
immunoperoxidase technique. (X 300). 
FIGURE 4.2. B 
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MDBK cells inrected v.rith LSDV (1 day post-infection) after incubation with inum.!!!~ 
serum from a cow infected with LSDV (diluted 1/100). Cells were stained using an 
indirect immunoperoxidase technique. (X 600). 
FIGURE 4.2. C 
MDBK cells infected with LSDV (2 days post-infection) after incubation with 
immune serum from a cow infected with LSDV (diluted 11100) and stained using an 
indirect immunoperoxidase technique. (X 300). 
FIGURE 4.2. D 
MDBK cells infected with LSDV (3 days post-infection). Cells were exposed to 
immune serum from a cow infected with LSDV (diluted 1/100) and were stained 
using an indirect immunoperoxidase technique (X 600). 
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FIGURE 4.3. A 
Uninfected MDBK cells stained for the presence of DNA using the Hoechst DNA-
fluorescence stain. Only the cell nuclei fluoresce strongly. (X 600) 
FIGURE 4.3. B 
49 
MDBK cells infected with LSDV (2 days post-infe~tivil) and stained for the presence 
of DNA using the Hoechst DNA-fluorescence stain. Arrows indicate discrete foci of 
DNA in the cytoplasm. (X 600) 
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4.4 DISCUSSION AND CONCLUSIONS: 
It was found that LSDV could be propagated in three separate types of cells, viz. primary 
lamb testis (LT), primary foetal calf kidney (CFK) and a continuous line of bovine kidney 
·· cells (MDBK). A tturnber of techniques wcr~ compared for the propugatioi1 oi primary 
culture cells, as high yields of virus have been obtained from these cells (refer to Chapters 5 
and 6). It was found that the use of foetal tissue yielded the best cultures, as these cells were 
the least differentiated and able to replicate for a number of generations in cell culture. A 
compromise was reached between the use of low temperatures for trypsinisation ( 4 °C) and 
high temperatures (3 7 °C), as neither of these techniques were found to yield cultures of a 
high viability. Tissue was heated to 30 oc and was left to cool to room temperature while 
being stirred with a magnetic stirrer. This method yielded the desired viability of cells with 
cultures attaining confluency within two days. 
Evidence of LSDV infection was found in the appearance of distinctive CPE. After 
comparing the CPE produced by LSDV in the 3 cell types, it was decided that MDBK cells 
were the best suited for titration of LSDV. In MDBK cells, LSDV produces characteristic 
raised ridges or foci that appear within 2-3 days post-infection, whereas CPE were only 
detectab~c ~~ :nfected CFK and LT cells from 3 days post-infection, and took 4-5 days to 
develop into discernible plaques. In addition, the foci produced by infected MDBK cells are 
more readily detectable than the CPE produced in L T and CFK cells, and the continuous cell 
line nature of the MDBK cells made them more readily available than primary cells. MDBK 
cells were therefore utilised for all virus titrations. 
The optimal method for counting viral foci was determined using a number of different 
techniques. Conventional staining with the Ziehl Neelsen carbol fuchsin stain was found to 
mask the location of the viral foci as the stain gave the entire cell monolayer a ridged 
appearance. Thus foci were counted on unstained cells. Leaving the culture medium in the 
wells led to an inaccurate count as the medium produced a ring of shadow around the edge of 
the wells making it impossible to see foci falling within this ring. Removing the medium was 
found to eliminate this shadow and revealed foci previously hidden by the shadow. The use 
of a grid overlay yielded more consistent results as this divided the wells into smaller sections 
which could be scanned without the risk of counting the same foci twice or missing foci 
:1hugether. Removal of culture medium and division of the wells into sections using ~ grid 
overlay was thus found to be the most consistant and accurate technique for determining the 
exact number of foci per welL 
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A formula comprising the average number of foci on a number of wells, multiplied by both 
the reciprocal of the dilution, and the reciprocal of the inoculum volume, was used to 
determine the concentration of infectious virions in infectious units/mi. 
Other factors exist which might have produced cytopathic effects in the :MDBK cells, such as 
mycoplasma. However, mycoplasma contamination of cells and virus stocks was eliminated 
with the use of antibiotics. Confirmation of the localisation of viral antigen to the foci 
observed in infected :MDBK cells was obtained using an indirect immunoperoxidase staining 
technique and LSDV -specific bovine hyperimmune serum. Viral antigen was detectable as 
early as 24 hours post-infection with copious amounts present in the cytoplasm of infected 
cells by 3 days post-infection. The DAB staining was restricted to foci, and control 
uninfected cells were not stained. This focus localisation of DAB also indicated a lack of 
. the low level of endogenous peroxidase activity that is said to be associated with some cell 
lines. 
Further evidence of LSDV infection in :MDBK cells was obtained using the Hoechst DNA 
fluorescence stain. In addition to fluorescence of cellular DNA in cell nuclei, brightly 
fluorescing foci were observed in the ~ytci)lasm cf irrtc~ted cells. Their appearance in the 
cytoplasm supports their viral nature as poxviruses are unique among DNA animal viruses 
(including iridoviruses) in their ability to replicate in the cytoplasm of infected cells (Moss, 
1990). These DNA foci were very prominent by 24 hours post-infection which suggests that 
viral replication occurs in less than 24 hours. The absence of mycoplasma was confirmed by 
the fact that no DNA fluorescence was seen in the cytoplasm or at the cell surface of 
uninfected :MDBK cells. 
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CHAPTERS 
YIELD OF INFECTIOUS VIRUS UNDER "STANDARD" CULTURE 
CONDITIONS: 
5.1 INTRODUCTION: 
Once an accl)rate technique had been detennined for calculating the concentration of 
infectious virions, it was possible to study the growth characteristics and infectivity of 
LSDV. A number of factors, such as temperature and type of cell line, influence the yield of 
virions produced in infected cells. It was the aim of this study to optimise the conditions 
necessary to produce the maximum yield of virions in cell culture. However, before these 
conditions could be determined it was necessary to establish a set of "standard" growth 
conditions. These "standard" growth conditions could then be used as a guide in establishing 
whether altering one or more of the culture conditions had a negative or positive effect on the 
yield ofLSDV virions. 
The growth conditions were selected from reports on a number of techniques used to grow 
poxviruses, including capripoxviruses (Mackett et al., 1985; Esposito et al., 1981; Kitching et 
a!., 1986). The "standard" conditions chosen were as follows: primary LT cells for ~the 
propagation of virions, a DMEM. 4 % FCS culture medium, the vaccine strain of LSDV 
(Neethling) as inoculating virus, a virus adsorption period of one hour and an incubation 
temperature of 37 °C. 
The propagation of LSDV under these culture conditions was determined by calculating the 
change in titre of both intracellular and extracellular virions over a period of seven days and 
then plotting the total number of infectious units against time, on a graph. 
5.2 MATERIALS AND METHODS: 
Ten 25 cm2 cell culture flasks (Nunclon, Nunc, Delta, Denmark) were seeded with primary 
LT cells in a DMEM. 10% FCS culture medium (Appendix 1 ). The cells were incubated at 
3 7 °C in a C02 incubator. Once 90 % confluent, the cells in each flask were infected with I 
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x 106 p.fu. from a freshly prepared stock of LSDV in 1 m1 of diluent (Appendix 1). After a 
60 minute adsorption period at 3 7°C, the virus inoculum was removed and the cells were 
washed with 1 m1 of prewarmed diluent (37 °C). This diluent was replaced with 4· m1 of 
O:MEM. 4% FCS. At this stage one flask was removed and the contents titrated to establish 
the baseline (t:!lle = 0 hours post-infectivli) of infecticus particles: The other flasks were 
returned to a C02 incubator for further incubation and one flask was removed at intervals of 
between 12 and 48 hours thereafter. 
The presence of intracellular and extracellular infectious virus in each flask was assessed in 
the following way: 
The medium was removed to a Universal bottle. The cells were washed in 2 m1 of PBS 
(4°C). The PBS was discarded and the cells were washed in 2 m1 trypsin (0,05%). This 
trypsin was discarded and was replaced with 1 m1 trypsin (0,05%). The cells were incubated 
at 3 7°C until they detached from the flask. These cells were removed to a Bijou bottle 
(labelled CELLS) and 1 m1 ofDMEM. 4% FCS was added to the flask to wash off remaining 
cells. This wash was pooled with the cells in the Bijou bottle. 
During this time, the medium in the Universal bottle was centrifuged at ! 300 rp•n fm 10 min 
at 4°C in a Sigma 301K benchtop centrifuge, to sediment the cells. The supernatant fluid was 
then removed to a sterile bottle (labelled MEDIUM) and the cell pellet was resuspended in 1 
m1 ofMcllvain's buffer (Appendix 1) and pooled with the rest ofthe cells. Both medium and 
cells were freeze-thawed three times between -20 °C and 4 oc to release virions from cells 
and the volume of each sample was adjusted to 6 m1 with Mcilvain's buffer. 
An aliquot was removed from each sample for titration in MDBK cells (Chapter 4, 4.2.7.1) 
in 24-well titration plates (Nunclon). A 0,5 log10 dilution series was prepared of each 
sample (i.e. 1 m1 of virus was diluted in 2.1 m1 of diluent for each dilution step). Four wells 
were used per dilution and 0.1 m1 of virus inoculum per well. A control row of wells 
(consisting of uninfected cells) was placed nearest the lowest virus dilution on each plate. 
The plates were incubated for 3 days at 3 7 °C and virus titre was calculated as follows: 
Virus titre was determined by counting the number of foci in each of the 4 wells at the virus 
dilution that resulted in between 1 0 and 200 foci~ Tb present:e of intracdlula!" and 
extracellular infectious virus was assessed in the following way: 
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A grid overlay was used (as described in 4.2. 7.2) to obtain the most accurate count. The 
average number of foci per dilution was multiplied by the reciprocal of the dilution (termed 
the dilution factor) and the reciprocal of the inoculum volume. The resulting value 
(p.fu./ml) was multiplied by the total volume of each virus sample (i.e. 6 ml) to give the 
total number of :nfectious particles per sample. These values were p:otted against 6:ne (in 
hours) post-infection. Standard deviation values were also calculated for the distribution of 
foci in each set of 4 wells, in order to gauge the degree of variation in p.fu. per dilution. 
5.3 RESULTS: 
A measure of the ability of LSDV to replicate in LT cells was obtained by inf~ctivity 
titrations of both intracellular and extracellular virions, harvested at intervals over a seven 
day period. Results are presented in Tables 5.1 and 5.2 respectively, and are graphically 
illustrated in Fig. 5 .1. 
Each flask was inoculated with 1 x 106 p.fu. of LSDV. Immediately after the viral inoculum 
was removed from the cells and they had been washed (0 hours post-infection), some 
infectiou;; viius (9.& x ~J3 p.fu.) was recovered from the culture medium. This probably 
represents virus which had either loosely attached to the walls of the plastic flask, or was 
loosely bound to cells and became detached after the diluent wash and before the medium 
was removed from the flasks. 
At the end of the adsorption period, 3.9 x 104 p.fu. of infectious virions were recovered 
from the cellular sample. Uncoating of virions. commences soon after they enter the cell, 
thus it is unlikely that internalised virus particles could be recovered from the cells and remain 
infectious. Therefore the infectious virus released from the cell sample at this stage probably 
represents virions that had attached to the outside of cells, but had not penetrated cell 
membranes. 
Within the first 26 hours of infection, there was no significant change in the titre of 
extracellular virus (Table 5.1 ), but the amount of infectious virus recovered from the cells 
had increased approximately 35-fold (Table 5.2). These results suggest that viral replication 
had occurred within ihis t\me period, but that none of the progeny virions had been rele:l:;ed 
from infected cells. The first indication that infectious virions were being released from the 
TABLE. 5.1 Titre of infectious extracellular LSD V virions in relation to. time after infection. 
X. Y. 
TIME POST AVERAGE DILUTION TOTAL NO. 
INFECTION NO. OF FOCI PER WELL NO. OF FACTOR OFFOCI. b 
(HOURS) FOCI PER 
WELL NO. WELL. a 
I 2 3 4 
0 23 14 14 17 17.0(±4.3) 9.61 9.80 X 103 
26 10 6 7 5 7.0 ( ± 2.2) 9.61 4.04 X 103 
52 23 25 16 12 19.0(±6.1) 29.8 3.40 X 104 
68 36 35 36 34 35.3 ( ± 1.0) 92.4 1.96 X IQS 
75 19 43 37 38 34.3 (± 10.5) 92.4 1.90 X IQS 
80 17 31 22 14 21.0(±7.4) 286 3.60 X IQS 
94 18 30 35 16 25.0 ( ± 9.2) 286 4.29 X IQS 
105 41 44 43 33 40.3 ( ± 5.0) 286 6.92 X IQS 
123 32 72 55 43 50.5 (±17.5) 286 8.67 X 105 
168 57 65 34 37 48.3 (± 15 .2) 286 8.29 X 105 
a = standard deviation values in brackets b= XxYx6x10 
TABLE 5 .2 Titre of infectious intracellular LSD V virions in relation to time after infection .. 
X. Y. 
TIME POST AVERAGE DILUTION TOTAL NO. 
INFECTION NO. OF FOCI PER WELL NO. OF FACTOR OF FOCI. b 
(HOURS) FOCI WELL 
WELL NO. WELL. a 
1 2 3 4 
0 16 22 20 30 22.0 ( ± 5.9) 29.8 3.93 X 1Q4 
26 118 69 82 64 83.3 (± 24.4) 286 1.43 X 1Q6 
52 29 24 34 34 30.3 ( ± 4.8) 887 1.61 X 106 
68 35 29 25 32 30.3 ( ± 4.3) 887 1.61 X 1Q6 
75 69 44 36 40 47.3 (± 14.9) 887 2.58 X 1Q6 
80 60 74 80 50 66.0 (± 13.6) 2751 1.09 X 107 
94 148 151 171 130 150.0 (± 16.8) 2751 2.48 X 107 
105 78 89 104 86 89.3 (± 10.9) 2751 1.47 X 107 
123 80 94 95 79 87.0 ( ± 8.7) 2751 1.44 X 107 
168 36 53 61 47 49.3 (± 1 0.6) 2751 8.14 X 106 
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FIGURE. 5.1 
Yields of infectious intracellular and extracellular LSDV particles (given as total p.f.u. x I04) 
measured over a 7 day period after infection. A; Presentation of data using the same scale 
to represent both intracellular and extracellular particles. B; Data presented on two scales to 
illustrate the smaller increases in titre of the extracellular particles (right-hand axis). Total 
yields of intracellular particles (left-hand axis) are represented as columns. 
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cells was seen at 52 hours after infection, and thereafter the titre of virus in the medium 
increased at a low but steady rate with approximately 2 x 105 p.f.u. of virus being added to 
the medium during each 24 hour period, up to day 6 (Fig. 5.1 B). 
The number of infectious virions that could be recovered from the infected cells remained at 
a fairly constant level (about 1.6 x 106 p.fu.) for the second and third days, but then 
increased rapidly to reach a peak of 2.4 x 107 p.fu. by 94 hours after infection (Fig. 5.1 A). 
The large increase in intracellular virus was not reflected in the number of extracellular 
particles. Rather, as already stated, virions escaped from the cells at a constant rate, 
suggesting that cellular mechanisms or components dictate the rate of virion release. 
Almost 98% of the infectious virus recorded at 94 hours remained intracellular. From 5 days 
after infection, a gradual decrease in titre of intracellular virus was observed. A possible 
explanation is that late in infection, mature particles become trapped within intracytoplasmic 
inclusions, and upon lysis of the cell these particles remain clumped. This would effectively 
serve to reduce the number of infectious units in the cell lysate. Thus the total p.fu. need 
not necessarily reflect the number of complete infectious virions. 
5.4 DISCUSSION: 
Although capripoxviruses have been propagated in culture by a number of other 
investigators (Weiss, 1968; Kitching eta/., 1986; Black eta/., 1986), no special attention 
has been give·n to the optimal culture conditions for LSDV. In this study, it was possible to 
establish baseline expectations for the propagation of LSDV in cell culture using a set of 
"standard" conditions. It was found that with an input virus titre of 1 x 106 p.fu. per flask 
of primary LT cells, a maximum yield of 2.5 x 107 p.fu. of infectious LSDV (pooled 
intracellular and extracellular virus) could be recovered at 94 hours post-infection. The 
majority (98%) of progeny virus remained intracellular, although a small proportion was 
recoverable from the medium. Esposito et a/. ( 1981) made similar observations with vaccinia 
virus propagated in various cell cultures. The ultimate aim of the present thesis was to 
perform comparative analyses on the genomes of a number of different isolates of LSDV. 
This necessitates obtaining high concentrations of pure viral DNA. In view of the fact that 
very few virions are released from infected cells during the cycle of virus replication, it 
would be necessary to rupture the infected cells to release intact virus particles which would 
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constitute the source of viral DNA. The manner in which this is achieved is discussed in 
Chapter 7. Over and above the cellular retention of large amounts of infectious virus, it is 
probable that the cellular fraction will contain a fair percentage of viral genomes which are 
incompletely packaged (and therefore uninfectious) but which could nonetheless serve as a 
source of viral DNA for molecular studies. 
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CHAPTER6 
ESTABLISHING OPTIMAL CULTURE CONDITIONS FOR LSDV 
6.1 INTRODUCTION: 
Once the propagation of the vaccine strain of LSDV had been established using a set of 
"standard" culture conditions (Chapter 5), it was possible to test the propagation ofLSDV by 
changing one or more of these "standard" culture parameters and then comparing the 
resulting yield of virus with that obtained using "standard" conditions. Those altered 
parameters which resulted in an increased yield of infectious virions were considered 
favourable, and were then combined to form an optimum set of culture conditions. 
6.2 MATERIALS AND METHODS: 
6.2.1 Primary and continuous cell lines: 
Primary LT, CFK and foetal bovine testes (FBT) cells were prepared as described in Chapter 
4. Primary chick embryo fibroblast (CEF) cells were prepared in a similar manner, except 
that an entire 5-day old chicken embryo was used in the culture preparation. 
Continuous lines of MDBK cells (described in Chapter 4), Vero (African green monkey 
kidney cells, ATCC Catalogue, reference CRL 1587), CV1 (African green monkey kidney 
cells, ATCC Catalogue, reference CCL 70), RK13 (5-week old rabbit kidney cells, ATCC 
Catalogue, reference CCL 37) and Don (Chinese hamster lung cells, ATCC Catalogue, 
reference CCL 16) were obtained from stocks maintained in liquid nitrogen in the 
Department of Medical Microbiology, UCT. 
6.2.2 Egg inoculation: 
6.2.2.1. Inoculation of CAMs with LSDV: 
Embryonated hens' eggs (White Rock crossed with Cornish Game, Golden Grove Poultry 
Farm, Ottery, Cape Town) were candled and two pencil marks were made on the shell, one 
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over the air sac and the other over an area of the chorioallantoic membrane (CAM) that was 
not directly above a blood vessel. The egg shell was then punctured at both positions using a 
punch "pen". Using the area of punctured shell as an entry point, the air sac was then 
pierced using a fountain pen nib. A drop of PBS was placed on top of the puncture hole 
over the CAM and. this hole was then enlarged by rotating the fountain pen nib under the egg 
shell horizontally with the blunt end of the nib facing downwards, ensuring that the CAM was 
not pierced. The CAM was then dropped by removing the air from the air sac using a 5 ml 
rubber teat. The egg was allowed to stabilise for 60 min at 35 °C. 
The virus stock was diluted in PBS to a concentration of 5 x 104 p.fu./ml and 0,1 ml was 
placed on the CAM. Molten wax was spread over the hole above the CAM and the egg was 
gently swirled to spread the virus evenly. The egg was incubated at 35.5 oc for 5-7 days and 
then the virus was harvested. 
6.2.2.2. Yolk sac inoculation: 
The egg CAMs were dropped as described above and then a large hole was created in the 
egg shell above the dropped CAM. A drop of sterile paraffin oil was spread over the CAM, 
giving rise to a clear view of the yolk sac. A sterile needle was then inserted into the sac and 
the viral inoculum was injected. The egg was then wrapped in plastic cling-wrap and was 
placed at 35.5 oc for 5-7 days. 
6.2.2.3. Harvesting of infected CAMs: 
Gloves were worn at all times during the harvesting of the CAM's. The eggs were held in the 
left hand over a metal bucket containing Biocide 10 detergent (Lever Industrial, Durban, 
South Africa) while an incision was made starting at the air sac and continuing forwards and 
downwards towards the pointed end of the egg. The egg was then pried open, the blood 
vessels connecting the embryo and CAM were severed and the embryo was discarded into 
the Biocide. The CAMs were lifted away from the shell membranes and placed in 
physiological saline (Appendix 1) in a beaker. Only CAMs from live embryos were 
harvested. 
After five CAMs had been harvested, they were washed in fresh physiological saline and 
transferred to a Universal bottle containing glass beads (0.3 mm diameter), to a depth of 1.5 
em. These bottles were kept on ice. Paper towel and saline were discarded into the Biocide 
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and the scissors and forceps were boiled in water for 10 minutes in order to prevent 
contamination of other virus stocks. Mcilvain's buffer was added to each Universal bottle (1 
ml per CAM). The bottles were shaken for 2 minutes, were left on ice for 90 minutes and the 
disrupted membranes were then centrifuged at 1 000 rpm ( 120g) at 4 oc for 1 0 min in a 
Sigma 301K benchtop centrifuge. The supernatant fluids were retained and were dispensed 
into Bijou bottles to be stored at -20 °C. 
6.2.3. Establishment of optimal cell culture criteria for LSDV: 
A number of experiments were performed to assess criteria for optimal LSDV infectivity and 
yield. The vaccine strain of LSDV (Neethling) was used for all experiments (as described in 
Chapter 4). For most of the experiments primary CFK cells were used. There is a seasonal 
availability of LT cells (used in the "standard" culture conditions), and CFK cells were more 
readily available than LT cells. They also divided more rapidly (than LT cells) and were 
therefore maintained using DMEM. 2% FCS (as opposed to DMEM. 4% FCS for LT cells). 
Unless otherwise stated, conditions used for the culture, harvesting and titration of virus 
were as follows: 
Cell culture flasks (25 cm2) (Nunclon, Delta, Nunc, Denmark) were each seeded with 6 x 105 
primary CFK cells in 3 ml of DMEM. IO% FCS (Appendix I). The cells were incubated at 
37 °C in a 5 % C02 incubator (Queue, U.S.A) until they formed a 90 % confluent 
monolayer. The culture medium was then removed and replaced with I ml of 3 x I 06 p.fu. 
of LSDV in diluent. The flasks were returned to the incubator (3 7 °C). After an adsorption 
period of one hour, the virus inoculum was removed and the cells were washed with I ml 
of diluent (3 7 °C). The diluent was replaced with 3 ml of DMEM. 2 % FCS and the cells 
were incubated further at 3 7 °C in a C02 incubator. 
The virus was released from the cells by adding 3 ml of Mcilvain's buffer to the culture 
medium and then subjecting the cells to three cycles of freeze-thawing (between -20 °C and 
room temperature). A O.I ml aliquot of released virus was removed for titration on MDBK 
cells as described in Chapter 4 (4.2.7.I). The virus titre (p.fu./ml) was converted to total 
virus yield (total p.fu.) by multiplying the virus titre by the total volume of the virus 
suspension (i.e. 6 ml for most of the experiments). In those experiments where graphs were 
plotted, the total virus yield values were converted to log10 values and these were plotted 
against time post-infection. 
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6.2.3.1. LSDV growth at different temperatures. 
The effects of temperature were assessed first in LT cells grown at 35 °C, 37 °C and 39 °C 
and virus yield was calculated after 24, 48, 72 and 96 hours post-infection. The method is as 
follows: 
Thirteen culture flasks, containing 90 % confluent cell monolayers, were each inoculated 
with 1 x Io6 p.fu. of LSDV. Once the viral inoculum had been replaced with DMEM. 4% 
FCS, the flasks were humidified in a C02 incubator at 37 oc for 30 minutes. One flask was 
then treated to release virus from infected cells (as described above) and 0.1 ml was removed 
for titration. The total yield of virus recovered from this flask was used as the time 0 post-
infection value for the graph. 
Twelve of the flasks were then placed in plastic containers (four flasks per container) and 
floated in waterbaths set at the relevant temperatures. One flask from each container was 
removed at 24, 48, 72 and 96 hours post-infection. Virus was released from infected cells 
and 0.1 ml aliquots were removed for titration. Graphs of the log10 total virus yield values 
(intracellular plus extracellular virus) versus time post-infection were plotted for the different 
incubation temperatures. 
The experiment was repeated using CFK cells. An additional incubation temperature of 3 3 oc 
was included. CFK cells incubated at 33 oc and 35 ·c were also assessed for virus yield at 
120 hours post-infection. 
6.2.3.2 LSDV growth in different culture media. 
Four different cell culture media were tested: Eagle's Minimal Essential Medium (MEM), 
I 
DMEM, Basal Eagle's Medium (BEM) and DMEM combined 1:1 with HAM's F-12 medium 
(all media supplied by Highveld Biological Products, South Mrica) (Appendix l). 
Four flasks of90% confluent primary CFK cells were each infected with LSDV as described. 
The virus inoculum was removed and replaced with 3 ml of 2% FCS in either DMEM, MEM, 
BEM or DMEM +HAM's F-12 and the flasks were incubated at 37 °C for 3 days in a 5 % 
C02 incubator. 
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6.2.3.3 Pretreatment of viral stock with trypsin prior to infection. 
Treatment of vaccinia virus with trypsin before infecting culture cells is reported to increase 
viral infectivity (Mackett et al., 1985). A similar approach was adapted for LSDV as follows: 
Trypsin was added to a stock of LSD V (containing 3 x 1 ()6 p.f u.) in diluent to give a final 
concentration of 0,25 mglml. This virus-trypsin mixture was incubated at 37 oc for 30 
minutes. The trypsin was then inactivated by the addition of FCS to a final concentration of 
0, 1 %. The final volume of the treated virus was adjusted to 1 ml with diluent and was then 
used to infect. one flask of primary CFK cells as described. Virus was harvested after 3 days 
and the titre was determined. 
A control flask was infected in a similar manner, with 3 x 1 o6 p. f u. of stock virus (diluted in 
1 mi of diluent) which was not pretreated with trypsin or FCS, although it was incubated at 
3 7 °C for 30 minutes. 
6.2.3.4 Changing the period of virus adsorption. 
It is standard practice to infect cells with poxviruses for a period of 60 minutes at 37°C 
(Mackett et al., 1985). It was the aim of this experiment to determine whether these 
conditions were relevant to LSDV infectivity, and whether changing the period of adsorption 
would have an effect on virus yield: 
Each of two flasks was infected with LSDV as described. The virus inoculum was 
removed from one flask after an adsorption period of 60 minutes and from the other flask 
after 24 hours. Inocula were replaced with 3 ml DMEM. 2% FCS. The cells were incubated 
for 3 days in total and the virus titres were then determined. 
6.2.3.5 Splitting of infected cells: 
Studies performed at Onderstepoort Veterinary Research Institute have shown that LSDV 
yield can be increased by infecting rapidly-dividing cells (Fick, personal communication). 
Those findings were tested in the following way:-
A flask containing a 50 % confluent monolayer of primary CFK cells was infected with 1.5 x 
106 p.fu. LSDV in 1 mi of diluent as described. The inoculum was removed after 60 
, 65 
minutes and was replaced with 3 m1 DMEM.1 0 % FCS. The cells were incubated for 24 
hours in a 5% C02 incubator at 37°C and were then split 1:2 (section 4.2.4). They were 
seeded into two new flasks and incubated for 3 days. After freezing and thawing, viral 
suspensions from both flasks were pooled, and a 0.1 m1 aliquot was removed for titration on 
MDBKcells. 
A control flask containing a 90 % confluent monolayer was infected with 3 x 106 p.f.u. of 
virus. The inoculum was removed after 60 minutes and was replaced with 3 m1 DMEM.2 % 
FCS. The cells were incubated for 3 days in a 5 % C02 incubator at 37°C. After freezing 
and thawing, a 0.1 m1 aliquot was removed for titration on MDBK cells. 
6.2.3.6 Infecting cells with different concentrations ofLSDV: 
Ten flasks of 90 % confluent CFK cells were infected with LSDV as follows: five of these 
were each infected with 1.5 x 107 p.f.u. and the other five were infected with 6 x 105 p.f.u. 
By means of cell counts (using a haemocytometer) it was calculated that each flask contained 
approximately 3 x 1 o6 cells at the time of_ infection. Thus the multiplicity of infection 
(M.O.I.) was taken to be in the order of 5 p.f.u./cell and 0.2 p.f.u./cell for each set of cells 
respectively. After removal of the inoculum and washing with pr~w-a.rmed dii_lltnt, 3 ml 
DMEM. 2 % FCS was added. At this stage, cells from one flask in each set. of inoculum 
concentrations were disrupted, and 0.1 m1 aliquots were removed for titration on MDBK 
cells (these titres were taken as the zero time post-infection values). The remaining flasks 
were incubated over a period of 4 days at 37 °C. Virus was harvested from one flask in each 
set at 24 hour intervals, and 0.1 m1 of virus was used for titration on MDBK cells. 
6.2.3. 7 Growth in different cells. 
The efficiency of replication of LSDV was tested in a number of different cells; viz. MDBK 
(both mycoplasma -ve and mycoplasma +ve), Vero, CFK, LT, CV1, RK13, Don and CEF 
cells. 
Infected cells were incubated for 3 days, then the virus was harvested and titrated on MDBK 
cells. 
A lower yield was obtained from Vero, Don, CVI and RK13 cells. Therefore further studies 
were performed to assess whether LSDV could be passaged in these cell lines. 
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6.2.3.7.1 Growth of LSDV in Vero cells. 
One flask containing a 90% confluent monolayer of Vero cells was infected with 3 x 1 o6 
p.fu. of LSDV in 1 ml of diluent. The virus inoculum was removed after 60 minutes, the 
cells were washed with prewarmed diluent (3 7 °C) and this was then replaced with 3 ml of 
DMEM. 2% FCS. The flask was then placed at 3 7 oc in a 5 % C02 incubator. After a 3 
day incubation period, virus was harvested and titrated on MDBK cells. A volume of 0, 1 ml 
of the harvested virus was diluted in 0.9 ml of diluent which was then used to inoculate a 
new flask of 90 % confluent Vero cells. These cells were incubated for 3 days before virus 
was harvested. Virus was passaged three times in this manner. 
6.2.3.7.2 Growth of LSDV in Don cells. 
One flask containing a 90 % confluent monolayer of Don cells was infected with 3 x 1 o6 
p.fu. of LSDV as described. After a 3 day incubation period, virus was harvested and 
titrated on MDBK cells. A volume of 0,1 ml of the harvested virus was added to 0.9 m1 of 
diluent which was then used to inoculate a new flask of Don cells. LSDV was passaged five 
times in this manner. After the fifth passage, 0, 1 ml of virus was inoculated onto Don cells 
growing on glass coverslips. The cells were incubated for a further 3 days and were then 
examined for the presence of LSDV antigen using the indirect immunoperoxidase staining 
technique described in Chapter 4 ( 4. 2. 8.1). 
6.2.3.7.3 Growth of LSDV in CVl cells: 
One flask of90% confluent CVI cells was infected with LSDV as described in 6.2.3.7.1 
above. After 3 days the virus was harvested and passaged twice more in CVI cells as 
described for Don cells above. 
6.2.3.7.4 Growth ofLSDV in RK13 cells: 
One flask of 90% confluent RK13 cells was infected as described in 6.2.3. 7.1 above. After 
3 days the virus was harvested and passaged twice more in RK 13 cells as described for Don 
cells above. 
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6.2.4 Growth of LSDV in embryonated chicken eggs: 
\ 
Van Rooyen et al. (1969) reported on the optimal conditions for the growth of LSDV on 
chicken egg CAMs. Using their recommendations, the growth of LSDV on CAMs was 
monitored by serial passage as follows: 
Eight 7-day old embryonated hens' eggs were each infected with 5 x 103 p.fu. of LSDV: 
Four were inoculated onto their CAMs (as described in section 6.2.2.1) and four were 
inoculated into their yolk sacs using a sterile needle (6.2.2.2). The infected eggs were placed 
in an incubator at 35,5 °C. Virus was harvested from the CAMs of four of the eggs (two 
from each inoculation route) after 5 days and from the CAMs of the other four eggs after 7 
days. The virus titre was then determined by titration on MDBK cells. 
A volume of 0,1 ml ofvirus that was recovered from the 7 day infection (CAM inoculation 
route) was used to inoculate the CAMs of another two 7-day old embryonated eggs. These 
were also incubated for 7 days at 35,5 °C before virus was harvested. The virus was 
passaged a further four times as described above, and the virus harvested after each passage 
was titrated on MDBK cells. 
6.3 RESULTS: 
6.3.1. LSDV growth at different temperatures: 
The titres of LSDV obtained in LT cells at 35 °C, 37 oc and 39 oc are presented in Table 
6.1 and Fig. 6.1 It can be seen that there is virtually ,no difference in the amounts of 
infectious virus recovered during the first three days from cultures grown at either 3 5 oc or 
37 °C. However, by 96 hours post-infection, the virus titre at 37 °C had decreased slightly 
(about 0.5 log) whereas the virus titre at 35 oc had increased by a similar amount. 
Replication of LSDV is apparently less efficient at 39 oc than at the other two temperatures. 
An initial increase in titre (from 6.0 x 104 p.fu./ml at 24 hours to 6 x 106 p.fu./ml at 36 
·hours) showed that the replication started at the same rate as reflected in cultures grown at 
either 35 oc or 37 °C, but thereafter the titre (at 39 °C) decreased and there was no extra 
gain in the recovery of infectious virus. 
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TABLE. 6.1: Effect of temperature on the growth of LSDV in LT cells 
TIME AVERAGE TOTAL LOG10 
POST TEMP NO. OF DILUTION NO. OF TOTAL 
INFECTION FOCI FACTOR FOCI NO. FOCI 
(HOURS) (°C) PER WELL 
0 - 8.0 102 4.8 X 104 4.7 
24 35 3.0 103 1.8 X 105 5.3 
37 3.0 1.8 X 105 5.3 
39 1.0 6.0 X ·104 4.8 
48 35 16.0 104 9.6 X 106 7.0 
37 15.0 9.0 X 106 7.0 
39 10.0 6.0 X 106 6.8 
72 35 8.0 104 4.8 X 106 6.7 
37 12.0 7.2 X 106 6.9 
39 2.0 1.2 X 106 6.1 
96 35 28.0 104 1.7 X 107 7.2 
37 4.0 2.4 X 106 6.4 
39 3.0 1.8X106 6.3 
The effect of temperature on the replication of LSDV was then investigated using CFK cells 
(in place of LT cells). Because of the apparent slight advantage seen at 35 oc at 96 hours 
post-infection in LT cells, the CFK experiments were designed to include titrations after an 
additional 24 hour period at 35 °C, and virus yields were also measured after replication at 
33°C. The results are presented in Table 6.2 and Fig. 6.2. There was little difference 
(between LT and CFK cells) in the patterns of growth at either 35 °C or 37 °C. However, 
39 oc was apparently even less favourable for LSDV replication in CFK cells than in LT 
cells, and no significant yield of infectious virus could be obtained at that temperature. The 
most favourable temperature for virus yield in CFK cells was 33 °C, where titres rose more 
rapidly and attained higher levels than those obtained from cells infected at higher 
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temperatures. At both 33 oc and 35 °C, maximum titres were shown at 120 hours after 
infection, the main difference being that at 33 oc peak levels of infectious virus were reached 
and maintained from 48 hours after infection, but at 35 oc titres rose slowly and steadily 
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FIGURE 6.1. 
Growth of LSDV at different temperatures in LT cells over a four day infection period. 
Log
10 
values of total p.f.u. are plotted against time. 
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TABLE 6.2: Effect of temperature on the growth of LSDV in CFK cells 
TIME AVERAGE TOTAL LOG10 
POST TEMP NO. OF DILUTION NO. OF TOTAL 
INFECTION FOCI FACTOR FOCI NO. FOCI 
(HOURS) (°C) PER WELL 
0 - 8.5 103 5.1 X 1Q5 5.71 
24 33 4.7 104 2.8 X 106 6.50 
35 1.4 104 8.4 X 10s 5.92 
37 2.0 104 1.2 X 106 6.08 
39 4.5 103 2.7 X 105 5.43 
48 33 2.5 105 1.5 X 107 7.20 
35 5.0 104 3.0 X 106 6.48 
37 1.0 105 6.0 X 106 6.78 
39 6.5 103 3.9 X 1Q5 5.59 
72 33 1.5 105 9.0 X 106 6.95 
35 1.0 105 6.0 X 106 6.78 
37 3.6 104 2.2 X 106 6.34 
39 1.5 104 9.0 X 105 5.95 
96 33 1.7 1Q5 1.0 X 107 7.00 
35 1.3 105 7.8 X 106 6.89 
37 1.5 105 9.0 X 106 6.95 
39 2.5 103 1.5 X 105 5.18 
120 33 3.0 105 1.8 X 107 7.30 
35 2.2 105 1.3 X 107 7.12 
log p.f.u .. 
5 
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FIGURE 6.2. 
Growth of LSDV at different temperatures in CFK cells over a four day infection period. 
Log
10 
values of totaJ p.fu. are plotted against time. 
6.3.2. Growth in different cell culture media: 
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CFK cells infected with LSDV were grown in the presence of different culture media to 
assess whether the choice of medium might affect the ultimate yield of infectious virus. 
Titres are given in Table 6.3. Cells cultured in Drvt:EM supplemented with Ham's F-12 
nutrient medium, produced the highest yield ofLSDV (4.2 x 107 p.f.u.). This titre was 2- to 
. 3-fold higher than those obtained from cells grown in DMEM alone (1.2 X 107) or BEM (2.6 
X 107), although more than 10-fold higher than when MEM was used (2.4 X 106). 
6.3.3. Pretreatment of virus with trypsin: 
Although it has been reported that pretreatment of vaccinia virus with trypsin increases its 
infectivity, the opposite effect was found for LSDV infectivity (Table 6.3). The titre obtained 
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after 3 days with a LSDV stock which had been pretreated with trypsin (6.0 X 106 p.fu.) 
was slightly lower than that obtained with virus which had not been treated (1.0 X 101 p.fu.). 
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6.3.4. Changing the period of adsorption: · 
Leaving the virus inoculum in contact with the cells for a period of 24 hours, as opposed to 
.. one hour had no significant effect on the vield of LSDV recovered :-...-4:er 3 da~·;:; (lAX 107. 
p.fu. and 1.2 X 107 p.fu. respectively) (Table 6.3). 
6.3.5. Splitting of infected cells: 
The procedure of splitting the culture cells 1 :2 at 24 hours after infection with LSDV, 
resulted in only a slight increase in the yield of LSDV recovered; 1.6 X 107 p.fu. as 
opposed to 1.2 X107 p.fu. for cells not split (Table 6.3). This difference was not considered 
to be significant. 
6.3.6. Infecting cells with different concentrations of LSDV : 
Titrations were performed to assess the extent to which the dose of infecting virus affected 
the ultimate yield of infectious particles. Two doses were compared in which inocula 
cont~!r•~(l !itres of t::ilher Sx less or Sx more than the standard inoculum dose. The results 
{Table 6.3) indicated that infection at an M.O.I. of 5 resulted in only a slight increase in the 
maximum yield ofLSDV (1.7 X 107 p.fu.) over that obtained with a starting M.O.I. of 0.2 
(1.2 X 107 p.fu.). Overall, however, the initial dose of infecting virus had a negliable effect 
on the growth of LSDV in CFK cells, or on the yield ofLSDV virions {Table 6.3). 
6.3.7. Growth in different cell lines: 
Table 6.4 contains results ofLSDV yields in different cell lines. Moderate titres (in the order 
of 3. 0 x 1 o6) were obtained in MDBK cells, and the presence of mycoplasma had no 
adverse effect on LSDV growth. However, both primary LT and CFK cells resulted in a 7-
fold increase in the yield of LSDV over that obtained in MDBK cells. No replication of 
LSDV was detectable in Vero, CVI or RK13 cells and the virus yield consequently 
decreased rapidly with each passage. In Don cells, this decrease in LSDV yield occurred at a 
much slower rate and and virus was detectable until passage 5. Don cells infected at passage 
6 failed to reveal the presence of viral antigen when stained using an indirect 
iriiHiur..opcroAidZLiie ;;taini11g technique. 
/ 
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In CEF cells the first cycle of infection yielded titres equivalent to those obtained in MDBK 
cells. -This titre was 1 o3 -fold lower on the second passage, but remained constant on passage 
three, indicating that CEF cells may well support the growth of LSDV to a limited extent. 
TABLE 6.4 : Growth of LSDV in different types of cells. 
CELL TYPE VIRAL PASSAGE NO. TOTAL TITRE (P.F.U.) 
MORK (m: )h~rna -V(l) 1 _b6X 106 
MDBK (mycophu~m:t +ve) 1 3 X 106 
LT 1 -
CFK 1 -
VER_Q 1 J.5X1~ 
2 1.5X101 
3 < 5 X 101 
DON 1 5.7 _X 105 
3 3 X 102 
5 <l_X_lQ2 
CV1 1 _! __ ._£_::( _lQ_4 
2 <]_)(_lQ3 
3 __!_.1__K_!Q 1 
RK 1 3.6 X 104 
2 ~~ 
3 < 1.5 X 102 
CEF _1_ 3 X 106 
2 6.9 X 103 
3 6 X 103 
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6.3.8. Growth in embryonated chicken eggs: 
Evidence was obtained that embryonated hens' eggs could support the replication of LSDV 
(Table 6.5). Inoculation into the yolk sac of 7-day old embryos resulted in premature death 
of the embryos despite the fact that only a low titre of viral inoculum (5 X 103 p.fu.) was 
used. Although the yield of virus obtained after CAM inoculation was no higher than that 
obtained from inoculation of the yolk sac, only one embryo died when inoculated onto the 
CAM as opposed to three when inoculated into the yolk sac, showing that the former route 
of inoculation is safer. LSDV could be repeatedly passaged in eggs (via the CAM route of 
inoculation) and even after six passages, 1.5 X 105 p.fu. per egg was recoverable (Table 
6.6). 
TABLE 6.5: Growth of ISDV in embryonated chicken eggs. 
INOCULATION No. OF No. OF EGGS No. OF EGGS TITRE OF VIRUS 
ROUTE DAYS POST INOCULATED SURVIVED RECOVERED 
INFECTION PER EGG 
YOLK 5 TWO ONE 7 X 104 
CAM 5 TWO TWO 7.5 X 104 
YOLK 7 TWO NONE -




TABLE 6.6: Passage of LSDV In embryonated chicken eggs. 
PASSAGE INOCULUM No. EGGS No. EGGS TITRE PER 
NO. PER EGG INOCULATED SURVIVED EGG (P.F.U.) 
2 2XJ04 ONE ONE 7X 105 
3 2X 103 FOUR TWO 2.5 X 105 
4 1 X 103 TEN SIX 7.3 X 104 
5 2X 103 TEN EIGHT 5 X 104 
6 2 X 103 TEN EIGHT 1.5X105 
6.3.9. Optimal conditions for the culture of LSDV: 
A comparison of the yields of infectious LSDV obtained by changing individual culture 
parameters indicates that certain conditions are more favourable for growth than others. The 
culture conditions, which produced the highest yields of infectious virus from each set of 
altered parameters, is presented in Table 6. 7. Also shown is the good yields obtained using 
foetal bovine. testes cells (FBT) grown in the presence of the most favourable culture 
medium. 
Although none of the conditions tested produced a dramatic increase (> 1 0-fold) in the yield 
of infectious virus (when compared with the yield obtained using standard conditions), even 
an increase of two- to three-fold was considered as being significant. 
·--:a..,.·.a:.a.::J:&.;;11":&.~01V.l :c1-;-DMEM FBT, DMEM + HAMs 
1.6 X IQ7 7 X IQ7 
n 
TABLE 6.7: Summary of optimal culture conditions for maximum yield of 
infectious LSDV. 
PARAMETER STANDARD OPTIMAL 
CONDITION CONDITION 
37 °C, LT cells 35 oc 
TEMPERATURE 9.0 X 106 1.7x107 
3 7 °C, CFK cells 33 oc 
9.0 X 106 1.8x107. 
CULTURE MEDIUM DMEM DMEM +HAMs F-12 
1.2 X 107 4.2 X 107 
CELL TYPE CFK LT 
1.6x 107 2.1 X 107 
CELL TYPE and MEDIUM LT,DMEM FBT, DMEM +HAMs 
1.6 X 107 7 X 107 
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6.4 DISCUSSION: 
Extensive tests were performed to establish optimal conditions of culture for maximum 
yields of infectious LSDV. Although few of the techniques tested had a profound influence 
on the established '!standard" procedures (i.e. > 10-fold increase or decrease in viral yield), 
the combination of a number of changed parameters were found to be advantageous. 
Lowering the incubation temperature of infected cells to 33 °C, the combined use of DMEM 
and Ham's F-12 supplement as the culture medium, and the choice of primary bovine or ovine 
kidney or testes cells, all contributed to increasing the yield of infectious LSDV virions. 
During these studies a number of interesting aspects concerning the in vitro culture of 
LSDV were observed. 
LSDV has proved to be extremely host-specific with respect to natural transmission and 
infection as evidenced by the total absence of reports of capripoxvirus infections in sheep or 
goats in South Africa (cited by Kitching et al., 1989). In the present study, it was shown that 
cell cultures established from both ovine and bovine tissue were able to support the 
replication of the virus. Highest yields were obtained with primary cell cultures of either 
testes or kidney cells. A continuous cell line of bovine kidney cell origin (MDBK cells) was 
also permissive for propagation of LSDV, but a 5-fold increase in virus yield was obtained 
from primary CFK cells over that obtained in the MDBK cell line, even in the absence of 
mycoplasma. 
CFK culture cells are routinely maintained at 3 7 °C. It is of interest that higher titres of 
LSDV could be obtained when cultures were grown at the lower temperatures of 33 °C and 
35 °C. Enzymatic activity has strict temperature boundaries. Since poxviruses encode most 
of the enzymes required for their replication, it may be deduced that LSDV-encoded 
enzymes operate preferentially at 33 °C. It is possible that the advantage conferred by the 
lower temperature on the in vitro production of infectious virus may reflect the natural 
conditions of the site of virus replication in vivo. 
The successful replication of LSDV in vitro is apparently dependent upon additional nutrient 
requirements supplied in the culture medium. Studies showed that standard MEM medium 
was suboptimal for good yields of infectious virions, and of the various culture media tested, 
best yields were obtained when cells were grown in DMEM with the addition of HAM's F-
12 supplement. Media containing a broader spectrum of amino acids and vitamins, or higher 
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concentrations of certain amino acids, in particular L-glutamine, were found to be best 
suited. The HAM's supplement contained, in addition, a number of critical trace-elements 
and organic factors required for cellular metabolism. 
Receptors on the surface of the virion itself play a major role in virus infectivity. Chand and 
Black (personnal communication) have identified a 32 kDa major structural protein of a 
capripoxvirus (KS-1) which is involved in attachment of the virions to the surface of 
cultured lamb testis cells. The terminal portion of this protein is removed by trypsin, leaving 
a 22 kDa fragment associated with. the virus surface, and reducing the virus infectivity by at 
least 10-fold. This may in part explain our observation that treatment ofLSDV with trypsin 
prior to the inoculation of CFK cells resulted in reducing the final yield by almost half, despite 
the recommendation ofMackett et al. {1985) that pretreatment of vaccinia virus with trypsin 
results in increased infectivity. 
Little is known about the viral receptors on susceptible cells, nor about the manner in which 
LSDV is able to enter each of the different types of cell. A constant observation during 
these studies was that a certain amount of infectious virus could be recovered from the 
cellular fraction at the end of the adsorption period. It was assumed that this represented 
virus particles which had adsorbed to the cell surfaces, but had not been internalised. The 
reason for their inability to penetrate the cells is unknown. The length of time for which the 
inoculum was left in contact with the cells did not result in any apparent increase in the 
efficiency of infection. In the case of herpesvirus infections it has been reported that 
multiple infections of a single cell are inhibited by herpesvirus-encoded proteins (Johnson 
and Spear, 1989). It is possible that similar mechanisms may exist for poxviruses, and might 
explain why a 25-fold increase in the M.O.I. of the inoculum did not result in an appreciable 
increase in the final yield of progeny virus particles. 
In the present study, the yield of LSDV virions was measured only in terms of infectivity in 
MDBK cells. The majority of virions released from infected cells were shown by electron 
microscopy to be enveloped (unpublished data; see also Fig. 2.1). It is possible that 
procedures used to release intracellular virus (low ionic strength buffer, freezing and thawing, 
etc.) may damage or even completely remove the envelope. It is not known at this stage 
what effect this might have on virion infectivity. It has been reported that enveloped 
vaccinia virus particles are more rapidly adsorbed to the cell membrane (as cited by Sordeik 
et al., 1993), but both enveloped and naked virions are infectious. The nature and 
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prevalence of cell receptors on the various cell types will in part determine their degree of 
susceptibility to infection by the morphologically different forms of the virion. 
The host-cell species specificity noted in natural infections of LSDV were reflected in the 
inability to achieve replication of LSDV virus in cells of rabbit, hamster or monkey origin· 
(RK13, Don, CV-1 or Vero cells). Gershon and Black (1988) also reported failure in 
attempts to grow capripoxviruses in cells derived from hosts other than from goats, sheep or 
cattle, although Weiss et al. (1968) reported experimental induction of LSDV infection of a 
number of ovine and bovine cell lines as well as in foetal rabbit kidney and skin cells, chick 
embryo fibroblasts, adult vervet monkey kidney cells and baby hamster kidney cells. 
Van Rooyen et al. (1969) reported growth and serial passage of LSDV in chicken 
chorioallantoic membranes which resulted in an attenuated virus, later developed for use as a 
vaccine against lumpy skin disease. As the vaccine strain of LSDV (Neethling) was used in 
all the present studies, it is probably not surprising that chick embryo cells were able to 
support LSDV replication and that the virus could also be repeatedly passaged in hens' eggs. 
However, only comparatively low yields of infectious virions could be recovered from the 
avian cells. It is known that host specificity in poxviruses is linked to the non-conserved 
terminal regions of their genomes which contain host-range genes (Gershon and Black, 
1988). Serial passage of LSDV in CAMs, and even sheep cells, might have resulted in the 
loss or rearrangement of genes concerned with host-range specificity, thus endowing the 
vaccine strain with the ability to overcome the avian host-range restriction. DNA 




Once an optimal set of conditions for the growth of LSDV had been established, the 
following step was to optimise procedures for the purification and recovery of viral DNA for 
restriction digestion analysis. In this respect a number of factors were considered as a 
balance had to be found between the maximum recovery of virions and obtaining virus that 
is free of contaminating cellular material. The lysis technique for recovering DNA from 
purified virus particles also required special attention as the DNA would have to be of a 
high quality and yield and sufficiently pure to ensure complete restriction with site-specific 
endonucleases. 
A number of techniques are available for the purification a.iJ.d !~·:;i~ c:· po;,.~;irus virions 
(Mackett et a/., 1985; Black et a/., 1986). Most virion purification techniques involve the 
use of density gradient centrifugation, which inevitably result in the loss of an appreciable 
amount of.virions. These losses are affordable when purifying virions from poxviruses which 
grow to high titres in cell culture, but some poxviruses, such as LSDV, do not, and it was 
thus necessary to consider alternative techniques for the purification of LSDV. Esposito et 
a/. ( 1981) described the use of a non-ionic detergent and reducing agent for isolating 
orthopoxvirus DNA from the cytoplasm of infected cells. He found that incubation of 
infected cells in the presence of low concentrations of Triton X-100 and J3-
mercaptoethanol, and removal of cell nuclei by low speed centrifugation, resulted in a 5-fold 
increase in the yield of viral DNA over that recoverable from purified virions. This 
intracellular source of viral DNA was of a similar quality to DNA obtained from virions. 
As has already been noted for LSDV growth in lamb testes cells, a high percentage of 
infectious virus remains intracellular (Chapter 5). Although techniques such as douncing and 
freeze-thawing are effective in releasing virus from ir>.fcctcd cells, they appear to lyse cell 
nuclei resulting in cellular DNA contamination of viral preparations. A more gentle 
technique is thus necessary for recovering viral DNA from cells. It was thus the aim of this 
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experiment to assess the viability of using Esposito's technique (Esposito et a/., 1981) for 
the recovery of LSDV from infected cells. In addition, a variety of virus lysis techniques 
were assessed in terms of obtaining the maximum yield and quality of viral DNA. 
7.2 MATERIALS AND METHODS: 
7.2.1. Pulse field gel electrophoresis: 
Although conventional electrophoresis (non-pulsed) is sufficient for resolving small fragments 
( < 20 kbp ), larger fragments migrate with a common mobility (Bostock, 1988). Alternating 
the direction of the electric field was found to enhance the separation of large DNA 
molecules by causing them to continually reorientate themselves as they migrate through the 
gel matrix (as reviewed by Lai et a/., 1989). Pulse Field Gel Electrophoresis [or Field 
Inversion Gel Electrophoresis (FIGE)] was one of the techniques developed to enhance the 
resolution of large DNA fragments. A forward to reverse pulse ratio of 3:1 is used, with 
long pulse times being required for the separation of large fragments and shorter pulse times 
for the separation of small fragments. Ramping the forward and reverse pulses has the added 
advatii.<::·.ge uf ir,e;! easing the range of fragment sizes which can be separated during one 
electrophoretic run. 
7.2.1.1 Preparation of gels and electrophoresis of DNA: 
Agarose gels (0.8 %) were prepared by adding 0.8 g of agarose (Agarose MP, Boehringer 
Mannheim, Germany) per 100 ml of 0.5 x Tris-Borate-EDTA (TBE) buffer (Appendix 1). 
The agarose was dissolved by heating the solution to boiling temperature in a microwave 
oven (Sharp Carousel). After cooling to 56 °C, 250 ml of the 0.8% agarose was cast in a 
large casting tray (25 em x 19 em x 0.75 em). A 20-toothed comb was used and the gel was 
left to set for at least 2 hours at room temperature. Once the comb had been carefully 
removed, the gel was placed in a Hoefer Super Sub electrophoresis tank (Hoefer Scientific 
Instruments, San Fransisco, U.S.A.). Only 1.2 litres of 0.5 x TBE buffer was required for 
this tank as it employs a buffer recirculation system through a refrigerated waterbath (Haake 
D8-G, Germany). Internal buffer circulation was obtained using a magnetic stirrer linked to a 
Hoefer Multi-Spin Stir Controller. A constant temperature of 13-15 °C ccu!d ~hus be 
,maintained for the duration of the run. After loading DNA samples, a non-pulsed prerun of 
150 V (or as otherwise stated) for 15 minutes was initiated. The electrodes were then 
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reconnected to a Hoefer PC 750 Pulse Controller and electrophoresis was continued using 
conditions as specified for each individual run. 
NOTE: For each FIGE run, forward pulses (F) were approximately three times longer than 
reverse pulses (R) and the pulses were ramped by increasing the forward and reverse pulse 
times by an incremental rate (r) for the duration of the electrophoretic run. 
7.2.1.2. Staining, viewing and photographing gels: 
Following electrophoresis for the required time period, the power supply was disconnected 
and gels were stained in 500 nglml ethidium bromide (EtBr) (Merck, Germany) (diluted in 
0.5 X TBE buffer) for 30 minutes. The fluorescing DNA bands were visualised on a UVP 
Transilluminator (model TM-40E, 302 nm wavelength) (UVP, U.S.A). Gels were 
photographed as described (Appendix 2). 
7.2.2 Virus purification for DNA isolation: 
The method of Esposito et a/. (1981) for the recovery of orthopoxvirus DNA from the 
cytoplasm of infected cells was adapted for the purification of LSDV. At each stage of the 
purification, an aliquot of virus was removed for titration in order to ascertain which 
fractions, produced during the purification procedure, contained LSDV virions. 
One 175 cm2 cell culture flask was seeded with primary LT cells. Once the cells had 
reached 90 % confluency, they were infected with 1 x 107 p.fu. of LSDV vaccine as 
described (4.2.6). After 3 days, 90 % of the cells exhibited CPE. Intracellular and 
extracellular virus was then harvested as follows (Fig. 7.1): 
The medium (20 ml), containing detached cells and extracellular virions, was harvested and 
the cells remaining attached to the floor of the flask were removed with mild trypsin 
digestion ( 4.2.4). These cells were pooled with the medium and an aliquot was 
removed for titration (labelled "Sample #I"). The rest of the pool was centrifuged at low 
speed in a Sigma 301K benchtop centrifuge (1500 rpm for 10 min at 4 °C). The supernatant 
fluid was removed and an aliquot was titrated ("Sample #2"). The cell pellet was 
resuspended in 4 mi ofMcllvain's buffer, an aliquot was removed for titration ("Sample #3") 
and the volume was adjusted to 18 ml in Mcilvain's buffer. This cell suspension was divided 
A 
Infected cells+ medium (Sample #1) (22 ml) 
1500 rpm, 10 min, 4 °C 
~ 
medium (Sample #2) (22 ml) 
cell pellet (Sample #3) + 4 ml Mcilvain's buffer 
~ 
Resuspended pellet ( 4 ml) + 
14 ml Mcilvain's buffer (18 ml) 
Ice, 10 min 
l ml Triton + 25 f.il 13-mercaptoethanol I ml Mcilvain's buffer 
Ice, 10 min 




Supernatant fluid Supernatant fluid 
cell debris + 10 ml Mcilvain's buffer cell debris + 10 ml Mcilvain's buffer 
Supernatant fluids 
pooled (Sample #4) 
Ice, 10 min 




cell debris (Sample #6) cell debris (Sample #7) 
Figure 7.1. Flow diagram of virus purification from Triton-treated (A) and untreated (B) 
cells. 
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into two equal portions. These were placed on ice for 1 0 minutes and were then treated as 
follows: 
1) · One portion was treated to release intracellular virus by the addition of I ml of I 0 % \ 
(v/v) Triton X-100 (diluted in Mcilvain's buffer) and 25 Jll 6-mercaptoethanol. 
2) 1 ml of Mcilvain's buffer was added to the other portion. 
Triton-treated (I) and untreated (2) cells were processed in parallel in the following way: 
After incubation for a further 10 minutes on ice, with occasional gentle shaking, the cell 
suspension (containing released virus) was centrifuged at 2000 rpm for 5 minutes. The 
supernatant fluid was collected. The cell debris was resuspended in Mcilvain's buffer and 
was centrifuged at 2000 rpm for 5 minutes. This supernatant fluid was pooled with the first 
supernate and an aliquot was removed for titration (Sample #4 from Triton-treated cells 
and Sample #5 from untreated cells). An aliquot of the remaining cellular debris was also 
removed for titration (labelled "Sample #6" and Sample #7" for treated and untreated cells 
respectively). 
The supernatant pool was then divided into three equal portions, and virus particles were 
concentrated by centrifugation at 11 000 rpm ( 19000g) for 60 minutes at 4 °C in a Beckman 
J2-21 centrifuge (JS 13-1 swing-out rotor). 
7.2.3 Viral DNA purification: 
The three virion pellets were each resuspended in 25 Jll T.E. buffer (10 mM Tris-HCl, 1 
mM EDT A, pH 9,0) and one of the following virion lysis buffers was added:-
1. 25 Jll of lysis buffer A (1% SDS, 20 mM EDT A, 20 mM 6-mercaptoethanol) (adapted 
from Mackett eta/., 1985). 
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2. 25 J.d lysis buffer B (IOmM Tris-HCl, pH 9; 20 nlM NaCl; 100 mM EDT A; 2% sodium 
lauroyl sarcosinate) (adapted from Esposito eta/., 1981). 
3. 25 J.ll of lysis buffer C (2,5 J.ll 200 mM B-mercaptoethanol; 100 mM Tris (pH 7,8) and 
22,5 J.l! 54 % sucrose; 4 % soqiur .• iet!rcyi :)a.rco~~inate) (adapted from Niassung and Moyer, 
1991). 
Proteinase K (final concentration = 100 J.lg/ml) was added to each sample and they were 
incubated at 56 oc for two hours. 
Each of the final 6 samples (three originating from Triton-treated cells and three from 
untreated cells) was assayed for DNA yield by field inversion gel electrophoresis (FIGE). 
Parallel electrophoresis was performed on DNA extracted from the following samples:-
a) samples of cell debris (#6, #7) using lysis buffer C 
b) uninfected MDBK cells using lysis buffer A 
c) purified vaccinia virus (DIE), as a marker (Kindly ~upp!ied by ~.!r,.ddaine 
Richardson, previously of the Department of Medical Microbiology, UCT). 
d) Triton-treated sample lysed with lysis buffer C, after phenol/chloroform 
clarification 
Electrophoresis was performed as follows: 
A 10 J.ll aliquot of each sample was diluted in 10 J.ll of T.E. buffer (pH 9,0) and 3 J.1l of Stop 
buffer (X6) (Appendix 1). These were loaded onto a 0,8 % agarose gel and subjected to 
FIGE using the following conditions: 
Prerun: 
Run: 
200 V, 68 rnA, 15 min at 14 °C, 
200 V, 68 rnA, 12 hours, Forward (F)= 1,0 sec, Reverse (R) = 0.3 sec and 
ramp (r) = 1,0 at 14 °C. 
The gel was stained and visualised as described (7.2.1.2). 
I 
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Samples #1 to #7 were titrated as described in Chapter 4 (4.2.7.1) after 3 cycles of freeze-
thawing at -20 oc and room temperature. The titre of each sample (in p.f.u./ml) was 
multiplied by the respective volume (in ml) of the original sample to give the total number of 
infectious units. 
7.3 RESULTS: 
The number .of infectious virus particles recovered at various stages of the extraction 
procedure is shown in Table 7.1. It was calculated that 3.9 x 107 p.f.u. could be obtained 
from one 175 cm2 flask of primary LT cells (Sample #1) and 3.3 x 107 p.f.u. from the cell 
fraction alone (Sample #3). These estimates were drawn from titrations of infectious virions 
released from sample aliquots by freezing and thawing. 
Alternative methods of achieving cell lysis .and releasing intracellular virus particles were 
assessed. These included disruption of the cell membranes with a mixture of Triton X-1 00 
and ~-mercaptoethanol, or with the hypotonic Mcilvain's buffer. The number of infectious 
particles released by each method were compared and this provided an indication of the 
minimal amount of intact viral DNA that could be obtained from the respective cell lysates. 
The use of Triton X-100 and ~-mercaptoethanol allowed the recovery of 1.5 x 107 p.fu. of 
infectious virus, which is slightly less than the titre estimated to be gained by freezing and 
thawing an equivalent volume of cells (50% of fraction #3) and slightly higher that obtained 
with Mcilvain's buffer (1.2 x 107 p.f.u.). The small difference in yield of infectious virus 
recovered from the two experimental cell lysates was reflected in the relative amounts of 
infectious virus remaining in the cellular debris - 4. 7 x 1Q6 p.fu. were recovered from 
Triton-treated cell debris, and 9. 7 x 1 o6 p.f.u. from the debris of cells lysed in Mcilvain's 
buffer alone. 
The quality and quantity of viral DNA that could be obtained from the respective cell lysates 
was assessed by subjecting virus particles released from infected cells (either with or without 
Triton X-1 00) to 3 different methods to release viral DNA. In order to assess the yield and 
quality of DNA, samples were electrophoresed using FIGE. This electrophoresis technique 
allows for separation of high molecular weight DNA (e.g. LSDV; 152 kb) from lower 
molecular weight cellular DNA (e.g. mitochondrial DNA;= 20 kb). 





VIRUS RELEASED FROM CELLS TREATED 
WITH TRITON 
CELL WITHOUT 
1.5 X 107 
1.2X107 
9.7 X 106 
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Vaccinia (DIE) DNA and DNA from uninfected cells (Fig. 7.2, lanes 11 and 10 respectively) 
were used as markers to help distinguish between viral and cellular DNA bands. Each lane in 
Fig. 7.2, consisting of DNA derived from cells infected with LSDV (lanes 1-8 and 13), 
contains a DNA band migrating slightly slower than the 145 kb marker fragment (lane 12). 
The relative position of this band is in agreement with the expected position of LSDV DNA 
(152 kb). As the band is absent from uninfected cells (lane 10), it can be assumed that it 
represents unit length genomes of LSDV DNA. Vaccinia virus DNA (lane 11) appears to 
co-migrate with the 194 kb marker fragment (lane 12), which is in agreement with the 
genome size of this isolate (190 kb ). 
Relative amounts of DNA were assessed by loading an equal proportion of each sample 
(115) per lane (Fig. 7.2, lanes 1-6). The use of lysis buffer B (lanes 1 and 4) resulted in a 
lower yield of DNA than when lysis buffer A (lanes 3 and 6) or C (lanes 2 and 5) were used. 







Agarose gel of LSDV (Neethling) vaccine DNA purified using various techniques. 
Lanes 1, 2 and 3 = untreated cells. Lanes 4, 5 and 6 = cells pretreated with 
Triton X-1 00. Virus particles lysed using lysis buffer B (lanes 1 and 4), or lysis 
buffer C (lanes 2 and 5) or lysis buffer A (lanes 3 and 6). Lane 7 =cell debris 
from untreated cells. Lane 8 =cell debris from cells pretreated with Triton X-
1 00. Lane 9 = well leaked. Lane 10 = cell debris from uninfected cells treated 
with Triton X-100. Lane 11 =Vaccinia (DIE) DNA, uncut. Lane 12 = High 
Molecular Weight marker. Lane 13 = Phenol/Chloroform purified DNA (from 
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lane 5). FIGE conditions: 200 V, 69 rnA, 14"C, 12 hours. F = 1.0 sec, R = 0.3 sec, 
r = 1.0. 
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Cells lysed in standard lysis buffer (Mcllvain's buffer only) (lanes 1,2,3) yielded a slightly 
higher quantity of viral DNA over that obtained from cells pretreated with Triton X-100 in 
conjunction with B-mercaptoethanol (lanes 4,5,6), except for lanes 1 and 4 where the 
opposite result was obtained. 
A comparison of lanes 7 and 8 shows that the amount of viral DNA remaining in the cell 
debris is proportional to the number of infectious virions in that less viral DNA appears to 
remain in cell debris after Triton treatment (lane 8) than in cell debris from untreated cells 
(lane 7). Although the viral bands in lanes 7 and 8 are intense, these DNA samples are three 
times as concentrated as the samples shown in lanes 1 to 6. 
Although the viral DNA in lanes 1 to 6 appear to contain low levels of contaminating DNA 
only, they are probably also contaminated heavily with protein and lipid remnants of the lysed 
virus particles. Removal of these potential contaminants is necessary for restriction of viral 
DNA with endonucleases. Lane 13 contains DNA from the same sample as in lane 5 (but 
approximately three times more concentrated), which has been purified from these 
contaminants using phenol-chloroform extractions (8.2.2.2). The DNA was precipitated and 
resuspended in T.E. buffer. Not only does this treatment purify the DNA from protein and 
hpid couta.-::inant:;, but it also appears to result in removal of low molecular weight Dt.;A 
without degrading the viral DNA (lane 13). A small loss of DNA results during a 
phenol/chloroform extraction, but the recoverable DNA is pure, non-degraded and should 
thus restrict to completion with restriction endonucleases. 
7.4. DISCUSSION: 
A technique, which was first developed for the purification of orthopoxviruses from infected 
cells as an additional source of viral DNA besides extracellular virus (Esposito eta/., 1981), 
was evaluated for the purification of intracellular LSDV particles. Advantages are that the 
technique is rapid and alleviates the need for density gradient centrifugation. The use of a 
nonionic detergent (Triton X-1 00) and reducing agent (~-mercaptoethanol) to release viral 
particles from the cytoplasm of infected cells resulted in a good yield of infectious virions. It 
may be assumed that for virions to be infectious, they need to be intact. This result is in 
siighi contrast to a report on the action of a non-ionic detergent (Nonidet P40) and reducing 
agent (~-mercaptoethanol), which were shown to free viral cores of vaccinia virions by 
solubilising the outer~ virion envelope (Easterbrook, 1966). The vaccinia virions were, 
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however, subjected to much higher concentrations of chemicals at an elevated temperature 
and for a longer period than the LSDV infected cells. In addition, previous studies on the 
culture of LSDV (Chapter 5) have shown that intracellular particles are infectious and 
electron micrographs of intracellular LSDV particles have revealed the presence of 
membranes encapsulating groups of virus particles (Fig. 2.1) (Stannard, personal 
communication). It is thus possible that the mild chemical treatment of infected cells used in 
this study preferentially solubilized these cellular membranes to release individual virions, and 
that only a low percentage of the virion outer membranes were solubilized, leaving the 
majority of virus particles infectious. 
A fair percentage of infectious virus particles were located in the cellular debris in both 
Triton-treated and untreated cells. It is possible that these particles were not released from 
infected cells, even after treatment with Triton, or that they were trapped beneath clumps of 
cellular material which caused them to co-precipitate during centrifugation. This loss of viral 
DNA was, however, considered negligible when compared to the high yield and purity of 
viral DNA recovered from virus particles in the supernatant fluid. The small loss of DNA 
resulting from phenol/chloroform purification, is also considered negligible, as, without this 
process, contaminating proteins and lipids would interfere with the restriction of viral DNA 
with endonucleases. 
Various combinations of detergents and 13-mercaptoethanol were evaluated to find an 
optimal lysis buffer for release of DNA from intact virus particles. The lysis buffer with the 
highest concentration of 13-mercaptoethanol (lysis buffer C), in conjunction with Triton 
treatment of cells, proved to be the best for virion lysis, as almost no contaminating 
mitochondrial DNA co-precipitated with the viral DNA. Viral DNA preparations were also 
completely free of high molecular weight chromosomal DNA and restricted to completion 
with endonucleases (personal observation). 
Thus, the combined use of Triton X-100 and 13-mercaptoethanol to release intracellular 
LSDV particles from infected cells, and a virus lysis buffer containing a high concentration of 
13-mercaptoethanol, was found to produce a high yield and quality of viral DNA. In 
subsequent infections, involving the combined use of optimal culture and purification 
conditions and infection of -1 x 1 os cells, enough viral DNA was recovered on average for 




RESTRICTION ENDONUCLEASE ANALYSIS OF LSDV ISOLATES: 
8.1 INTRODUCTION: 
Site-specific restriction endonucleases have been successfully used to distinguish different 
isolates of capripoxviruses (Black et al., 1986), whereas serological testing failed due to the 
presence of a common major antigen (Kitching et a/., 1986). Hin dill restriction digest 
patterns of different capripoxviruses from Africa and Asia, including LSDV from South 
Africa, indicated a close degree of relatedness (Black et a/., 1986). Their results further 
showed that isolates from different hosts display specific differences in their restriction 
patterns, which appear to relate to the animal host. A very close relationship was shown 
between Kenya sheep-and-goatpox virus and different isolates of LSDV. The genome 
length of a Kenyan capripoxvirus, which is associated with outbreaks of LSD in Kenya (KC-
1), has been estimated to be 145.6 kbp (Gershon and Black, 1987). This contrasts with the 
South African (Neethling) vaccine strain of LSDV which has recently been accurately 
mapped and sized to give a genome length of 152.61 kbp (Perlman, 1993). Recent molecular 
studies in Cape Town have identified LSDV homologues of the vaccinia virus intermediate 
class of transactivating genes, as well as a rifampicin gene (Cohen, personal communication). 
Early attempts to create a recombinant LSpV expressing a bluetongue virus antigen (virus 
protein 7), using heterologous recombination between the LSDV TK and vaccinia virus TK 
genes, were unsuccessful due to the heterologous nature of the LSDV and vaccinia virus TK 
genes (Brand, 1993). ParaHel studies have identified LSDV genes which are strongly 
expressed during infection, and may contain promoters suitable for use in the development of 
a recombinant vaccine (Fick, 1992). No research has been published on analysis of virulent 
LSDV strains originating in southern Africa. As recombinant LSDV work is in progress, a 
comparison of restriction endonuclease patterns of southern African field isolates of LSDV 
would be of interest in determining whether these are closely related to the virulent South 
African (Neethling) strain. 
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Hin diii, Eco RI, Pst I and Bam HI were used to cleave the DNA genomes of the four 
LSDV field isolates and the vaccine strain. Field inversion gel electrophoresis (FIGE) has 
been successfully used to separate and size poxvirus restriction digest fragments (Massung 
and Moyer, 1991; Bostock, 1988). FIGE was thus used to separate the LSDV DNA 
fragments and the resulting patterns were analysed. 
8.2 MATERIALS AND METHODS: 
8.2.1 Source of virus isolates: 
Attenuated LSD V vaccine and virulent field isolates were originally obtained from the 
Virology Section, Onderstepoort Veterinary Institute, Pretoria as freeze-dried cell culture 
supernatant fluid. Virus particles were rehydrated in sterile, distilled water and were then 
passaged in cell culture as indicated. 
(Refer to Figure 8.1 for the original locations of the LSDV isolates used in this study.): 
\ 
1) LSDV (Neethling) - this isolate was isolated from infected cattle from the Marico District 
of the Western Transvaal, South Africa (Thomas and Mare, 1945). The virus was passaged 
4 times in calf kidney cells and then 6 times in lamb kidney cells, before being freeze-dried. 
The rehydrated sample used in this study was passaged 11 times in MDBK cells and then 
twice in LT cells before viral and DNA extraction. 
2) LSDV (Neethling) vaccine - this isolate is derived from the original virulent LSDV 
(Neethiing) isolate which was passaged in eggs and cell culture to produce an attenuated live 
vaccine (as described by Weiss, 1968). The sample used in this study was kindly supplied by 
D. Kow (Department of Medical Microbiology, Medical School, UCT) after several 
passages in CFK cells. The virus was then passaged 12 times in MDBK cells. After 2 further 
passages in FBT cells, viral DNA was extracted from infected cells. 
3) LSDV (Gaborone) -this virus isolate was also kindly supplied by D. Kow after several 
passages in CFK cells. It was then passaged 10 times in MDBK cells and viral DNA was 
extracted after two further passages in FBT cells. First described in 1959. 
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4) LSDV (Haden)- was rehydrated and passaged 13 times in MDBK cells. Viral DNA was 
extracted after two further passages in FBT cells. It was first described in 1954. 
5) LSDV (Maputo)- This isolate was originally called "LSDV 74-8", but was changed to its 
present name for convenience in designating it by its source of origin. Rehydrated virus was 
passaged 7 times in MDBK cells and then twice in FBT cells for DNA extraction. First 
described in 1955. 







A map of southern Africa indicating the locations of the LSDV isolates. 
1 = LSDV (Neethling), 2 = LSDV (Haden), 3 = LSDV (Gaborone) and 
4 = LSDV (Maputo). 
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8.2.2 Purification of LSDV: 
8.2.2.1. Preparation of routine virus stocks : 
The infected cells {LT or FBT) were harvested, either by shaking the flask vigorously to 
dislodge the cells (only possible when the cells were heavily infected) or by scraping the cells 
loose using a "rubber policeman" or by removing them gently using trypsin (4.2.4). The 
medium (DMEM and Ham's F12) containing the loose cells was dispensed into Universal 
bottles. These bottles were balanced and centrifuged at low speed in a Sigma 301K benchtop 
centrifuge at 1500 rpm (250g) for 10 min at 4°C. The cell pellets were lysed in 2 ml 
Mcilvain's buffer and left on ice for 10 min. The lysed cells were centrifuged at 2000 rpm 
(450g) for 10 min and the supernatant fluid was collected. The cell debris was resuspended 
in Mcilvain's buffer and was again centrifuged at 2000 rpm ( 450g) for 10 min. The 
supernatant fluid was collected and pooled with the first virus-containing supernatant fluid. 
An aliquot of the purified virus was removed and the titre of the virus was determined 
(Chapter 4, 4.2.7). The rest of the virus suspension was diluted in glycerol to produce a final 
concentration of 70 % glycerol and was dispensed into ampoules and frozen at -70°C. 
8.2.2.2. Preparation of pure LSDV for DNA extraction (Esposito et al., 1981): 
The culture medium was removed from flasks containing infected cells exhibiting 90 % CPE. 
The infected cells were harvested by using trypsin to release them from the flasks ( 4.2.4). 
The cells were pooled with the medium, dispensed into centrifuge tubes and 0.5 ml of 36% 
sucrose was layered at the bottom of each tube. The virus/cell suspension was centrifuged 
at 11 000 rpm (19000g), 60 min., 4 oc in a Beckman 12-21 (Beckman Instruments, CA, 
U.S.A.) high speed centrifuge in a JS13-1 (Beckman Instruments, C.A., U.S.A.) rotor. The 
pellet was resuspended in 9 ml of Mcilvain's buffer ( 4 mM) and left on ice for 1 0 min. B-
mercaptoethanol (26 11l) and 1 ml of 10 % Triton X-1 00 (in Mcilvain's buffer) were then 
. added and the suspension was further incubated on ice for 1 0 min to disrupt the cells. The 
cell debris was removed by centrifugation at 2000 rpm (450g) for 5 min., 4 °C in a Sigma 
301K benchtop centrifuge (Sigma, Germany) and the supernatant fluid was collected. The 
cell debris was resu!:pt:Hdt:d in Mcilvain's butTer and the centrifugation was repeated (2000 
rpm (450g) for 5 min., 4 ac in a Sigma 301K benchtop centrifuge). The supernatant fluid 
was collected and pooled with the first virus-containing supernatant fluid. This fluid was 
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transferred to a centrifuge tube and 0.5 ml of· 36 % sucrose [prepared in TE (10 mM Tris, 1 
mM EDT A, pH 9.0)] was layered beneath. Virus was then pelleted [centrifuged at 11 000 
rpm (19000g), 60 min., 4 oc in a Beckman J2-21 high speed centrifuge in a JS13-1 rotor]. 
The pellet was resuspended in 0.5 ml ofTE buffer. Lysis buffer (Appendix 1 and no. 3 from 
. chapter 7) and 26 ~I proteinase i( (Buehringer Mar!.r!heim) (fina.I ~ncentration = 100 ~g/ml) 
were added and the virus mixture was incubated for 3 hours at 56 °C. 
Viral DNA was purified as follows (Sambrook eta/., 1989): 
To remove extraneous proteins, one volume of phenol (Merck, Germany) was added to the 
viral extract and the mixture was inverted gently a number of times. It was then centrifuged 
in an Eppendorf Centrifuge 5415 C (Eppendorf, Germany) at 14 000 rpm for 5 min. The 
aqueous phase was carefully removed using a truncated sterile pipette tip and the viral DNA 
was further purified using 0. 5 volumes each of phenol and chloroform (24: 1 chloroform : 
isoamylalcohol), in the manner described above. This was then followed by a final 
purification step using one volume of chloroform. The DNA was precipitated by the 
addition of sodium acetate (NaAc) (final concentration= 0.3 M) (Lasechem, LASEC, South· 
Africa) and two volumes ice cold 100 % EtOH and left 0/N at -20 °C. The DNA was then 
concentrated by centrifugation at 14 000 rpm for 30 min. in a11 EpptH\knf Centrifhge. The 
DNA pellet was washed in 70% EtOH, resuspended in sterile distilled H20 or TE buffer and 
stored at 4 °C. 
8.2.3 Restriction endonuclease digestion and FIGE separation of LSDV isolates: 
8.2.3.1. Endonuclease restriction: 
DNA was purified from the four field isolates of LSDV and from the vaccine strain and was 
then restricted with the endonucleases Hin dill, Eco RI, fst I and Bam Ill: 
Digestion mixes were prepared in 1,5 ml Eppendorf tubes (Eppendorf, Germany): 10 ~I 
DNA (the concentration of this DNA was variable and depended on the individual sample 
being digested), 2 ~I 1 OX enzyme dilution buffer (the type of buffer depenried on the specific 
enzyme being used), 1 ~I restriction endonuclease (10 units) and 7 ~I distilled H20 to give a 
final volume of 20 ~1. This mixture was incubated overnight in a waterbath at the 
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manufacture's recommended temperature. The digestion was stopped with the addition of 3 
J.d 6X Stop Buffer (Appendix 1 ). The restricted DNA was then electrophoresed on an 
agarose gel. 
1t2.~,2" ~'IGE separation of LSDV restricted DNA fragment;: 
Gels were prepared and samples were electrophoresed as described in Chapter 7 (7.2.1), 
except that a custom-made electrophoresis tank was used, containing 3,5 litres of pre-cooled 
0.5 x TBE buffer (Appendix 1) (this large volume was required to act as a heat sink). No 
internal cooling system was employed, thus electrophoresis was performed in a cold room. 
Although this room was maintained at a constant temperature of 4 °C, a slight incr~ in 
temperature occurred over the entire course of each run (4 oc- 13 °C). 
Digests, along with fragment size markers produced by either Pst I or Hin dill digestion of 
phage Lambda DNA (Appendix 3), were loaded on 0,8 % agarose gels and the DNA 
restriction fragments were separated using the following FIGE conditions: 
Prerun: 
Rut~: 
220 V, 70 rnA, 4 °C, 15 min. 
220 V, 4 °C, 16 hours 
F = 90 msec, R = 30 msec, r = 0,5 
Separation of larger fragments (> 11 kb) was obtained by running the samples further using 
these conditions: 
Run: 220 V, 4 °C, 9 hours 
F = 1.0 sec, R = 0.3 sec, r = 1.0 
Gels were stained in EtBr ( 500 ng/ml), viewed under a UV Transilluminator and 
photographed with a Mamiya medium-format camera (7.2.1.2). 
8.2.3.3 "Snap-back" analysis of LSDV DNA fragments: 
The viral DNA was restricted with a restriction endonuclease. An ice bath was prepared by 
placing dry ice into absolute ethanol. A sample of the restricted DNA w~.s dcnattlred for 5 
minutes in boiling water (100 °C) and was then plunged into the ice bath. It was removed 
after 2 minutes and centrifuged at 14000 rpm in an Eppendorf Centrifuge 5415 C 
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(Eppendorf, Germany) for 3 seconds to concentrate the DNA. The denatured DNA was then 
immediately loaded onto a 0.8% agarose gel, alongside a non-denatured sample of the same 
restricted DNA. 
8.3 RESULTS: 
Although Pst I, Ava I and Sal I maps of the vaccine strain of LSDV are available (Perlman, 
1993), Ava I and Sal I only restrict the genome in six and seven places respectively, 
producing a small number of relatively large fragments. In order to detect minor differences 
in the genomes of the isolates, it was thus necessary to restrict them with nucleases which 
have short, or frequently occurring recognition sequences and which would thus restrict the 
LSDV genome to produce a large number of relatively short fragments. Pst I, Hin dill, Eco 
RI and Bam HI meet these criteria and were thus used in this study. 
Comparisons of electrophoretic patterns of the DNA of all five isolates of LSDV restricted 
with Pst I, Hin dill, Eco RI and Bam HI are illustrated in Figures 8.2, 8.3 and 8.4. Reference 
to a specific DNA band from a digest is made by refering to the largest fragment (that 
fragment which is nearset th0 ret: of t!1c photvgraph) as "fragment A" and to the next largest 
fragment (one fragment below the top fragment) as "fragment B" etc. Approximate sizes are 
given for bands of interest using Lambda DNA restricted with Pst I and Hin dill as reference 
markers. A more accurate sizing of bands would require the production of a ladder of 
Lambda fragments consisting of a large enough number of fragments so that each marker 
fragment co-migrates with each LSDV DNA fragment. This is due to the fact that fragments 
separated using conventional or pulse field gel electrophoresis do not migrate at a rate 
directly proportional to the size of fragment (Bostock, 1988). 
As can be seen from Figure 8.2, all of the bands produced by Pst I restriction appear to have 
co-migrated, although it is possible that fragment E of the Maputo isolate (lane 6) has 
migrated slightly slower, and is thus larger, than the equivalent fragments of the other four 
isolates. The Maputo isolate contains a number of additional faint bands which may have 
arisen from partial digestion. Attempts were made to re-clarify the stock of Maputo DNA 
used for the Pst I digestion and a new stock of virus was prepared, from which DNA was 
extracted. How~ver, re-digestion o£ both nt-IA stocks failed to resolve these extra bands 
(results not shown). 
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Hin dill restriction patterns (Fig. 8.3), indicate that most of, but not all, the bands co-
migrated. Due the large number of fragments produced using Hin dill(> 30), it is difficult 
to distinguish between discrete viral bands and background levels of degraded DNA. This is 
especially true for fragments smaller than 2.5 kbp in size in lanes consisting of digests of the 
field isolates (lanes .4-6) . However, comparison of LSDV (Neethling) and the vaccine strain 
reveals the presence of a smalll.5 kbp band for LSDV (Neethling) (lane 3, arrow), which is 
absent in the vaccine strain (lane 2). Maputo (lane 6) appears to have produced an 
incomplete restriction pattern with Hin dill, as was the case for Pst I restriction in Fig. 8.2. 
Eco RI and Bam HI restriction digests revealed a number of interesting differences in the 
genomes of the LSDV isolates (Fig 8.4). Although most of the bands co-migrated, the H 
(=5.9 kbp) and K (=4.9 kbp) fragments of the Eco RI digests and the Bam HI fragments, G 
(=9.0 kbp) and J (=4.8 kbp), did not all co-migrate. These fragment length polymorphisms 
are summarised in Table 8.1. The positions of the fragments from the vaccine strain are 
compared relative to those from the virulent LSDV isolates. Except for Haden, which 
consists of co-migrating fragments (marked with a "="), the fragments from the virulent 
isolates are mostly larger than those of the vaccine strain (marked with a "+"). All fragments 
from the Eco RI and Bam HI digest patterns of the vaccine strain (Fig. 8.4, lanes 2 and 9) 
and LSDV (Haden) (lanes 4 and 11) appear to have co-migrated. LSDV (Neethling) and 
LSDV (Maputo) both seem to lack the Eco RI K fragment, although it is possible that it is 
co-migrating with another fragment to form a doublet. A closer inspection of the Neethling 
and Maputo Eco RI J fragments suggests that these have migrated as doublets (results not 
shown). Although it is less clear, it also appears that LSDV (Neethling) (lanes 3 and 1 0) and 
LSDV (Maputo) (lanes 6 and 13) produce identical Eco RI and Bam HI restriction patterns. 
LSDV (Gaborone) (lanes 5 and 12) is unique in the Eco RI and Bam HI restriction profiles it 
produces. 
An analysis of the Eco RI and Bam HI digestion patterns was made using the "snap-back" 
method to identifY the co-terminal fragments, as these are regions in poxvirus genomes where 
the sequences are generally non-conserved (Massung and Moyer, 1991; Gershon et a/., 
1989). Terminal cross-linked restriction fragments have been shown to renature rapidly on 
release from denaturing conditions (as cited by Esposito et a/., 1981 ). These terminal 
fragments are thus able to co-migrate with their corresponding fragments from a non-
denatured digest, when separated on an agarose gel, whereas the rest of the denatured 
fragments are unable to renature and are therefore not detectable as discrete bands. 








Agarose gel showing Pst I digests of the LSDV isolates separated using FI GE. 
Lane 1 = Lambda Pst I marker. Lane 2 = LSDV vaccine. Lane 3 = LSDV 
(Neethling). Lane 4 = LSDV (Haden). Lane 5 = LSDV (Gaborone). Lane 6 = 
LSDV (Maputo). Lane 7 = Lambda Hin dill marker. FIGE conditions: 
Prerun: 220 V, 4 OC, 15 min. Run: 220 V, 4 OC, 16 hours, F = 90 msec, R = 30 
msec, r = 0.5, then 220 V, 4 OC, 9 hours, F = 1 .0, R = 0.3, r = 1 .0. 
100 




H K G J 
NEETHLING + absent + + 
HADEN = = = = 
GABORONE + + + + 
MAPUTO + absent + + 
+ fragment larger than the vaccine strain 
= fragment co-migrates with the vaccine strain 
absent: fragment equivalent of the vaccine strain is not visible. 
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Denatured Eco RI and Bam ill digests of LSDV (vaccine) were prepared as described and 
were run (Fig. 8.4, lanes 1 and 8) next to the non-denatured Eco RI and Bam ill digests of 
LSDV (vaccine) (lanes 2 and 9). The presence ofthe co-terminal fragments are identifiable 
as these are the bands which have reannealed and co-migrated with corresponding bands 
from the non-denatured digests. The co-terminal fragments are thus the Eco RI H and K 
fragments and the Bam ill G and J fragments. 
FIGURE 8.3 










Agarose gel showing Hin dill digests of the LSDV isolates separated using FIGE. 
Lane 1 =Lambda Pst I marker. Lane 2 = LSDV vaccine. Lane 3 = LSDV 
(Neethling). Lane 4 = LSDV (Haden). Lane 5 = LSDV (Gaborone). Lane 6 = 
LSDV (Maputo). Lane 7 = Lambda Pst I marker. FIGE conditions: Prerun: 
220 V, 4 °C, 15 min. Run: 220 V, 4 °C, 16 hours, F = 90 msec, R = 30 msec, r = 
0.5, then 220 V, 4 °C, 9 hours, F = 1.0, R = 0.3, r = 1.0. The arrow depicts the 
position of a 1.5 kbp fragment which is present in the Neethling digest only. 
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Agarose gel showing Eco RI (lanes 2 - 6) and Bam HI (lanes 9 - 13) digests of the 
LSDV isolates. Lane 1 = LSDV vaccine Eco RI (snap-back). Lane 2 = LSDV 
vaccine. Lane 3 = LSDV (Neethling). Lane 4 = LSDV (Haden). Lane 5 = LSDV 
(Gaborone). Lane 6 = LSDV (Maputo). Lane 7 =Lambda Hin dill marker. Lane 8 = 
LSDV vaccine Bam HI (snap-back). Lane 9 = LSDV vaccine. Lane 10 = LSDV 
(Neethling). Lane 11 = LSDV (Haden). Lane 12 = LSDV (Gaborone). Lane 13 = 
LSDV (Maputo). Lane 14 = LambdaHin dill marker. FIGE conditions: Prerun: 220 
V, 4 °C, 15 min. Run: 220 V, 4 °C, 16 hours, F = 90 msec, R = 30 msec, r = 0.5, 
then 220 V, 4 °C, 9 hours, F = 1.0, R = 0.3, r = 1.0. 
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8.4 DISCUSSION : 
The restriction endonucleases Pst I, Bin dill, Eco RI and Bam Ill were used to cleave the 
DNA genomes of four southern African field isolates of LSDV and the vaccine strain. The 
genonlic fragments were separ~.~~d using FIGE. An anu.~ysis of m~ "~"esulting patterns 
revealed a high degree of genonlic conservation. These results are in agreement with 
Kitching eta/. (1989) who described sinlilar findings for comparisons of restriction pattern 
profiles of seven cattle isolates of capripoxvirus, including the LSDV (Neethling) isolate. 
Comprehensive comparisons of the Bin dill restriction digest patterns of the virulent .LSDV 
isolates was not possible due to the large number of fragments generated using Bin dill 
(>30) resulting in a low viral DNA to background DNA ratio. However, it did appear that 
the virulent Neethling strain contained a 1,5 kbp fragment which was absent from the vaccine 
Bin dill digest. 
Of major interest were the differences noted for the ternlinal fragments of the isolates. Eco 
RI and Bam HI digest patterns revealed slight differences in the ternlinal repeat regions of 
these isolates. Although less clear, it also appeared that the ternlinal E fragment ( deternlined 
by P.::dmaii., 1993) of the Maputo isolate was the only Pst I fragment which failed t\l co-
nligrate with corresponding fragments of the other isolates. Snap-back analysis was used to 
confirm the location of the Eco RI and Bam Ill fragment polymorphisms in the terminal 
regions of the genome. The ternlini of poxviruses are generally non-conserved regions 
consisting of genes specific for host range (as cited by Gershon and Black, 1988). A 
comparison of the ternlinal polymorphisms of the vaccine strain and the field isolates 
indicated that the vaccine strain consisted of the shortest ternlinal regions. The loss of 
virulence of the vaccine, after a long passage history in eggs and culture cells, nlight thus be 
explained by the loss or rearrangement of genes in the ternlinal regions as compared to the 
virulent LSDV (Neethling) isolate from which it originated. 
An overall analysis of the genomes of the five LSDV isolates compared in this study 
suggests that the Neethling and Maputo isolates are almost identical, the vaccine and Haden 
isolates are identical and the Gaborone isolate is the most diverse. It is interesting that the 
vaccine isolate is more sinlilar to the Haden isolate than the Neethling isolate, from which it is 
meant to have originated. It would be difficult to explain why the ternlin?..! regiuus of certain 
isolates appear similar to each other (in respect to the conservation of restriction sites) and 
yet, different from other isolates, as factors such as history of passage in culture cells, 
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recombination, distribution and date of isolation could have influenced the changes occurring 
in the genomes. It is also possible that the field isolates were not recent descendants of a 
common ancestor, thus allowing for a greater period of time for the genomes to diversify. 
In lieu of the extremely narrow host-range exhibited by the vaccine strain of LSDV (Chapter 
6) and the occurrence of deletions in the terminal regions of its genome, it would be of 
interest to determine whether the field isolates are able to replicate in cells other than those 
derived from sheep, cattle or chicken. This would seem unlikely, however, as the southern 
African isolates of LSDV have proved to be extremely host specific and in South Africa, 
LSDV has never been reported in hosts other than cattle (as cited by Kitching et a!., 1989). 
Experimental transmission to game animals was reported (Young et a!., 1970) and yet 
attempts to re-culture virus, claimed to have been recovered from infected animals displaying 
disease symptoms, failed in this laboratory. 
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CHAPTER9 
MAPPING OF RARE RESTRICTION SITES OF LSDV: 
9.1 INTRODUCTION: 
Poxviruses are being used as vectors for recombinant vector vaccines (Taylor eta/., 1988; 
Taylor eta/., 1992; review .by Baxby and Paoletti, 1992). Homologous recombination in 
vivo has been extensively used for the construction of recombinant viruses (Falkner and 
Moss, 1990). A non-essential gene is used as an insertion site and this gene usually has the 
ability to be used as a selectable marker. A plasmid is constructed containing flanking 
sequences of the non-essential gene interrupted by a foreign gene. Cells infected with the 
wild-type virus are transfected with this plasmid. Double recombination between the virus 
and the plasmid results in the formation of a recombinant virus containing the foreign gene 
and displaying a negative phenotype for the non-essential gene. This altered phenotype can 
then be used to select only recombinant virus particles. This technique has its limitations due 
to rearrangements of DNA occurring during the bacterial cloning steps or loss of efficiency 
of homologous recombiHai:~vn -w·ith iiii ~rH.:reasing length of insert (as cited by Merchlinsky 
and Moss, 1992). 
More recently, successful cloning of large fragments of DNA (up to 26 kbp) into the 
genome of vaccinia virus has been achieved with the use of in vitro ligation (Merchlinsky and 
Moss, 1992). Unique restriction sites found in non-essential regions of the genome were 
used, or were created, for use in the cloning strategy as insert DNA could then be ligated 
directly into whole genomic DNA. Propagation of recombinant viruses was made possible 
by first infecting mammalian cells with a conditionally lethal temperature-sensitive vaccinia 
virus mutant which provided the machinery necessary for replication and packaging, but 
which was unable to replicate itself Purified vaccinia virus DNA, containing a foreign gene 
insert, was then transfected into these cells and incubation was performed at the non-
permissive temperature of 40 °C for two days. Even without selection, up to 25 % of 
virions recovered from infected cells were found to contain inserts. Although the 
construction of recombinant capripoxviruses has been described using homologous 
recombinat!an (Romero et a!., i Y93 ), ihc use of in vitro ligation may provide a more 
efficient method for the cloning of very large inserts. 
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An aim of this thesis was the identification and mapping of rare restriction sites within the 
genome of LSDV vaccine strain. If these sites occur within non-essential regions ~f the 
genome, then they might eventually be used as cloning sites for the construction of a 
recombinant LSDV using in vitro ligation as described by Merchlinsky and Moss (1992) for 
the construction of a recom~ina<it vaccmi:< ·v!m~. 
9.2 METHODS: 
Most poxvirus genomes contain a higher percentage of A-T bases than G-C bases (as 
reviewed by Moss, 1990) and therefore a number of restriction endonucleases were chosen 
which recognise long DNA sequences that are rich in guanine and cytosine. The enzymes 
chosen were: Not I, Sma I, Nar I, Nae I, Ksp I, Apa I and Bss IDI (Boehringer-
Mannheim, Germany). 
Digests of vaccinia (DIE #7) virus DNA, using these enzymes, were set up in parallel as a 
control to ensure that the enzymes had retained their enzymatic activity. Purified DNA of 
LSDV (Neethling) vaccine and vaccinia virus was digested overnight as described (8.2.3 .1 ). 
The digests were then run on a 0,8% agarose gel using the following FIGE conditions (using 
the same gel tank and cooling apparatus as described iu 7.'2..! ): 
Prerun: 
Run : 
220 V, 70 rnA, 4 °C, 15 min, no pulse 
220 V, 70 rnA, 4 °C, 12 hrs 
F = 1,0 sec, R = 0,3 sec, r = 1,0 
The gel was stained with EtBr, viewed and photographed as described (7.2.1.1 ). 
In order to further separate the fragments, the gel was run for an extended period under the 
following conditions: 
Run: 220 V, 70 rnA, 4 °C, 22 hrs 
F = 90 msec, R = 30 msec, r = 0,5 
The gel was restained and photographed. 
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In order to map the precise locations of rare restriction sites, a number of double digests 
were prepared: 
The first endonuclease restriction was prepared as described for single digests (8.2.3.1), 
except that no Stop Buffer was added. DNA was precipitated with ethanol as described 
(8.2.2.2) and resuspended in distilled H20. The second restriction enzyme and buffer was 
then added and restriction was continued overnight at the appropriate incubation 
temperature. The reaction was stopped with the addition of 3 Jll 6X Stop Buffer and the 
sample was electrophoresed on an agarose gel. 
LSDV (Neethling) vaccine DNA was restricted with Pst I, Ava I and Sal I [as the location of 
these sites has been mapped (Perlman, 1993)]. The DNA was ethanol-precipitated, 
resuspended in distilled H20 and then the second enzymes were added in their respective 
buffers in these combinations: 
Pst VSma I, Pst VApa I, Pst I/Bss HII, Ava VApa I 
Sal VApa I, Sal VSma I and Ava VSma I 
The samples were incubated overnight, enzyme activity was stopped with Stop buffer (X6) 
and the digests were separated on a 0,8 % agarose gel using FIGE as follows: 
Two sets of pulse conditions were used as Ava I and Sal I cleave LSD V DNA at fewer sites 
than Pst I, therefore producing larger fragments. Single digests of Pst I, Ava I and Sal I 
were also prepared for comparison with the double digests. 
The Pst I single and double digests were run using these conditions: 
Prerun: 220 V, 70 rnA, 4 °C, 15 min. 
Run 220 V, 70 rnA, 4 °C, 12 hrs 
F = 1,0 sec, R = 0,3 sec r = 1,0 
The Ava I and Sal I single and double digests were run using these conditions: 
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Prerun: 220 V, 70 rnA, 4 °C, 15 min. 
Run: 220 V, 70 rnA, 4 °C, 9 hrs 
F = 2 sec, R = 0,6 sec, r = 0 
The electrophoretic conditions were then altered and the gel was run for a further 16 hours as 
follows: 
Run : 220 V, 4 °C, F = 90 msec, R = 30 msec, r = 0,5 
Gels were stained, viewed and photographed as described (refer to 7.2.1). 
9.3 RESULTS: 
LSDV vaccine DNA was restricted with a number of rare cutting restriction endonucleases. 
The fragments which were generated were separated on agarose gels using FIGE and the 
resulting patterns were analysed in order to determine which enzymes contained unique 
restriction sites within the LSDV vaccine strain genome. Fragments were sized to 
approximate values and the use of double restriction digestion, in conjunction with the 
accurate Pst I, Ava I and Sal I restriction maps of the LSDV vaccine genome elucidated by 
Perlman (1993) (Fig. 2.2 B), allowed relatively accurate determination of the location of 
unique sites. 
The resulting single digest restriction profiles are illustrated in Figures 9.1 and 9.2 (Fig. 9.2 is 
the same gel as in Fig. 9. I, but after extended electrophoresis), and an estimation of the 
number and size of the fragments generated are summarised in Table 9.1. It can clearly be 
seen that LSDV (Neethling) vaccine lacks Not I, Ksp I and Nar I restriction sites (lanes 9, 12 
and 13) as the single bands in these lanes have co-migrated with the uncut LSDV DNA (lane 
7). The enzyme activities of the three endonucleases were active as evidenced by their 
ability to cleave vaccinia virus (Die #7) DNA (lanes 3, 4 and 5). 
Sma I and Apa I (lanes 8 and 1 0) cleaved LSDV DNA once producing fragments of 
approximately 85 and 67 kbp with Sma I, and 30 and 122 kbp with Apa I. Bss HII (lane 14) 
cleaved the genome twice producing three closely sized fragments (ranging in size between 
42 and 60 .kbp ). Nae I (lane 11) restriction produced five fragments which add up to a total 
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genome size greater than 152.6 kbp. It can therefore be assumed that at least one of these 
sites restricted partially. Further attempts to resolve the partial digestion failed. 
The LSDV vaccine genome thus contains unique Sma I and Apa I restriction sites. As it only 
contains two Bss llll sites, de~..;;rmining the location of th~se ~it~s was ~lso of interest. 
TABLE 9.1. Sizes and number of the restriction fragments generated by single 
digestion of the LSDV vaccine DNA with rare restriction endonucleases. 
SIZE OF FRAGMENT 
FRAGMENT (kbp) 
No. uncut Smai Not I Apal Naei Narl Ksp I BssHII 
A 152.6 85.6 152.6 122.6 * 152.6 152.6 60.6 
B 67.0 30.0 70.6 50.0 
c 55.0 42.0 
D 27.0 
"-i" 
E * I 
* partial digest fragments 
In order to determine the exact location of the restriction sites of Sma I, Apa I and Bss IDI, 
double digests of these enzymes, and Pst I, Ava I or Sal I, were prepared .. Single digestion 
sizes of Pst I, Ava I or Sal I fragments are presented in Table 9.2. These results can be seen 
in Figs. 9.3, 9.4 and 9.5 and are summarised in Table 9.3. Tables 9.2 and 9.3 represent the 
fragment number and sizes obtained from single and double digestion of LSDV DNA with 
Pst I, Ava I and Sal I. 
Sma I cut the Pst I D fragment (12,3 kbp) to produce two fragments of 9,1 and 3,2 kbp 
(smaller band not visible on the photograph) (Fig. 9.,3, lane 3). 
Apa I cleaved the Pst I J fragment (3,6 kbp) to produce two fragments of 3,4 kbp and 0,2 
kbp (smaller band not visible on the photograph) (Fig. 9.3, lane 4). 
! 
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Bss HII cut the Pst I A (42,0 kbp) and C (19,76 kbp) fragments producing three bands of 
approximately 35, 8,2 and 7 kbp (Fig. 9.3, lane 5). These fragments do not add up to the 
expected total of 61,7 6 kbp (sum of the Pst I A and C fragments) and it is thus possible that 
at least one band is co-migrating with another Pst I band (No further attempts were made to 












Agarose gel of LSDV and vaccinia (DIE #7) DNA restricted with rare restriction 
site endonucleases: 1st run. Lane 1 =High Molecular Weight marker. Lane 2 = 
Vaccinia uncut. Lane 3 = Vaccinia Not I. Lane 4 = Vaccinia Nar I. Lane 5 = 
Vaccinia Ksp I. Lane 6 = Lambda Pst I marker. Lane 7 = LSDV uncut. Lane 8 = 
LSDV Sma I. Lane 9 = LSDV Not I. Lane 10 = LSDV Apa I. Lane 11 = LSDV 
Nae I. Lane 12 = LSDV Nar I. Lane 13 = LSDV Ksp I. Lane 14 = LSDV Bss HII. 
Lane 15 = Lambda Hin dill marker. FIGE conditions: 150 V, 54 rnA, 14 ·c, 12 
hours, F = 1.0 sec, R = 0.3 sec, r = 1.0. 
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Agarose gel of LSDV and vaccinia (DIE #7) DNA restricted with rare restriction 
site endonucleases; 2nd run: Lane 1 =High Molecular Weight marker. Lane 2 = 
Vaccinia uncut. Lane 3 = Vaccinia Not I. Lane 4 = Vaccinia Nar I. Lane 5 = 
Vaccinia Ksp I. Lane 6 =Lambda Pst I marker. Lane 7 = LSDV uncut. Lane 8 = 
LSDV Sma I. Lane 9 = LSDV Not I. Lane 10 = LSDV Apa I. Lane 11 = LSDV 
Nae I. Lane 12 = LSDV Nar I. Lane 13 = LSDV Ksp I. Lane 14 = LSDV Bss HII. 
Lane 15 = LambdaHin dill marker. FIGE conditions: 150 V, 65 rnA, 14 oc, 22 
hours, F = 90 msec, R = 30 msec, r = 0.5. 
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From Fig. 9.4 it can be seen that the 41 ,62 kbp Ava I B fragment (lane 2) was cleaved by Apa 
I to produce two fragments of 37 and 4,62 kbp (smaller band not visible on the photograph). 
Apa I cleaved one of the three Sal I A fragments (33, 15 kbp; lane 4) to produce two bands 
of30 and 3.2 kbp (smaller band not visible on the photograph) (lane 5) . 
From Fig. 9.5, it is unclear whether any one of the Ava I fragments is cleaved by Sma I as 
there is no noticeable change in the migration of any of the Ava I fragments when 
comparing the Ava I single (lane 2) and double (lane 3) digest patterns. 
TABLE 9.2. Sizes of the restriction fragments generated by double and single 
digestions of LSDV vaccine DNA with Pst I, Ava I and Sal I. 
.< ' 
. _ ,:. , . l ·. 
I 
A T47 .35 A'" 26.16 A' " '" T33 .15 A'" 26.5 A 42 .0 A 30.1 
8 41 .62 8 20.7 8 T20 .7 8 12.5 8 T26.5 8 26.4 
c 28.2 c 19.05 c 12.5 c 12.1 c 19.76 c 19.76 
D T26 .16 D 14.1 D 8. 71 D 11.2 D 12.3 D 12.1 
E 4.54 E 12.5 E 8.33 E 8.71 E T12 .1 E 12.00 
F 2.92 F 8.71 F 2.8 F 8.2 F 8.5 F 8.5 
G 2.1 G'" 6.75 G 7 .05 G 8.2 G 8.2 
H 2.96 H 6.95 H 6.0 H 6.0 
I 2.92 I 6.0 I 4.7 I 4.7 
j 2.8 j 4.7 j 3.6 j 4.3 
K 2.1 K 3.6 K 3.25 K 3.6 
L 1.58 L 3.25 L 2.82 L'" 3.25 
M 3.0 M 2.4 M 2.92 
N 2.85 N 2.82 
0 2.82 0 2.4 
p 2.4 p 2.1 
Q''' 1.44 Q 0.20 
R 1.35 R 0.15 
152.as- . · I ·· 153:24· 152.49 1- ,.152.56 1·, 152.13 _. ,. 1 -7- •'~152;8&·;" 1 
T = terminal fragment, 1 11 111 = no . of co-migrating fragments . 
(Perlman, 1993) 
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Agarose gel of LSDV vaccine DNA Pst I double digests of rare restriction 
endonucleases. Lane 1 = Lambda Pst 1 marker. Lane 2 = Pst I. Lane 3 = Pst II 
Sma I. Lane 4 = Pst II Apa I. Lane 5 = Pst II Bss HII. Lane 6 = Lambda Hin dill 
marker. FIGE conditions : 100 V, 14 oc, 12 hours, F = 1.0, R = 0.3, r = 1.0 
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Agarose gel of LSDV (vaccine) DNA double digests. Lane 1 =Lambda Hind III 
marker. Lane 2 = LSDV Ava I. Lane 3 = LSDV Ava I!Apa I. Lane 4 = LSDV Sal I. 
Lane 5 = LSDV Sal I/Apa I. Lane 6 = LSDV Pst I marker. FIGE conditions: 
Prerun: 220 V, 4 °C, 15 min. Run: 220 V, 4 °C, 16 hours, F = 90 msec, R = 
30 msec, r = 0.5, then 220 V, 4 °C, 9 hours, F = 1.0 sec, R = 0.3 sec, r = 1.0 
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Agarose gel ofLSDV (vaccine) DNA double digests. Lane 1 =Lambda Hind III 
marker. Lane 2 = LSDV Ava I. Lane 3 = LSDV Ava I/Sma I. Lane 4 = LSDV Sal I. 
Lane 5 = LSDV Sal I!Sma I. Lane 6 = LSDV Pst I marker. FIGE conditions: 
Prerun: 220 V, 4 °C, 15 min. Run: 220 V, 4 °C, 16 hours, F = 90 msec, R = 
30 msec, r = 0.5, then 220 V, 4 °C, 9 hours, F = 1.0 sec, R = 0.3 sec, r = 1.0 
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A clear distinction between LSDV DNA cleaved with Sal I only (Fig. 9.5, lane 4) and Sal 
I!Sma I (lane 5) is possible as Sma I cleaves one of the Sal I A fragment triplets (33 .15 kbp) 
to produce two fragments of 25.0 kbp and 8.1 kbp (lane 5). 
TABLE 9.3. Sizes of the restriction fragments generated by double and single 
digestions of LSDV vaccine DNA. 
FRAGMENT SIZES * 
.(kbpl 
Pst I Pst I Pst I Pst I Ava I Ava I Sal I Sal I Ava I Ava I Sal I Sal I 
Smal Apa I BssH Apai Apa I Smai Smal 
A 42.0 42.0 42.0 !:i~$~2·:: 47.4 47.4 33.2 33.2 47.4 47.4 33.2 33.2 
41.61\" :::f 20.71 ················: 
:-:-:-;.:.:-:.:-:-:-:-:-:-:-:-:-· 
B 26.5 26.5 26.5 26.5 41.6 41.6 20.7 f:•:h~l'( 
c 19.8 19.8 19.8 12.3 28.2 28.2 12.5 20.7 28.2 28.2 12.5 12.5 
D 12.3 12.1 12.3 12.1 26.2 26.2 8.7 12.5 26.2 26.2 8.7 8.7 
E 12.1 :it¥: 12.1 8.5 4.5 J:::B· 8.3 8.7 4.5 4.5 8.3 8.3 
•&•>··~········· 
F 8.5 8.5 8.5 8.2 2.9 4.5 2.8 8.3 2.9 2.9 2.8 
................. 
, .......... , ............... 
G 8.2 8.2 8.2 ! g~qi: 2.1 2.9 • 2.1 2.1 2.8 H 6.0 6.0 6.0 6.0 2.1 2.8 
I 4.7 4.7 4.7 4.7 
J 3.6 36~ 3.6 
K 3.3 3.3 3.3 3.3 
L 2.8 1112.8 2.8 
I 
M 2.4 2.8 lli 2.4 N 2.4 
* shaded areas represent sizes of fragments of interest 
The exact location of the unique Apa I and Sma I restriction sites could then be determined 
using the results described above and the Ava I, Sal I and Pst I restriction map (Fig. 9.6): 
The Apa I site is located either 0.2 kbp from the left- or right-hand end of the Pst I J 
fragment (Fig. 9.3). As double restriction of Apa I with Ava I results in restriction of the 
Ava I B fragment to produce two fragments of 37.0 and 4.62 kbp, and as the Pst I site 
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(separating the Pst I B and J fragments) and Ava I site (separating the Ava I D and B 
fragments) are located close to each other, it is apparent that the Apa I site is located 0.2 kbp 
from the left-hand end of the Pst I J fragment. If it was located nearer the right-hand end, 
then double restriction with Ava I would have failed to result in a noticeable shortening of 
the Ava I B fragment. 
A c 
B c A F E 
E M K A F G 
FIGURE 9.6 
E GF B 
A 











Genomic map of LSDV (Neethling) vaccine showing the location of Ava I, Pst I 
and Sal I restriction sites. The location of the unique Apa I and Sma I sites have 
also been indicated. (Reproduced with kind permission of the author, Perlman, 
1993). 
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The Sma I site is located either 3.0 kbp from the left- or right-hand end of the Pst I D 
fragment (Fig. 9.3). Although it is unclear which Ava I fragment is restricted by Sma I, as 
double restriction of Sma I with Sal I results in restriction of the central Sal I A triplet 
fragment (as this is the only Sal I A fragment which overlaps with the Pst I D fragment) to 
produce two fragments of 25.0 and 8.1 kbp. As the Pst I site (separating the Pst I G ec1d D 
fragments) is located close to the Ava I site (separating the Ava I D and B fragments), it is 
apparent that the Sma I site is located 3. 0 kbp from the right-hand end of the Pst I D 
fragment. If it was located nearer the left-hand end, then double restriction with Sal I would 
have resulted in the Sal I A fragment being shortened by only 3.0 kbp. 
9.4 DISCUSSION: 
The construction of recombinant poxviruses using in vitro ligation requires the creation or 
identification of unique restriction endonuclease sites (Merchlinsky and Moss, 1992). Seven 
rare cutting endonucleases were tested on LSDV (Neethling) vaccine DNA. Not I, Ksp I and 
Nar I failed to restrict, even though the enzymes had retained their full enzymatic activity as 
evidenced by their ability to restrict vaccinia virus (DIE #7) DNA. Using site-directed 
mutagenesis, it would be possible to create Not I, Ksp I or Nar I restriction sites within any 
non-essential regior, ia th(: LSDV genome for use as a cloning site for foreign DNA. 
The LSDV genome was shown to contain two Bss IDI restriction sites. Attempts to map the 
exact locations of these sites however, failed as co-migrating fragments were generated 
when using double digests of Pst I and Bss mi. Mapping the Bss IDI sites using Ava I and 
Sal I was not attempted as only unique restriction sites were of interest. 
Two of the enzymes tested, Sma I and Apa I, restricted the genome once producing 
fragments of almost exactly 87 and 65 kbp, and 122 and 30 kbp respectively. If the Sma I 
and/or Apa I restriction sites occur in non-essential regions, then they may be used as cloning 
sites without the need to use site-directed mutagenesis. In order to test this possibility, it 
would be necessary to attempt to clone a reporter gene into the Sma I and Apa I sites. A 
helper virus, such as an avipoxvirus, could then be used to recover recombinant LSDV 
virions expressing the reporter gene. If either of these cloning sites proved successful, then 
the reporter gene could be replaced with an antigen from a pathogen, which would eventually 
result !!! th~ uevelopment of a recombinant vaccine. The identification of unique restriction 
sites is thus a useful first s~ep in creating a recombinant virus for use as a recombinant .vector 





ISOLATION AND CHARACTERISATION OF AVIPOXVIRUSES: 
10.1 INTRODUCTION: 
Avipoxviruse& have been isolated from many bird species and are probably also able to infect 
those species from which they have not yet been isolated (Kirmse, 1969). It was as recent as 
1969 when the first cases were diagnosed in Norway in wild terrestrial birds (as cited by Holt 
and Krogsrud, 1973 ). The introduction of avian poxviruses to the Hawaiian Islands has been 
attributed to the extinction of much of its avian fauna (as reviewed by Warner, 1968). 
Early attempts to sample the diversity of the avian poxviruses met with limited success due 
to inherent limitations of the tests applied (as cited by Mockett, 1987). However, the ability 
of site-specific restriction endonucleases to cleave DNA at sequence-dependant recognition 
sites opened the way for the characterisation of viruses at the molecular level. Analysis of 
the patterns produced by restriction cleavage of poxviral DNA, and electrophoretic 
separation, indicated that members of the Orthopoxvirus genus possess a considerable 
degree of homology between the internal regions of their genomes, while the corresponding 
terminal regions can. be quite variable (as cited by Schnitzlein et al., 1988; as cited by 
Gershon and Black, 1988). In contrast, members of the Parapoxvirus genus contain DNA 
molecules with extensive heterogeneity as reflected in the variability of their DNA 
restriction patterns (as cited by Schnitzlein et a/., 1988). Members of the Capripoxvirus 
genus have also been successfully distinguished using restriction endonuclease pattern 
analysis of their DNA (Gershon and Black, 1988). Recent comparisons of avipoxviruses 
have indicated that isolates from different bird species possess a high degree of sequence 
diversity (Coupar, personal communication; Kow, 1992). Their findings contradict those of 
Schnitzlein et a/. (1988) who reported that the restriction endonuclease profiles of 
fowlpox, juncopox and pigeonpox viruses were very similar implying greater than 80% 
homology between the isolates. 
Although fowlpox and pigeonpox vaccines are commercially available, previously vaccinated 
birds are still susceptible to poxvirus infections (as cited by Ghildyal eta/., 1989). These 
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infections are probably a reflection of the host range of antigenically distinct avipoxviruses. 
In this regard, commercial poultry and pigeons may be susceptible to various members of the 
A vi poxvirus genus. Thus a thorough knowledge of field and vaccine strains is important in 
distinguishing poxvirus re-infections of vaccinated birds. Poxviruses have been isolated from 
a number of southern African bird species and it is in the interests of vaccine safety and 
efficacy to characterise these in relation to one another and to other well-characterised 
avipoxviruses such as fowlpox and canarypox virus. 
This thesis contains the first reported study of the isolation and characterisation of an 
avipoxvirus isolated from a juvenile Rock pigeon. The pigeon was discovered in the 
Rondebosch suburb of Cape Town and died within 24 hours of developing macroscopic 
lesions on its head and feet. The virus isolate was compared with other local isolates and 
strains of fowl pox virus, canarypox virus and pigeonpox virus. 
10.2 MATERIALS AND METHODS: 
10.2.1 Source of avipoxvirus isolates: 
a. Fowlpox and canarypox reference isolates were obtained from stocks originally supplied 
to the Medical Microbiology Department of the University of Cape Town by Professor A. 
Mayr from the University of Munich, Germany. 
b. Penguinpox virus was isolated on two separate occasions from Jackass Penguins at 
SANCOB, Tableview, Cape Town. 
c. Parrotpox virus was obtained from imported parrots displaying pocks held in quarrantine 
at the Onderstepoort Veterinary Institute, Pretoria. 
d. The Turtle dovepox virus was isolated from lesions on a Turtle dove found in Cape Town. 
All the isolates were passaged in embryonated chicken CAMs by D. Kow (I 992). She 
. prepared crude stocks of semi-purified virus (refer below) and stored them at - 20 o C. These 
crude stocks were then inoculated onto 20-40 CAMs in order to obtain high tit res of virus 
for the extraction ofDNA. 
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1 0.2.2 Inoculating egg CAMs with avipoxviruses: 
Egg CAMs were inoculated as described for LSDV (6.2.2.1), except that eggs were only 
incubated for 3-4 days. 
1 0.2.3. Harvesting of infected CAMs: 
CAMs were harvested as described for LSDV (6.2.2.3). 
10.2.4. Preparation of pure virus for DNA extraction. 
Once all the CAMs had been harvested, 3.75 ml of Mcilvain's buffer and 1.25 ml of Arklone-
X (I, 1,2-trichloro-1,2,2-trifluroethane) (AECI, South Africa) was added per Universal bottle. 
These were shaken vigorously for 1.5 minutes and were then centrifuged at 1000 rpm (120g) 
at 4 °C for IO min in a low speed Sigma 301K benchtop centrifuge. The supernatant fluids 
were transferred into fresh Universal bottles and the precipitates were resuspended in another 
3.75 ml ofMcilvain's buffer and 1.25 ml of Arklone-X. The shaking was repeated for 1.5 
min and the resuspended precipitates were centrifuged at I 000 rpm ( I20g) at 4 °C for I 0 
min. The supernatant fluids were pooled and this time the precipitates were resuspended in 5 
ml of Mcilvain's buffer . Shaking and centrifugation was repeated as described above. All 
the supernatant fluids were pooled and left on ice for 90 min. They were then centrifuged at 
3000 rpm at 4 °C for I5 min and the supernatant fluids were placed into polycarbonate 
centrifuge tubes. A sucrose cushion was formed by pipetting 0.5 ml of 36% sucrose (in TE 
buffer) into the bottom of each tube. The balanced tubes were centrifuged in a pre-cooled 
Beckman JS13-I (Beckman Instruments, C.A., U.S.A.) rotor (the buckets also having been 
pre-cooled) at 11 000 rpm (19000g) at 4 °C for 60 min in a Beckman J2-2I (Beckman 
Instruments, C.A., U.S.A.) centrifuge. The virus pellets were resuspended in a small 
volume of TE buffer. A biphasic gradient was then prepared in a number of centrifuge tubes 
using a 2: I ratio of IO% T 10 dextran (Sigma, USA) (in TE buffer) and 36% sucrose (in 
TE buffer) by first layering the dextran and then the sucrose into the bottom of each tube. 
The virus suspensions were layered on top of the biphasic gradients and centrifuged at 11 
000 rpm (I 9000g) at 4 oc for 60 min in a Beckman 12-21 centrifuge in a JS I3-I rotor. The 
pellets, containing purified virus, were either : 
(i) resuspended in a small volume of Mcilvain's buffer, dispensed into Bijou bottles and 
stored at - 20 oc or 
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(ii) resuspended in 1 ml TE buffer and lysis buffer (Appendix I) for DNA extraction (as 
described in Chapter 8, 8.2.2.2). 
10.2.5. Preparation or rvut;ae vir~~ :::tock. 
Egg CAMs were harvested (as described above) and 0,75 ml of 90% glycerol [diluted in 
Mcilvain's buffer (pH 7.4)] and 0,25 ml of Arklone-X was added per membrane. The 
membranes were shaken in Universal bottles containing glass beads for 2 min and were left 
on ice for 90 min. The disrupted membranes were then centrifuged at 1000 rpm (120g) at 
4°C for 10 min in a Sigma 301K benchtop centrifuge. The supernatant fluids were retained 
and were dispensed into Bijou bottles to be stored at -20 °C. 
10.2.6. Agarose gel electrophoresis: 
a) Conventional electrophoresis using medium-sized gels: These gels were cast in relatively 
small casting trays (22 em x 12.5 em x 0.75 em) (as described, 7.2.1) and electrophoresis was 
performed overnight at 40 V in electrophoresis tanks .;ontaining 1300 ml of 1 x TAE. 14-
or 20-toothed combs were used. No pulsing was used. 
b) FIGE: Gels were prepared and electrophoresis was performed as described in Chapter 7 
(7.2.1.1 ). The same electrophoresis apparatus was used, including the cooling system. 
1 0.2. 7 Isolation of a virus from a Rock pigeon: 
Lesions, from the head and feet of a dead, juvenile Rock pigeon (also called a Speckled 
pigeon) (Columba guinea), were removed and placed in a solution of Mcilvain's buffer, PS 
(XS) and Fungizone (2,5 Jlg/ml) (Appendix 1). The lesions were then ground finely in a 
mortar and placed at 4 oc overnight. A 1 0-fold dilution series of this mixture was prepared 
in Mcilvain's buffer and PS (XI). The CAMs of six embryonated chicken eggs were 
inoculated with different dilutions of the lesion mixture. The eggs were incubated at 37 oc 
for three days. The CAMs were removed and examined tbr t~ie presence of pocks and 
bacterial and fungal infections. CAMs which displayed pocks, and appeared free of bacterial 
and fungal infections, were ground in Universal bottles containing glass beads ( 4mm 
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diameter) and a solution of90% (v/v) glycerol (diluted in Mcilvain's buffer). A crude virus 
stock of the infected CAMs was prepared as described (10.2.5) and was stored at- 20 °C. 
An aliquot of this sample was later removed and inoculated onto a number of CAMs. The 
virus was passaged four times in this manner. 
10.2.8 Characterisation of the virus from a Rock pigeon as a poxvirus: 
Chicken CAMs which displayed pocks were fixed in a 2% (v/v) solution of gluteraldehyde 
(diluted in PBS). These were then photographed as described (Appendix 2). 
Crude stocks of the virus were inoculated onto 40 chicken CAMs, and after a 3 day 
incubation period the CAMs were harvested and virus was purified from them as described 
(10.2.4). After centrifugation through a dextran-sucrose gradient, virion pellets were 
prepared for electron microscopy by Dr L.M. Stannard, Department of Medical 
Microbiology, UCT. Particles in a drop of distilled water were placed on a formvar-coated 
grid, negatively stained with 2% phosphotungstic acid (pH 6.2), and examined in a Hitachi 
600 transmission electron microscope operating at 75 kV. 
10.2.9. Restriction endonuclease analysis of avipoxvirus DNA: 
DNA was extracted from the purified Rock pigeon virus as described (10.2.4) and, along 
with DNA from the well-characterised fowlpox and canarypox viruses (kindly supplied by 
Mrs D. Marais, Department of Medical Microbiology, UCT), was digested with the 
restriction endonucleases Eco RI and Bam HI (Chapter 8, 8.2.3 .1 ). Restriction was 
terminated with the addition of Stop buffer (X6). The digests were then run on a 0,8 % 




100 V, 34 rnA, 10 min, 14 °C 
100 V, 19 hours, 14 °C, 34 rnA 
F = 450 msec, R = 150 msec, r = 0,1 
The gel was then stained, viewed and photographed as described (7.2.1.2). 
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DNA was also prepared from an avipoxvirus isolated from a Turtle dove (Streptopelia 
capico/a). Pst I was used to digest this DNA, as well as DNA from a local poxvirus isolate 
from a Jackass penguin (Spheniscus demersus), the Rock pigeon isolate, fowlpox virus, 
canary-pox virus- and parrotprjx virus (DNA from the pe;lguin and parrot poxviruses was also 
kindly supplied by Mrs D. Marais, Department of Medical Microbiology, UCT). The digests 
were run on a 0,8 % agarose gel in a Hoefer Super Sub electrophoresis tank using the 
following FIGE parameters: 
Prerun: 
Run 
130 V, 12 °C, 15 min. 
130 V, 12 °C, 12 hours 
F = 1.0 sec, R = 0.3 sec, r = 1.0 
The gel was stained, viewed and photographed as described (7 .2.1.2). 
A pigeonpox virus vaccine, produced locally from a naturally occuring strain (Jordaan), was 
obtained from Onderstepoort Veterinary Institute (Erasmus et al., 1988). DNA was 
extracted from purified virions and was digested with Eco RI. This digest was then run on a 
medium-sized 0,8 % agciJose; ge! u•·.der non-pulsed electrophoretic conditions, along with an 
Eco RI digest of the Rock pigeon isolate. The gel was run in IX Tris-acetate-EDTA buffer 
as follows: 
Run: 40 V, 34 rnA, 16 hours, 25 °C. 




10.3.1 Characterisation of the virus isolated from a Rock pigeon: 
Chicken CAMs infected with the Rock pigeon virus produced macroscopic pocks within 
three days post-infection (Fig 10.1 ). The white appearance of the pocks suggests that they 
are not haemorrhagic. 
Electron microphotographs of the Rock pigeon vtrus purified from the CAMs of 
embryonated .chicken eggs (Fig. 10.2, A to C) revealed the presence of brick-shaped 
particles with characteristic poxvirus morphology. A number of these particles are apparent 
in Fig. 10.2 C. The particles are separated by large quantities of collagen, probably derived 
from the CAMs. Higher magnification reveals finer ultrastructural detail (Fig. I 0.2 A and B). 
The outer surface of the particles displays ridges which resemble surface tubular elements. 
FIGURE 10.1 
Macroscopic pocks produced on the CAMs of embryonated chicken eggs infected 






Electron micrographs of the poxvirus-like particles isolated from CAMs infected 
with the Rock pigeon virus. (A and B X 150 000, and C X 35 000). (Photographs 
kindly supplied by Dr L.M. Stannard, Department of Medical Microbiology, UCT) 
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10.3.2 Restriction endonuclease analysis of avipoxviruses: 
Eco RI and Bam m restriction endonuclease digests of fowlpox, canarypox and the Rock 
pigeon virus DNA w~re ~eparated r ::1 <>- P agarose gel using FIGE (F'ig 10.3). Both H'J/11 HI 
and Eco RI digests of Rock pigeon virus DNA (lanes 1 and 5 respectively) revealed a 
distinctly different number and distribution of bands to Bam Ill and Eco RI digests of either 
fowlpox virus (lanes 2 and 6) or canarypox virus (lanes 3 and 7) DNA. 
In contrast, when Eco RI digests of the local vaccine strain (Jordaan) of pigeonpox virus 
and the Rock pigeon virus, were separated on an agarose gel using conventional 
electrophoresis, most, if not all, the fragments co-migrated (Fig 1 0.4). 
Pst I restriction digests of the DNA from well-characterised avipoxviruses (fowlpox virus 
and canarypox virus) were compared with digested DNA from local isolates (penguinpox 
virus, dovepox virus and Rock pigeon virus) and from imported parrotpox virus. The use of 
FIGE to separate the restriction fragments (Fig. 10.5) showed that the Rock pigeon viral 
DNA (lane 2) differed from poxviruses isolated not only unrelated avian species [such as 
penguin (lane 4), fowl (lane 5), canary (lane 6) a,-,d parrot (lane?)] but also from more 
closely related species such as dove (lane 3). 





Agarose gel of restriction digests of Rock pigeon virus (lanes 1 and 5), fowlpox 
virus (lanes 2 and 6) and canarypox virus (lanes 3 and 7) DNA. Lane 1 = Rock 
pigeon Bam HI. Lane 2 = fowlpox Bam HI. Lane 3 = canarypox Bam HI. 
Lane 4 = empty. Lane 5 = Rock pigeon Eco RI. Lane 6 = fowlpox Eco RI. 
Lane 7 = canarypox Eco RI. Lane 8 = LarnbdaPst I marker. FIGE conditions: 
100 V, 19 hours, 14 OC, F = 450 msec, R = 150 msec, r = 0.1. 
130 




FIGURE 1 0.4. 
Agorose gel showing Eco RI digests of DNA from the Rock pigeon isolate and 
pigeonpox vaccine. Lane 1 = Lambda Pst 1 marker. Lane 2 = Rock pigeon, 
Lane 3 = pigeonpox vaccine. Non-pulsed gel electrophoresis on medium sized 
gel: 40 V, 30 rnA, 16 hours, 24 oc. 
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Agarose gel showing Pst I digests of DNA from various avipoxvirus isolates. 
Lane 1 = Lambda Pst I marker. Lane 2 = Rock pigeon. Lane 3 = Turtle 
dovepox. Lane 4 = penguinpox. Lane 5 = fowlpox. Lane 6 = canarypox. 
Lane 7 = parrotpox. FIGE conditions: 130 V, 12 OC, 12 hours, F = 1.0 sec, 




A pathogen extracted from lesions on the head and feet of a dead juvenile Rock pigeon 
(Columba guinea) was identified as a poxvirus by its ability to form characteristic pocks on 
the CAMs of infected eggs. The pocks resembleJ thv~~ prod~Jc~d by fowl pox virus ::md a 
vaccine strain (Jordaan) of pigeonpox virus (Kow, 1992; personal observation). Electron 
microscopy confirmed that the virus particles extracted from the CAMs had typical poxvirus 
morphology. They appeared as brick-shaped particles with tubular structures on their outer 
surface, and were similar in size and shape to other avipoxviruses (Holt and Krogsrud, 
1973). 
Analysis of the DNA extracted from these particles after restriction with site-specific 
endonucleases, showed that the restriction pattern profiles were distinct from patterns 
produced by other well-characterised avipoxviruses and also from local isolates of poxviruses 
from Jackass penguin and Turtle dove. Yet they were similar, if not identical, to patterns 
produced by DNA extracted from a local vaccine strain (Jordaan) ofpigeonpox virus. 
These results provide conclusive evidence that the Rock pigeon pathogen is a member of the 
Avipoxvints genus of the Poxviridae family and is closely related to a local vav.;~ne strain uf 
pigeonpox virus. Although the use of FIGE to compare the restriction patterns of the DNA 
of the pigeonpox virus isolates, might have yielded a more accurate comparison than 
conventional electrophoresis, time constraints prevented the preparation of more viral DNA. 
The origin of the Rock pigeon isolate is unclear. It is possible that pigeonpox virus is 
endemic in Rock pigeons and other southern African members of the Columbidae, but on the 
other hand its appearance in these indigenous species may be fairly recent due to 
introduction of the virus to southern Africa through birds imported from Europe and 
America. Another possibility is that the vaccine strain (Jordaan) of pigeonpox virus was 
transmitted to Rock pigeons and, although protective in racing pigeons (for which the 
vaccine was specifically developed), has proved to be pathogenic for Rock pigeons. The 
pathogenic nature of this virus is of concern as it has the potential to pose a serious threat to 
the populations of indigenous pigeons found throughout southern Africa. 
Of further interest is the degree of genomic diversity exhibited by avipoxviruses as evidenced 
by restri.ction pattern polymorphism of their genomic DNA Even resttiction patterns of 
closely related members of the same family (Rock pigeon and Turtle dove) were distinct. 
Although some avipoxviruses (such as fowlpox virus and pigeonpox virus) are able to cross-
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protect non-host avian species, other members are unable to do so, such as quailpox virus 
and parrotpox virus (as cited by Winterfield and Reed, 1985). These observations may relate 
to evolutionary ties between different avipoxviruses or to selective constraints imposed on 
the viruses by their avian hosts. Sequence analysis of shared genomic regions may prove a 






LSDV is a member of the Capripoxvirus genus of the Poxviridae family (Matthews, 1982). 
This genus consists of two other members, namely goatpox virus and sheeppox virus, and 
collectively they are economically the most important group of the poxviruses (Kitching et 
a/., 1989). They are responsible for causing severe stock losses of cattle, sheep and goats 
throughout Africa and parts of Asia. The use of restriction endonucleases to compare the 
genomes of capripoxviruses has revealed that members of this genus fall into one of five 
groups depending on their degree of host-specificity and geographic distribution (Gershon 
and Black, 1988). It has also been shown that capripoxviruses causing LSD in central Africa 
are genetically distinct from isolates occurring in southern Africa (Gershon and Black, 1988; 
Perlman, 1993). In addition, the southern African isolates of LSDV are extremely host-
specific as they have only been isolated from cattle, whereas Kenyan isolates appear to be 
able to infect sheep and possibly even goats (Weiss, 1968; Davies, 1981 ). 
Although sporadic outbreaks of capripoxvirus infections occur, effective and safe attenuated, 
live vaccines have been in use for a number of decades (Kitching, 1986 b). These vaccines 
have been useful in limiting the epidemic spread of capripoxviruses and yet their total 
eradication has been impossible due to their various modes of transmission, including insect 
transmission, and their probable long term maintenance in wild ungulates (Kitching and 
Mellor, 1986; Davies, 1982). With the recent advent of recombinant vaccines and the use 
of poxviruses as vector vehicles for these vaccines, capripoxviruses have been targeted for 
development as potential vectors as they are host-range restricted to natural infection in only 
sheep, goats or cattle, and the vaccine strains have proven to be effective and safe (Gershon 
et a/., 1989a; Erasmus, 1988). A recombinant capripoxvirus, KS-1, has already been 
developed and is reported to protect cattle against challenge with virulent Rift Valley fever 
virus (Romero, 1993). Present studies are concentrating on the development of a 
recombinant vector vaccine from the southern African vaccine strain of LSDV due to its 
greater degree of host-range restrictiveness. 
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There is evidence to suggest that genetic recombination between the genomes of two 
capripoxviruses led to the formation of a third virus (Gershon et a/., 1989 b). It would be 
dangerous to release a vaccine virus into the field if there was a chance that recombination 
could occur between the vaccine and a virulent virus strain. The result of such an event 
could be the formation of an altered vaccine displaying virulent properties. There is possibly 
an even greater risk of this event occurring with a recombinant vector vaccine which might 
have been made more unstable due to the insertion of foreign genes into its genome. Thus 
before a recombinant LSDV vaccine can be released into the field, it is necessary to obtain an 
indication of the degree of stability of the LSDV genome. This aim was achieved by 
comparing th~ genomes of virulent southern African field isolates, collected almost forty 
years ago, with the presently used vaccine strain of LSDV. These results would also give an 
indication of the mutational rate of the genomes and might provide a useful means for 
distinguishing virulent field isolates from the vaccine strain. However, the limiting levels of 
replication experienced with LSDV cultured under "standard" conditions (25 infectious 
particles per cell) necessitated the optimisation of virus culture and purification conditions 
before the genomes could be compared. 
It was realised at the outset of the project that an accurate method for titrating infectious 
. LSDV particles was unavailable. It was thus necessary to develop such a technique before 
commencing studies on viral replication and growth in cell culture. Evidence of viral 
replication was obtained by infecting a number of different types of cell with the vaccine 
strain of LSDV and then observing the cells for cytopathic effects. A continuous line of 
bovine kidney cells (NIDBK) was found to produce the most easily recognisable cytopathic 
effects. The nature of the CPE in MDBK cells was quite distinct from infected primary 
bovine kidney cells. It is possible that the transformation of the MDBK cells to produce a 
continuous line results in major changes in the manner in which the cells react to viral 
infection stemming from possible genetic changes. An indirect immunoperoxidase staining 
technique was used to confirm that the foci seen in infected MDBK cells were associated 
with virus particles. Although the use of this technique allowed the detection of viral 
antigen within 24 hours post-infection, it was not considered for use in titrating infectious 
LSDV as it was extremely time consuming. A 10-fold dilution of a stock of LSDV, plated 
onto MDBK cells and left to incubate at 3 7 °C for two to three days, yielded discrete foci 
which could then be counted. Optimal titration conditions were obtained with the use of a 
grid overlay and the culture medium removed to expose the entire cell sheet. 
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The vaccine strain of LSDV was found to replicate more efficiently in primary cultures of 
foetal bovine or ovine tissue than in any other cell type tested. These results are in agreement 
with the host-range restrictiveness of southern African isolates of LSDV (Weiss, 1968). 
Low levels of replication were, however, obtained in chicken embryo fibroblasts and on the 
CAMs of embryonated hens' eggs. Although a 2 log increase in virus yield was obtained per 
egg CAM inoculated, increasing the concentration of viral inoculum failed to result in an 
appreciable increase in the amount of recoverable virus (results not shown). It is thus 
possible that the CAMs are only able to support a limited amount of LSDV replication and 
that once this limit is obtained, further replication is inhibited via the embryo's immune 
system. The .ability of LSDV to replicate in avian cells and not in most mammalian cells 
raises interesting questions as to the evolution of this virus. Vaccinia virus is also able to 
replicate in avian cells and is less host-range restrictive than LSDV (Joklik, 1962). The 
genome of vaccinia virus is much larger than LSDV and it is possible that the larger vaccinia 
virus genome contains genes necessary for replication in a wider range of animal cells, as 
well as genes responsible for eluding the host's immune system. 
Temperature was also found to affect LSDV replication. Lower temperatures than the 
standard 37 °C used to incubate culture cells were found to favour LSDV replication. LSDV 
infection is most commonly associated with the formation of nodules and ulcers on the skin, 
surface areas of respiratory tracts and the reproductive organs and it is thus probable that the 
average temperature of these organs is lower than the rest of the body (Weiss, 1968). It 
would be of interest to determine whether the LSDV enzymes associated with replication, 
transcription and translation have an optimal activity below 37 °C. 
Different types of culture media affected LSDV replication. The optimal culture medium, 
DMEM mixed 1:1 with Ham's F-12, contained more amino acids, vitamins, trace elements 
and organic chemicals than any of the other media tested, suggesting that the virus requires 
a wide range of organic and inorganic chemicals for optimal replication in cell culture. 
The best culture conditions for LSDV replication were obtained when foetal bovine testes 
cells were infected, and the DMEM plus Ham's F-12 culture medium was used. Under these 
conditions, 70 infectious LSDV particles were recoverable per cell. The recovery of viral 
DNA was optimised when the intracellular source was harvested as it was shown under 
"standard" culture conditions that almost 98% of infectious particles remained intracellular. 
A non-ionic detergent (Triton X-100) and reducing agent (13-mercaptoethanol) proved 
instrumental in releasing this additional source of viral DNA from infected cells. A fair 
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percentage of viral DNA was lost in the cellular debris fraction and it is possible that the 
development of better purification techniques might facilitate the recovery of this DNA. Of 
the viral lysis buffers tested, the buffer containing the highest percentage B-mercaptoethanol 
proved the most effective as the use of this buffer resulted in the recovery of viral DNA 
practically free of contaminating cellular DNA. 
Once conditions for the culture of LSDV and recovery of a high quality and quantity of 
DNA had been improved, it was possible to prepare large amounts of DNA required for 
restriction endonuclease analysis of the five LSDV isolates. The genomes of the four field 
isolates and v.accine strain were restricted with Pst I, Hin dill, Bam HI and Eco RI. The 
restriction patterns produced using FIGE were practically the same for all the isolates, except 
for some of their terminal regions. The terminal fragment polymorphisms allowed the 
isolates to be divided into three groups: the first group comprising the Maputo and Neethling 
isolates, the second group the Haden and vaccine isolates and finally the third group 
comprising just the Gaborone isolate. No feasible explanation can be offered as to why the 
vaccine and Haden isolates are more similar to each other than either is to the Neethling 
isolate from which the vaccine was derived. It is possible that during the development of the 
vaccine, the Haden isolate, and not the Neethling isolate, was used for the production of the 
vaccme. 
It thus appears that the southern African isolates of LSDV used in this study are extremely 
stable, and share a high degree of genomic conservation, as they yield almost identical 
restriction pattern profiles. Furthermore, they do not appear to recombine with other isolates 
or within their own genomes as evidenced by the fact that none of the isolates contained a 
mixture of different sized terminal fragments. These results are important for prospects on 
the development of genetically engineered LSDV recombinants as it suggests that it would 
be relatively safe to release these into the field without the risk of reversion to virulence. 
Although homologous recombination has been used to create recombinant vector vaccines, in 
vitro ligation has been shown to yield a higher percentage of recombinants (Merchlinsky and 
Moss, 1992). This technique makes use of rare or unique restriction sites for the insertion of 
foreign genes. Two such sites were mapped within the LSDV vaccine genome. The Sma I 
site has been mapped within the essential ribonucleotide reductase gene, whereas the Apa I 
site is located near one of the terminal regions. As the terminal regions generally contain 
"host-range" genes, it is possible that the Apa I site might prove useful as a cloning site (as 
cited by Gershon and Black, 1988). The vaccine strain also lacked Not I, Nar I and Ksp I 
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restriction sites and, if necessary, it would be possible to create any one of these sites in a 
non-essential region of the genome using site-directed mutagenesis. 
In summary, it was possible to improve the culture conditions of southern African field 
isolates and the vaccine strain of LSDV once its growth, using standard culture conditions 
and an accurate infectivity assay, had been established. Restriction digestion analysis of the 
viral genomes indicated that they were highly conserved and extremely stable making the . 
vaccine strain an excellent candidate for development as a recombinant vector vaccine. This 
prospect was enhanced by the identification and mapping of unique restriction sites, one of 
which might prove useful for the insertion of foreign genes. 
11.2 Avipoxviruses: 
Avipoxviruses are also economically important and are known to cause diseases in a large 
number of avian species (as cited by Winterfield and Reed, 1985). They have been targeted 
for use as recombinant vector vaccines due to their ability to express early gene products in 
mammalian cells, even though they are restricted to avian cells for complete replication and 
production of progeny virions (Taylor et a/., 1988). They are also more host-specific than 
viruses such as vaccinia virus, making them attractive candidates as recombinant vaccines. 
A knowledge of the genomic diversity and stability of avipoxviruses is also important for 
similar reasons to those described for LSDV. Comparisons were made of southern African 
isolates of avipoxviruses with well-characterised isolates from canaries and fowl. The 
isolation and ·characterisation of an avipoxvirus from a Rock pigeon presented an almost 
identical restriction pattern profile to that of a local vaccine strain of pigeonpox virus. 
However, when compared with other avipoxviruses, even with a closely related Turtle 
dovepox virus isolate, the restriction profiles produced were extremely different, indicating a 
low degree of sequence homology. These results indicate that avian poxviruses have 
evolved independently from each other and have shared a long and close evolutionary tie with 
their avian hosts. Although there are reports of close serological ties between various 
avipoxviruses, they are also reported to be extremely host-specific (Tripathy et a/., 1973; 
Kirmse, 1969). These reports of host-specificity are supported by the high degree of 
genome diversity as evidenced by the widely different restriction profiles. 
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The isolation and characterisation of avipoxviruses from a number of birds of the same 
species, such as Rock pigeons, would prove instrumental in determining the exact extent to 
which the virus is related to its host and would give an indication of the degree of sequence 
diversity of viruses isolated from the same host species. These results might then prove 
useful for determining the likelihood of natural recombination occurring between different 
avipoxviruses. Even though avipox:viruses undergo an abortive infection in mammalian cells, 
and there are no reports yet of any avipox:viruses able to replicate in mammalian cells, it is 




APPENDIX 1 CHEMICAL SOLUTIONS 
All chemicals, unless otherwise indicated were obtained from BDH (Poole, England). 
A. CHEMICAL SOLUTIONS USED FOR CELL CULTURE: 
These solutions were either prepared according to the manufacture's instructions or were 
adapted from recipes provided in Paul (1972). 
CELL CULTURE MEDIA : 
Foetal calf serum (FCS) was first heat inactivated before being added to culture media: 
A bottle of FCS (Delta Bioproducts, South Afiica) was thawed at room temperature and 
placed at 56 oc for precisely 30 min. The FCS was dispensed into 50 ml and 20 ml amounts 
after filtering through a 0,2 llm filter and was then refrozen at -20°C. 
DMEM .1 0% FCS : 
400 ml Dulbecco's Minimum Essential Medium (DMEM) (Highveld Biological, S.A.) 
50 ml FCS 
2.5 ml PG or PS solution 
32 ml of 5% bicarbonate of soda. 
A 1 0 % FCS concentration was used for early growth of cells in culture. 
DMEM .4 % FCS: 
450 mlDMEM 
20 ml FCS 
2.5 ml PG or PS 
32 ml of 5% bicarbonate of soda. 
A 4 % FCS concentration was used for the maintenance of most types of culture cells. 
D:MEM. 2% FCS: 
450mlD:MEM 
10 ml FCS 
2.5 ml PG or PS 
32 ml of 5 % bicarbonate of soda. 
A 2 % FCS concentration was used for the maintenance of rapidly dividing culture cells. 
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The following media were prepared in similar concentrations of FCS and antibiotic to those 
described above : 
Eagle's Minimum Essential Medium (MEM) (consisting of essential amino acids and 
vitamins), Basal Eagle's Medium (BEM) (consisting of lower concentrations of amino acids 
than :MEM) and a I: I combination of D:MEM (consisting of higher concentrations of, and 
additional, amino acids and vitamins than :MEM) and Ham's FI2 medium (HAM's F12) 
(consisting of higher concentrations of, and additional, amino acids and vitamins than MEM, 
as well as the addition of inorganic salts and cellular organic biochemicals) 
NOTE : Bicarbonate of soda was added to the above media according to the manufacture's 
instructions. 
PHOSPHATE BUFFERED SALINE : 
NaCl 8,00 g 
KCI 0,20 g 
KH2P04 0,12 g 
Na2HP04 (anhydrous) 0,91 g 
or Na2HP04.2H20 1,14 g 
or Na2HP04.I2H20 2,28 g 
Chemicals were dissolved in 800 ml of distilled water and made up to 1 I with distilled 
water. The pH was adjusted to 7,5. The solution was filter sterilized and dispensed into 100 
ml and 500 ml aliquots. 
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PHYSIOLOGICAL SALINE 
NaCI (8.5g) was dissolved in 800 ml of distilled water. The solution was made up to 1 I with 
d~stilled water, dispensed in 1 00 ml amounts and autoclaved at 1 04 kPa at 121 oc for 15 min 
to sterilize. 
0,4% PHENOL RED : 
Phenol Red (Gurr's, London) powder (0.4g) was dissolved in 60 ml of 0,05 N NaOH with 
the use of gentle heating. Once cooled to room temperature, the solution was made up to 
100 ml in distilled water. It was then filter sterilized, dispensed in 20 ml amounts and.stored 
at 4°C. 
PENICILLIN - STREPTOMYCIN (PS) 
Penicillin (Novopen, Novo Nordisk (PTY) LTD, South Africa) (5 x 106 units) was dissolved 
in 20 ml of physiological saline. Streptomycin (Novostrep, Novo Nordisk (PTY) LTD, 
South Africa) (5.0g) was added and the volume was adjusted ~0 !00 ml with physiological 
saline. 2,0 ml of 1 M HEPES (Sigma, USA) cl.d1er (pH 7,3) ~.nd 0,6 ml of0,4% phenol red 
were added and the pH was adjusted to 7,3 with 1 N NaOH. The final volume was made up 
to 125 ml with physiological saline. The antibiotic solution was filter sterilized, dispensed in 
2,5 ml amounts and stored at -20 °C. For use, 0.5 ml was added to 100 ml of culture 
medium (i.e. at a concentration of 100 J.lg/ml). 
PENICILLIN- GENTAMYCIN (PG) 
Penicillin (Novopen, Novo Nordisk (PTY) LTD, South Africa) (1 X 106 units) was dissolved 
in 25 ml ofGentamycin (Fermentmycin, Lennon LTD, South Africa). The solution was filter 
sterilized, dispensed in 2,5 ml amounts and stored at -20 oc. For use, 0.5 ml was added to 
100 ml of culture medium (i.e. at a concentration of 100 J.lg/ml). 
NOTE: Fermentmycin was found to be toxic for all primary and secondary culture cells such 




One vial ofFungizone (50 mg) (Fungizone Intravenous, Squibb Laboratories (PTY) Limited, 
lsando, South Afiica) was reconstituted in 1 ml of distilled H20. The solution was then 
removed from the vial and adjusted to a final volume of 200 ml with distilled H20. The 
Fungizone was filtered through a 0.2 J.lm filter, dispensed in 5 ml amounts and stored at -
20°C. The Fungizone was used at a final concentration of 2.5 J.lg/ml. 













The above chemicals were dissolved in 700 mls of distilled water. EDTA (2.0g), dissolved 
in 100 ml of distilled water, was added to the above solution. Phenol red (25 ml of a 0.4% 
stock) was then added and the solution was stirred, while adjusting the pH to 7.8 with 1 N 
NaOH, until a clear red colouration was obtained. The final volume was adjusted to 1 l 
with distilled water. The trypsin base was filtered through a 0.2 )..lm filter and was dispensed 
in 20 ml aliquots. It was stored at -20°C. 
5% TRYPSIN STOCK SOLUTION : 
Trypsin base (10 ml) and 0.5 ml of PS or PG was added to 90 ml of distilled H20. HCl (1.0 
N) was added dropwise until the solution turned bright yellow. This solution was then heated 
to 37°C for a few minutes in a beaker. Trypsin (Difco Laboratories, U.S.A.) powder (5.0g) 
was carefully sprinkled onto the surface of the yellow solution making sure that no lumps 
were formed. This was done slowly and without stirring. Once all the trypsin had been 
added, it was left to dissolve by either letting it stand at room temperature for a few hours or 
by leaving it overnight at 4°C. Once most of the trypsin had dissolved, it was filtered through 
a 0.2 )..lm filter, dispensed in 1 ml amounts into Bijou bottles and stored at -20°C. 
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ACTIVATED TRYPSIN VERSENE (A TV): 
A 0.05 % solution of trypsin was used for mild digestion of cells in order to remove them 
from culture flasks for cell passage or for virus isolation. The working solution of trypsin 
was prepared using sterile technique as follows: 
10 m1 of trypsin base was thawed and was added to 90 m1 of sterile distilled H20. PG or 
PS (0.5 ml) and I ml of 5% trypsin stock was added and the solution was stored at 4 oc. 
5% BICARBONATE OF SODA : 
NaHC03 (IOOg) was dissolved in 1.5 I of distilled H20. Phenol red (2 ml of 0.4% stock) 
was added. and the volume was made up to 2 I using distilled H20. Dry ice was then added 
to a 2 I conical flask. The neck of the flask was partially closed using a rubber stopper which < 
had a silicon tube running through it. The other end of the tube was placed in the bicarbonate 
solution and the C02 released by the dry ice was allowed to bubble through the solution until 
it became a pale pink colour. The solution was then filtered through a 0.2 11m filter and was 
dispensed into Bijou or Universal bottles filled to the brim. The bottles were stored at 4 oc. 
B. GENERAL CHEMICAL SOLUTIONS: 
MciLVAIN'S BUFFER: 
Solution A: 0.1 M citric acid (Merck, Germany) 
Solution A (I. 83 ml) a:nd 18,17 ml of solution B was added to 800 ml of distilled H20 
(Lennette and Schmidt, I969). The pH of the mixture was adjusted to 7.4 using solutions A 
and B (A= acid and B =base). The buffer was made up to a final volume of I I using 
distilled H20. It was then autoclaved at 104 kPa at 121 °C for 10 min and stored at 4 °C. 
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DILUENT: 
HEPES buffer (Sigma, USA) (1 ml of a 1M stock) was added per 100 ml of DMEM and 
the pH was adjusted to 7.4 with 1 N NaOH (Williamson, 1968). The solution was then 
filtered through a 0.2 r~m filter and stored at 4°C. 
VIRUS LYSIS BUFFER C: 
Solution A : 4 % Na-n-laurylsarcosinate (Sarkosyl) 
54% sucrose 
.· --·. 
Solution B : 200 mM B-mercaptoethanol (Merck, Germany) (wrapped in aluminium-foil) 
Both solution A and B were made in 100 mM Tris (pH 7.8) (Massung and Moyer, 1991). 
Solution A was autoclaved at 69 kPa at 115 oc for 10 min and both solutions were stored at 
4°C. 
STOP/LOADING BUFFER (X6) 
0.25% Bromophenol Blue (Merck, Germany) 
0.25% Xylene Cyanol (Merck, Germany) 
40% (w/v) sucrose (dissolved in distilled H20) (Sambrook eta/., 1989) 
TRIS - EDTA BUFFER (TE, pH 9.0) 
EDTA (Boehringer Mannheim, Germany) (93.05g) was added to 400 ml of distilled H20 
(Sambrook et a/., 1989). The EDT A was dissolved in NaOH (Univar, Saarchem, South 
Africa) and the pH was adjusted to 9.0. The final volume was made up to 500 ml with 
distilled H20. Tris (Boehringer Mannheim, Germany) (12.01g) was then dissolved in 80 ml 
distilled H20. The pH was adjusted to 9.0 using HCl and the final volume was made up to 
100 ml with distilled H20. The 0. 5 M EDTA and 1 M Tris-Cl solutions were diluted 
together in distilled H20 (1 :500 and 1:100 respectively) to give a solution containing .I mM 
EDTA and 10 mM Tris-Cl (pH 9.0). 
ELECTROPHORESIS BUFFERS: 
1 OX Tris-Borate-EDT A buffer (TBE): 
108 g Tris (Boehringer Mannheim, Germany) 
55.0 g Boric acid (Merck, Germany) 
9.3 g EDTA 
These chemicals were mixed and made up to a final volume of 1 litre in distilled H20 
(Sambrook eta/., 1989). 
50 X Tris-Acetate-EDT A buffer (T AE): 
242 g Tris 
57.1 g Glacial acetic acid 
100 ml EDTA (0.5 M, pH 8.0) 
This solution was made up to 1 litre in distilled H20 (Sambrook eta/., 1989). 
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APPENDIX 2: PHOTOGRAPHY: 
a) Photographic images for laboratory records were made using a Video Copy Processor 
(Mitsubishi, Japan) linked to a Gel Band Amplifier (UVP Gel Band Amplifier 5000, UVP, 
U.S.A.). Gels were viewed on a Sony SSM-320CE Black and White Monitor (Sony, Japan) 
and images were recorded onto thermal paper (Mitsubishi, Japan). Gels which were . 
illustrated in this thesis (or for publication) were photographed with bottom illumination 
using a Mamiya M645 1000 S medium format camera (Mamiya, Japan). This camera was 
fitted with a Haze UV filter (Korea), CPC Red filter (Japan) and a Kenko Close-up no. 1 
ring (Japan) . .The camera was permanentley set at F5.6. Film used was Ilford FP4 or Ilford 
FP4 Plus (Ilford LTD, England) with exposure times of 60 seconds and 30 seconds 
respectively. 
b) Fluorescence microscopy: These samples were illuminated with UV light at a wavelength 
of 360 nm and photographed with a Wild MPS 51 S SPOT camera linked to an electronic 
exposure meter (Wild PHOTOAUTOMAT MPS 45, Wild, Switzerland) mounted on a Leitz 
SM- LUX (Leitz and Wetzlar, Germany) light microscope. Black and white 35 mm Ilford 
HP5 (400 ASA) film was used and the camera's "Normal field" light metering system with 
1 00 second exposure times. 
c) Photomicroscopy of stained cells: The same camera and microscope were used as for the 
fluorescence microscopy (above). Kodak Ektachrome 160 tungsten EPT 135-36 (Kodak, 
Eastman Kodak Company, U.S.A.) film was used and the camera's "Dark field" light 
metering system with the camera set for "automatic exposure". 
d) Cells in culture dishes: Cells were photographed using Kodak Ektachrome 160 tungsten 
EPT 135-36 film and an Olympus OM 101 camera mounted on an Olympus CK2 inverted 
microscope (Olympus, Japan). The camera's automatic exposure setting was used. 
e) Pocks on chicken CAM's were photographed with Kodak Ektachrome 160 tungsten 
EPT 135-36 film at F5.6 and a 1/60 second exposure time. A blue background was used 
with side and bottom illumination. The sample was raised 15 em above the base platform. 
NOTE: Black and white negatives were developed using IIford ID-11 developer according 
to the manufacture's instructions. Prints were made on IIford Multigrade Paper using Filter 
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no. 4.5. Colour slides were converted to prints by the Medical Graphics Department, Groote 
Schuur Hospital, Cape Town. 
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APPENDIX 3 DNA MARKERS 
Three DNA molecular weight markers were used for calculating the sizes of LSDV and 
avipoxvirus DNA fragments. The first two contained either Hin dill or Pst I restriction 
fragments of phage Lambda CI 857 Sam 7 (Boehringer Mannheim, Germany), and the other 
one contained a mixture of Hin dill restriction fragments and concatemers of Lambda DNA 
[(Low Range PFG Marker (BioLabs, New England, U.S.A.)]. The sizes of the DNA 
markers are indicated in Tables A, Band C below. The Lambda Pst I and Hin dill markers 
each contain an extra band that coincides with the top bands in each case. This is due to the 
presence of Lambda cos sites which link two of the restriction fragments causing them to 
migrate slower than single fragments. Only sizes for single fragments are indicated below: 
TABLE A: Sizes of Lambda DNA Pst I fragments 
Fragment Size Fragment Size Fragment Size 
no. (kbp) no. (kbp) no. (kbp) 
1 11.5 11 1.7 21 0.22 
2 5.1 12 1.2 22 0.21 
3 4.8 13 1.1 23 0.20 
4 4.5 14 0.8 24 0.16 
5 2.8 15 0.5 25 0.15 
6 2.6 16 0.47 26 0.09 
7 2.5 17 0.45 27 0.09 
8 2.4 18 0.34 28 0.07 
9 2.1 19 0.27 29 0.02 
10 2.0 20 0.25 
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TABLE C: Sizes of Low Range PFG marker DNA. 
Fragment Size Fragment Size 
no. (kbp) no. (kbp) 
1 194.0 7 6.5 
2 145.5 8 4.3 
3 97.0 9 2.3 
4 48.5 10 2.0 
5 23.1 11 0.5 
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